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Abstract
The ERCC1/XPF complex is responsible for incision at the 5' side of the DNA lesion
during nucleotide excision repair and is also involved in homologous recombination
and inter-strand cross-link repair. The aim of the current study was to set up a better
model for examination ofErccl deficiency in the liver and to determine the DNA
lesions responsible. Initially, we used the Cre/lox system with the floxed Erccl gene
and a tamoxifen- inducible liver- specific Cre transgene. However, only low and
irreproducible levels of recombination were detected in vivo or in vitro with no
consistent biological effects. We therefore switched to a cell culture approach using
the loxP system and an AdenoCre virus. AdenoCre infection of hepatocyte cultures
led to high levels of recombination with no ERCC1 protein remaining at 48 hours
after infection. Flow cytometry failed to show high levels ofpolyploidy in knockout
hepatocytes 1 week after infection. This differed from the premature polyploidy seen
in this study in Erccl- deficient livers. We used AdenoCre to reduce ERCC1 levels
in adult liver in vivo. Low levels of recombination resulted in increased ploidy,
indicating that polyploidisation may be a protective mechanism triggered by
increased levels ofDNA damage in Erccl- deficient liver. Erccl- deficient
hepatocytes in vitro underwent higher levels of spontaneous, UV- and oxidative
damage- induced apoptosis than control cultures, implying that Erccl is essential for
liver maintenance. Lipid accumulation was observed in older Erccl- deficient
hepatocyte cultures, one week after AdenoCre infection in vivo and also in young
Erccl- deficient and wild type livers. Lipids disappeared in the wild type controls
with age, but persisted in Erccl Null livers. These findings suggest that a reduced
ability to repair oxidative DNA damage and a malfunction of oxidative pathways
could be responsible for the Erccl- deficient liver phenotype. Regeneration of liver
following exposure to carbon tetrachloride in AdenoCre infected livers led to an
increase in ploidy and S-phase independent of genotype, masking the increased
ploidy resulting from AdenoCre induced Erccl deficiency. Livers from simple Erccl
knockout mice showed no increase in malondialdehyde adducts. However, higher
levels of reactive oxygen species were detected in young Erccl- deficient livers
compared to controls. RT Real- time PCR was used to determine differences in
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expression of cell cycle regulation and survival genes between Erccl- deficient and
control livers. We succeeded in characterising Erccl deficiency in the liver further.
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DNA damage is one of the major causes of genome instability, mutation and
carcinogenesis as well as ageing. Hydrolysis, oxidation and non- enzymatic
methylation ofDNA can be detected in vivo with 2,000-10,000 purine bases being
subject to hydrolytic depurination in each human cell per day (Lindahl 1993). In
order to deal with the various types ofDNA damage and to ensure integrity of the
organism, several pathways have evolved to protect the cell. Mismatch repair
(MMR) is one of these pathways, dealing with unpaired and mispaired bases in the
DNA (Marti et al. 2002). Another pathway is known as base excision repair (BER).
It is involved in repair of smaller base modifications generated endogenously through
hydrolysis or reactive oxygen species (Klungland et al. 1999a). More severe damage,
caused by UV irradiation, psoralens, cross-linking agents and free radicals is dealt
with by nucleotide excision repair (NER) (Sancar 1996). Homologous recombination
(HR) dependent repair and non- homologous end joining (NHEJ) both repair double-
strand breaks (DSB) produced during recombination events and by ionising
radiation. In HR the homologous sister chromatid is used as a template. In contrast,
NHEJ requires no such extensive homology (Sargent et al. 1997). Translesion bypass
is a mechanism that allows the bypass of unrepaired DNA lesions by specific
polymerases that lack a proof- reading capacity, helping to prevent a collapse of the
replication fork during S- phase (Larsen et al. 2005).
In order to be able to extend the knowledge about human disorders involving defects
in one of the repair pathways, investigations in lower organisms such as Escherichia
coli (E. coli), Saccharomyces cerevisiae (S. cerevisiae) and mammalian cultured
cells have been made. In addition, mouse models have been created using gene
targeting as one of the major tools.
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1.2 MMR
MMR pathways in E. coli, S. cerevisiae and humans have been described, with the
methyl-directed MutHLS pathway of E. coli being the best-characterised (Marti et al.
2002). In this pathway, mismatches arising from replication errors, spontaneous or
induced base modifications or during recombination, are recognised and repaired.
Damage recognition takes place through MutS activation and formation of a
repairosome consisting ofMutS, MutH and MutL. The repairosome is responsible
for excision at the mismatched site and seems to load helicase II onto the damaged
DNA. The unwound DNA strand is then degraded by several factors including ExoX
and Exol, and eventually repaired by polymerase III and DNA ligase using the intact
single stranded counterpart as a template (Marti et al. 2002).
Key proteins in MMR are highly conserved from bacteria to mammals and multiple
homologues ofMutS and MutL have been described in yeast and mammals
(Buermeyer et al. 1999). Six MutS homologs have been identified in eukaryotes
named MSH1-6, as well as MLH1-3, PMS1 and PMS2 showing homology to
prokaryotic MutL (Prolla 1998). A model for the early steps of human DNA MMR
has been proposed with the MSH2/MSH6 heterodimer initiating the repair process.
The heterodimer binds to DNA mismatches and small insertion or deletion loops
spanning 1-2 bp (Prolla 1998). Alternatively, MSH2 can form a complex with MSH3
and recognise 2-5 bp long insertion or deletion loops (Buermeyer et al. 1999). The
initial step is then followed by ATP hydrolysis leading to a conformational change of
either heterodimer, allowing the MLH1/PMS2 complex to bind to the lesion. A
possible role in recruitment of other proteins and strand discrimination has been
suggested for the eukaryotic MutS/MutL complexes (Buermeyer et al. 1999).
Excision and re-synthesis of the damaged strand follows, involving EXOI/HEXI,
DNA polymerases 5 and s as well as PCNA and RPA. The DNA ligase that
completes the repair remains to be identified (Buermeyer et al. 1999).
Associations with mutations in MMR genes and human cancer have been made,
especially with colon cancers from families with hereditary non- polyposis colon
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cancer (HNPCC). HNPCC is an autosomal dominant, highly penetrant cancer
characterised by early onset of colon carcinomas and cancers of the endometrium,
stomach, upper urinary tract, small intestine and ovary after the fourth decade of life
(Prolla 1998). Mutations in MSH2, MSH6, MLH1, PMS1 and PMS2 have been
linked to HNPCC with MSH2 and MLH1 being the most frequently mutated factors
in HNPCC patients (Buermeyer et al. 1999). Affected family members usually
inherit one defective allele of the gene involved with an additional somatic mutation
in the other gene being necessary for cancer to occur.
1.3 BER
BER mechanisms are highly conserved in evolution and help to maintain the DNA
integrity. They evolved to deal with small base alterations that do not distort the
DNA helix. Defects in key activities are lethal at an embryonic state (Klungland et
al. 1999a). BER requires several distinct steps including a DNA glycosylase which
releases the damaged base by cleaving the bond that connects the base to the
deoxyribose (Klungland et al. 1999a). Different glycosylases deal with different
types of damage (Krokan et al. 2000), leaving an abasic site (AP). This abasic site is
then cleaved by hydrolytic AP endonucleases such as APE1 (= REF1) in mammalian
cells resulting in a 5'- terminal abasic residue (Demple and Sung 2005). In short
patch repair, dRp lyase, located in the N- terminal domain of mammalian polymerase
(3, excises this abasic residue and repair of the gap is undertaken by DNA polymerase
P and others, replacing one single nucleotide. DNA ligation is then carried out. In
contrast, two to eight nucleotides are replaced during long patch repair, where flap
endonuclease I (FEN 1) excises the displaced flap. DNA ligase I or DNA ligase III in
complex with XRCC1 finish the repair process (Demple and Sung 2005).
Although different enzymes and proteins central to BER and NER are used during
the actual repair process, some functional overlaps, especially concerning the
involvement ofXPG in oxidative damage repair, have been reported (Klungland et
al. 1999a). XPG is a structure specific endonuclease being responsible for the
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cleavage of the 3' end of different types of lesions in NER. However, BER is the
main repair pathway dealing with oxidatively damaged DNA bases. Typically, the
DNA glycosylase-AP lyase hNTHl performs the initial excision of the lesion with
XPG facilitating the binding of hNthl to the DNA substrate (Klungland et al. 1999a).
Thus, XPG seems to be involved in both repair mechanisms carrying out different
functions. Another example of functional overlap of the two systems is provided
through studies ofOGG1 DNA glycosylase. This glycosylase recognises the most
frequent oxidative base lesion named 8- oxo-guanine (8-oxo-G) which is normally
dealt with by BER (Klungland et al. 1999b). A report on Oggl deficient mice reveals
that these animals are viable but do not show any excision of the 8-oxo-G by an
alternative glycosylase in cell free tissue extracts. However, in an Oggl Null cell
line, slow repair could nevertheless be detected, indicating a possible role for NER as
an alternative system for repair of 8-oxo-G (Klungland et al. 1999b).
1.4 NER: global and transcription coupled repair
Dealing with many different kinds ofDNA damage that occur in the form of bulky
adducts, NER is one of the most flexible of all DNA repair mechanisms with similar
principles in prokaryotes and eukaryotes (de Boer and Hoeijmakers 2000). After
damage recognition, a dual incision is made at the damaged site to remove an
oligonucleotide containing the lesion (Figure 0). Gap-filling repair follows by using
the intact strand as a template (Sancar 1996). Two sub- pathways ofNER have
evolved with global genome nucleotide excision repair (GG- NER) removing lesions
throughout the genome and transcription coupled nucleotide excision repair (TC-
NER) ensuring a fast repair of lesions located on the transcribed strand of actively
transcribed genes (Gillet and Scharer 2006). As structurally different types ofDNA
damage is repaired by NER, the system may not recognise the lesion per se, but an






D) repair and ligation
C) excision
Figure 0: Global genome (GG) and transcription coupled (TC) nucleotide excision repair
(NER) in vitro. A) Damage recognition. In GG- NER damage recognition occurs upon binding
of XPC in complex with HHR23B. In TC- NER, stalled RNA polymerase (RNA pol) II in
complex with CSA and CSB recognises DNA damage. In both pathways, other NER factors
are then recruited to the site of the lesion, possibly with the involvement of XPE. B) DNA
unwinding. In both pathways, transcription initiation factor IIH (TFIIH), consisting often
subunits including XPB and XPD, and RPA protein are recruited to the complex to unwind
the DNA around the lesion. XPA, RPA and XPG then help to form a pre- incision complex
around the lesion. C) Excision. Upon recruitment of ERCC1/XPF complex to the damaged
site, 3' incision is performed by XPG followed by 5' incision which is catalysed by the
ERCC1/XPF complex. D) Repair and ligation. Immediate repair around the excision site
might be initiated by the 5' incision through ERCC1/XPF. RPA, RFC, PCNA and DNA
polymerases 8 and e are likely to carry out the gap- filling process. DNA ligase I completes
the repair process. DNA strands are symbolised by black lines. DNA lesions are marked as
black triangles.
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Although the main features are evolutionarily conserved from bacteria to man, NER
in eukaryotes involves around 20-30 proteins compared to prokaryotic NER which
employs only three proteins. In general, a convergent evolutionary event seems to be
represented in prokaryotic and eukaryotic NER with proteins sharing little structural
homology but functional similarities (de Boer and Hoeijmakers 2000).
NER has been extensively studied in E. coli revealing some of the basic mechanisms.
E. coli excision nuclease consists of three subunits: UvrA, UvrB and UvrC. The
UvrA2UvrB complex tracking along the DNA performs the damage recognition step
(Sancar 1996). In the event ofDNA damage the rather unspecific binding of the
complex to the DNA changes to a more specific binding. This first step involves
unwinding of the DNA by UvrB followed by a conformational change of the protein.
The conformational change ofUvrB leads to the formation of an intimate complex
between UvrB and the DNA (Sancar 1996). Dissociation ofUvrA is then essential
for dual incision by UvrB and UvrC. UvrB recruits UvrC to the damaged site as well
as being responsible for the 3' incision of the single stranded DNA lesion. The 5'
incision is made by UvrC releasing a 12-13 nucleotide oligomer. The final repair
process is then initiated by binding of helicase II. After dissociation ofUvrC, the 3'-
OH at the 5' site is revealed and becomes accessible for polymerase I to fill in the
gap and displace UvrB (Sancar 1996).
Studies in human NER have contributed to crucial understanding of global NER. In
vitro, the damage recognition step initially involves the XPC/ HHR23B complex to
recruit the whole repair machinery to the lesion (Gillet and Scharer 2006). XPE then
arrives at the damaged site and is thought to be involved in verification of the lesion.
XPC/ 1THR23B complex recruits TFIIH which opens the helix locally (Gillet and
Scharer 2006). This process is ATP dependent. TFIIE1 is a protein complex
consisting of ten subunits, including XPB and XPD helicases. If XPD encounters a
chemical modification ofDNA during NER, the TFIIE1 complex stalls at the site of
the lesion and signals for further assembly of other factors (Gillet and Scharer 2006).
TFIIH plays a role in NER as well as in transcription, and is required for local
unwinding of the DNA helix and the transcription initiation ofRNA polymerase II at
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the promoter (de Boer and Hoeijmakers 2000). Once the DNA is accessible, XPA,
RPA and XPG are recruited to the XPC-HR23B/TFIIH/DNA intermediate platform
and, upon protein to protein interaction, a stable pre- incision complex is formed,
leading to XPC- HR23B being expelled (Gillet and Scharer 2006). RPA helps to load
the ERCC1/XPF complex onto the damaged DNA site. The 3' incision is then carried
out by XPG followed by the 5' incision made by ERCC1/XPF. In addition, the
creation of a free 3'- hydroxyl end after ERCC1/XPF incision is thought to
immediately initiate repair. Excision of the 24-32 nucleotide oligomer containing the
lesion is followed by gap-filling carried out by RPA, RFC, PCNA and DNA
polymerase 5 and 8. DNA ligase I completes the final repair step (de Boer and
Hoeijmakers 2000). In general, a multitude ofweak protein protein interactions
rather than a strong interaction between some factors only is crucial to ensure smooth
transition during NER.
In vivo GG- NER is thought to require additional steps as chromatin remodelling is
essential to access the site of the lesion. XPE (= DDB), a UV- damaged DNA
binding factor, seems to be a central player in chromatin remodelling during NER
with its strong affinity for UV- damaged DNA and its association with known factors
involved in chromatin remodelling (Gillet and Scharer 2006). The re- assembly of
chromatin after NER is thought to be mediated by the histone chaperone CAF-1
which seems to be recruited by PCNA after the repair is completed.
Although global genome NER takes place in a general manner, there is preferential
repair carried out during transcription. This is not only true for eukaryotes but has
also been detected in procaryotic cells (Sancar 1996). Transcription-coupled NER is
essentially the same as global genome NER apart from the recognition step. On
encountering a DNA lesion during transcription, RNA polymerase II stalls and
signals the damage to the repair machinery. CSA and CSB are thought to help recruit
the NER machinery to the site ofDNA damage (Friedberg 2001). In order for the
repair proteins to associate with the DNA, RNA polymerase II must first dissociate
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from the site allowing the repair to take place.
In general, NER is carried out if bulky DNA damage is apparent in cells. TC-NER,
with a preference for the transcribed strand ofDNA, ensures that the transcription of
genes can be carried out correctly acting in a short-term manner. In contrast, global
NER repairs lesions in the overall genome more slowly, preventing mutations from
being passed on to the next generation and keeping the integrity of the genome
stable.
1.5 NER deficiencies in humans
NER deficiency in humans has been linked to several disorders with severe
phenotypes. Three rare recessive diseases with photosensitive syndromes can occur
from a defect in NER: Xeroderma pigmentosum (XP), Cockayne's syndrome (CS)
and Trichothiodystrophy (TTD).
1.5.1 Xeroderma pigmentosum (XP)
XP is associated with very high photosensitivity and 1000- fold increased risk for
skin cancer, as well as 10-to-20 fold higher risk for diverse internal cancers (Petit and
Sancar 1999). The most common skin cancers seen during the development of the
disease are basal cell carcinomas and squamous cell carcinomas with an average
onset age of around 8 years (de Boer and Hoeijmakers 2000). Other characteristics in
XP patients occur as ocular and neurological abnonnalities with a rate of 40% and
30-40% of the cases being affected respectively (Petit and Sancar 1999). Seven
complementation groups have been identified within the NER deficient group ofXP
patients, XPA to XPG. XP is a disease with defective overall NER.
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1.5.2 Cockayne's syndrome (CS)
CS is characterised by a cutaneous photosensitivity along with increased sensitivity
to some mutagenic agents in most patients. However, CS is a TC-NER defective
disease and no predisposition to developing skin cancer can be observed (Petit and
Sancar 1999). Instead, it is more likely that patients suffer from physical and mental
retardation. CS patients generally display skeletal abnormalities and progressive
neural degeneration (de Boer and Hoeijmakers 2000) giving rise to a possible link
between defective TC-NER repair of oxidative lesions and CS features. Mutations in
CSA and CSB seem primarily responsible for CS onset.
1.5.3 Trichothiodystrophy (TTD)
TTD patients show brittle hair and scaling of skin along with mental and physical
retardation as characteristics of the disease. Photosensitivity is reported in most
patients. Defects in TTD-A seem to be primarily causing the observed phenotype,
although additional mutations in NER factors such as XPD and XPB can also cause
photosensitivity in TTD patients (de Boer and Hoeijmakers 2000). TTD is a disease
with broad clinical heterogeneity and has therefore been described in association
with other syndromes. It is classed as a transcriptional syndrome.
Different mutations in the XPB, XPD and XPG genes give rise to a specific clinical
outcome leading to either XP, XP/CS or TTD (Andressoo and Hoeijmakers 2005).
This can be explained by the fact that those genes are not only involved in NER, but
also play a role in transcription. XP patients suffer from a NER related defect in
TFIIH resulting in photosensitivity and cancer development, while the basal
transcription function of TFIIH is affected in CS and TTD patients, leading to a
different range of symptoms (Andressoo and Hoeijmakers 2005). Moreover,
combined XP/CS patients display mutations that affect both functions ofXPD. In
general, XPD complementation group patients are generally found to be
heterozygous with one non-functional allele and a disease specific causative allele.
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1.6 Double strand break repair: Homologous recombination and NHEJ
DNA DSB are one of the most severe forms of damage to the cell as chromosome
rearrangements, loss of chromosome segments or even loss of the whole
chromosome can take place. To minimise the risk of loss of genetic information,
potent repair mechanisms have evolved using two different pathways.
One of these pathways, homologous recombination, has been extensively studied in
S. cerevisiae and is regarded as being an error-free process. A template, usually a
sister chromatid, is needed to carry out the repair event (Sargent et al. 1997).
Therefore, HR is only functional in late S/G2 phase. A current model in S. cerevisiae
suggests that after a DSB the 3' OH- end of the damaged DNA strand invades an
unbroken double-stranded homologue to form a heteroduplex (Thacker 1999).
According to this model, RAD50 along with other proteins form a complex that leads
to nucleolytic resection in a 5' to 3' direction, enabling RAD51 to bind specifically to
the 3' end of the damaged site (Jackson 2002). Other proteins such as RAD52
facilitate RAD51 binding. The RAD51 nucleoprotein is responsible for localisation
of the homologous DNA template, promotes the initial invasion step and catalyses
strand exchange events (Jackson 2002). Additional proteins of the RAD family help
to complete this process. DNA synthesis by polymerase I occurs at the 3' end of the
damaged strand, using the homologue as a template. Ends are joined by DNA ligase
I. The cross-overs are finally resolved by cleavage and further ligation resulting in
two intact DNA molecules (Jackson 2002). Mammalian homologues seem to exist
for all HR factors, but recombination repair in higher eukaryotes is likely to be more
complex.
Mammalian cells tend to make a more extensive use ofNHEJ repair, the second
pathway dealing with DSB (Sargent et al. 1997). This mechanism is not as accurate
but has an advantage for eukaryotes as no extensive homology is required. This
pathway is therefore able to operate in Gl. Because of the increased complexity of
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the genetic information in eukaryotes, appropriate homologous regions become
harder to locate and alternative methods are necessary in order to carry out repair of
DSB efficiently (Jackson 2002). Essential for NHEJ is the Ku heterodimer with its
Ku70 and Ku80 subunits. The complex recognises and binds to DSB in a specific
manner to then recruit other proteins to the damaged site (Jackson 2002). One of the
recruited elements is the DNA-dependent protein kinase catalytic subunit (DNA-
PKcs) that forms a holoenzyme along with the Ku heterodimer. Activation of this
complex is triggered by the single-stranded DNA region at the damaged site itself,
resulting in alteration of the complex's targets such as XRCC4 and replication factor
A (Jackson 2002). XRCC4 itself is thought to interact in a tight complex with DNA
ligase IV to stimulate end- ligation. Direct end-joining is most likely to lead to loss
of information and slightly alters the DNA sequence at the DSB. As most DSB result
from mutagenic agents, some DNA processing might be necessary before end-
joining can take place. A likely candidate for the processing step is the mammalian
MRE11/RAD50/NBS1 complex (Jackson 2002). Nevertheless, processing events
often lead to deletion or introduction of some nucleotides. NHEJ does not seem to
play a major role in yeast, but it seems to act as a complement to the homologous
recombination pathway. There is now mounting evidence that complementary
interaction of both pathways in prokaryotes and eukaryotes are a likely pattern to
repair DSB (Driscoll and Jeggo 2005).
Several DSB deficiencies in mammals are known with many of them being involved
in immunodeficiency related diseases. Severe combined immunodeficiency (Scid) is
one of the sterner immunodeficiency diseases in humans with one half of the patients
showing a defect in adenosine deaminase correctable by gene therapy (Weaver
2003). This form of the disease displays an autosomal recessive inheritance pattern
and patients are prone to serious infections. Some Scid syndromes are classified as a
disease with T and B lymphocyte (T'B") defects and are linked to the X chromosome.
T"B" Scid is thought to be caused by V(D)J recombination defects giving rise to an
increased cancer risk in lymphoid tissues (Weaver 2003). Ig rearrangements have
been observed from pre-B cells of B" patients leading to extended deletions that
destroy coding sequences. Additionally, chromosomal translocations with V(D)J
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recombination site breakpoints are frequently found in lymphoid malignancies where
the translocation alters the expression of genes such as c-MYC or BCL-2 (Weaver
2003). Patients with Ataxia Telangiectasia (AT) are at great risk for lymphoid
malignancies because of the repair machinery being unable to recognise DSB as
opposed to a lack of repair machinery (Weaver 2003). AT patients usually show
perturbations ofATM, a kinase involved in activation of checkpoint responses
following DSB (Lombard et al. 2005). Dysfunctional ATM leads to an accumulation
of unrepaired DSB and a severe phenotype including premature ageing,
immunodeficiency, cerebellar degradation and cancer (Lombard et al. 2005, Taylor
and Byrd 2005). Other proteins have been associated with DSB repair defects leading
to alterations of the cell cycle response. Phosphorylated BRCA1 or BRCA2 normally
interacts with RAD51, participating in DNA damage dependent cell cycle checkpoint
response (Zafonte et al. 2000). Mutations in BRCA1 and BRCA 2 may therefore lead
to accumulation of damaged DNA because of a failure to trigger cell cycle arrest
after DSB and contribute to increased cancer risk (Zafonte et al. 2000). In addition,
BRCA 1 and BRCA2 are thought to be involved in RAD51- mediated invasion of
homologous DNA during HR (Lombard et al. 2005). Defects in RAD51, BRCA1 and
BRCA2 can therefore lead to genomic instability, chromosome aberrations and
cancer (Thacker 2005).
1.7 Translesion bypass (TS)
TS allows the bypass of lesions by specific polymerases that lack a proof- reading
capacity (Larsen et al. 2005). This mechanism helps to prevent a collapse of the
replication fork during S- phase. In addition, TS is faster than NER and BER, but
potentially mutagenic (Larsen et al. 2005). There are multiple specialised
polymerases acting together during TS (Friedberg 2005). Specialised polymerase
have a preferred substrate which leads to replacement of nucleotides in an error- free
manner, but some specialised polymerases also allow repair in an error- prone
manner. A limited processivity is characteristic for all specialised polymerases
(Friedberg 2005). Usually, a switch from a high fidelity polymerase to a specialised
polymerase occurs when the replication fork is stalled during replication. Once the
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lesion is bypassed, the high fidelity polymerase resumes its activity around 1000 bp
downstream of the lesion, leading to successful DNA replication. In E. coli, the
replication fork helicase DnaB seems to be involved in the coordination of
replication re- initiation signalling through DnaG (Heller and Marians 2006). PCNA
acts as a DNA clamp and helps loading the specialised polymerases onto the DNA
(Friedberg 2005). Mechanisms involved in signalling for polymerase switching have
still to be discovered.
Interestingly, a defect in polymerase r\ function, a member of the Y- family of
translesion bypass polymerases, has been linked to a clinical syndrome in humans.
XP variant (XPV) patients display a XP phenotype with a late onset of around 30
years of age and much milder symptoms (Gratchev et al. 2003). In addition, NER is
functional in patients suffering from XPV. Polymerase rj has been implicated with
correct bypass of thymidine- thymidine cyclobutane pyrimidine dimers (Friedberg
2005). In the absence of functional polymerase r|, translesion bypass is catalysed by
other DNA polymerases with a high likelihood of incorporating incorrect
nucleotides. An increased mutation frequency is then responsible for the phenotype
observed in XPV patients over time.
1.8 ERCC 1
In 1984 Westerveld et al. (1984) reported the successful cloning of human ERCC1.
Since then, extensive genetic characterisation of the protein has been achieved. The
ERCC1 gene has been assigned to chromosome 19 with its exact location being at
19ql3.2-13.3 (van Duin et al. 1987). The gene is about 15 kb in length and consists
of 10 exons ofwhich exon 8 is subject to alternative splicing (van Duin et al. 1987).
The resulting mRNA products are 1.1 kb, 3.4kb and 3.8 kb in size with the 1.1 kb
transcript being the major mRNA species (van Duin et al. 1987). The 3.4 and 3.8 kb
mRNA transcripts most likely result from differential polyadenylation (van Duin et
al. 1987). The ERCC1 promoter is located at approximately 170 bp upstream of the
transcriptional start site and does not show any of the classical promoter motifs such
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as an AT-rich region or a TATA box (van Duin et al. 1987), indicating that this could
represent a specific class of promoters. A striking homology between the 297 amino
acids (aa) comprising human ERCC1 and the 210 amino acid S. cerevisiae RADIO
has been detected by van Duin and co-workers (1986). The C-terminus ofRADIO
shows significant homology to the central 110 aa of ERCC1. These homologous
regions are likely to display DNA- binding ability as structural comparisons to
typical DNA-binding motifs show (van Duin et al. 1986). In contrast, the N-terminus
of the ERCC1 product is not essential to carry out repair mechanisms in ERCC1
deficient cells as the N- terminus deprived ERCC1 protein is still active (van Duin et
al. 1986). In addition, ERCC1 carries a 53 residue long C-terminal extension that is
not part of the RADIO homology, but displays homology with the E.coli NER
protein UvrC (de Laat et al. 1996). This region, being located to residues 236-289,
consists of a double helix-hairpin-helix (HhH) motif. These motifs have been found
in a lot ofDNA break processing enzymes and are probably also involved in DNA
binding (de Laat et al. 1998). This region is essential for ERCC1 endonuclease
activity. Interaction with XPA is seen to be a crucial step in positioning the
ERCC1/XPF complex onto the DNA, making the 93-120 residues in the ERCC1
protein, which bind XPA, an important part of the protein (de Laat et al. 1998). The
regions responsible for binding XPF have been identified to be residues 224-297 in
ERCC1 and 814-905 in XPF (de Laat et al. 1998).
Lately, part of the structure of the human ERCC1/XPF complex has been revealed,
shedding more light onto the complex interaction between the two proteins
(Tripsianes et al. 2005). This study showed that only XPF contains the nuclease
domain of the complex but it does require ERCC1 for subsequent nuclease activity.
Moreover, the interaction of the two proteins has been confirmed to lie in their C-
terminal regions which both carry double helix- hairpin- helix (HhHfi domains
(Tripsianes et al. 2005). However, only the (HhH)? domain of ERCC 1 has been
found to have DNA binding properties and is thus responsible to ensure correct
positioning of the endonuclease upon DNA damage and interaction with other NER
proteins such as XPA (Tripsianes et al. 2005) . These findings reveal that within the
ERCC 1/XPF complex, each subunit has got a specific function, ensuring error- free
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processing ofDNA lesions.
Comparison ofmouse and human ERCC1 genes showed a high similarity and the
promoter region revealed a homologous sequence at 50-90 bp upstream of the
transcriptional start (van Duin et al. 1988). The N-terminal of the mouse ERCC1
protein seems to be less conserved than the human protein and a functional protein
arises even when the N- terminal of the protein is deleted. Moreover, the C-terminal
extension is also prominent in the mouse protein (van Duin et al. 1988). The
similarity between human and mouse ERCC1 offers the convenient opportunity to
use mice with Erccl deficiencies as a model for human defects.
1.9 ERCC1 in NER
The stable heterodimer formed by ERCC1 and XPF in vitro suggests that the two
proteins are unstable in the absence of each other (Enzlin and Scharer 2002). XPA
and RPA appear to have a role in damage verification and are also necessary to load
and position the endonuclease correctly onto the damaged DNA. Interaction of
ERCC1 and XPA at amino acids 93-120 ofERCC1 is thought to be required for
NER (Enzlin and Scharer 2002).
A truncation of seven aa at the C-terminal of the ERCC1 protein has been reported to
give rise to a decrease in the level of incisions. This leads subsequently to the
accumulation ofDNA breaks after unrepaired DNA damage persists in mouse cells
heterozygous for the Erccl mutation (Weeda et al. 1997). It also seems that
overexpression of ERCC1 can be lethal for cells and only minimum amounts of the
protein are available in the cell (van Duin et al. 1987). ERCC1 expression does not
seem to be UV-inducible (van Duin et al. 1988). So far, a defect of ERCC1 has not
been proven to lead to XP or any other human disease. This could be due to the
consequences of such a defect being embryonic lethal.
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1.10 ERCC1 in recombination and interstrand cross- link (ICL) repair
An additional role for ERCC1 is thought to be in homologous recombination.
Evidence is given by the fact that RADIO and ERCC1 share a significant homology
and that RADIO along with RAD1 is involved in recombinational repair in yeast.
Moreover, ERCC1/XPF deficient cells are the only cells with aNER defect showing
high sensitivity to interstrand cross-links created by mitomycin C. The repair of such
damage is believed to require mitotic recombination (Melton et al. 1998).
Adair and co-workers (2000) reported a necessity of ERCC1 for removal of long
non- homologous tails from 3'-OEl ends of invading strands during targeted
homologous recombination in Chinese hamster ovary (CEIO) cells. These findings
strengthen the assumption that recombinational repair is one of the functions for
ERCC1. Kuraoka et al. (2000) proposed a new model for the repair of interstrand
cross-links taking the incision properties of the ERCC1/XPF heterodimer into
account. According to this model, a Y structure is created near the damage for
example by the replication fork while in progression or by a DNA helicase.
ERCC1/XPF then cleaves at the 3' side of one arm of the cross-link and then makes
an additional incision at the 5' side. The fork collapses and recombination and NER
events can take place to complete the repair (Kuraoka et al. 2000).
Although some involvement of ERCC1 in recombination repair pathways cannot be
denied, it seems not to be an essential factor. Melton and co-workers (1998) induced
inter-strand cross links in Erccl-deficient murine cells and could only detect a
moderate sensitivity to mitomycin C, concluding that ERCC1 is not essential for
homologous recombination and that an additional pathway may exist to deal with the
damage. In S. cerevisiae RAD1-RAD 10 complex is involved in processing of non¬
homologous 3' tails during single strand annealing (Paques et al. 1999). Single strand
annealing is a pathway that evolved to repair ICL which are located between direct
tandem repeat sequences (Zheng et al. 2006). ICL induced single strand annealing
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was decreased in a cell line lacking XPF (Zheng et al. 2006). In addition, Chipchase
and Melton (2002) found that ERCC1- and XPF- deficient cells showed a lower
incidence of chromatid exchange to DSB when compared to Wt and other NER-
deficient cells after UV irradiation. UV- induced chromosome aberrations are
thought to form when unrepaired DNA damage is present during DNA replication.
These chromosome aberrations result from successful single strand annealing
between non- homologous chromosomes in the presence of ERCC1/XPF. When
ERCC1/XPF is absent, DSB accumulate as a consequence of impaired single strand
annealing. Thus, ERCC1/XPF is involved in successful single strand annealing
where the complex is most likely to trim non- homologous 3' tails arising during this
process (Chipchase and Melton 2002).
In general, reports show that lower levels of ERCC1 complex are needed for
elimination of cross-links compared to UV lesion removal (Sijbers et al. 1996).
ERCC1 does not seem to be a rate-limiting step in interstrand cross- link repair. This
could be explained by the assumption that ERCC1 displays a higher activity dealing
with interstrand cross- links or that removal of this type of damage only requires low
levels of the complex as the amount of interstrand cross- links in normal cells is very
low (Sijbers et al. 1996).
Sarkar et al. (2006) examined interstrand cross- link repair in S. cerevisiae further,
suggesting that a combination of pathways might be involved in lesion repair in G1
phase. Yeast cells are without homologous recombination substrate during the G1
stage of the cell cycle and can therefore not rely on the classical recombination based
pathway of repair of ICL repair (Sarkar et al. 2006). Instead, NER factors, such as
ERCC1/XPF and XPG, incise DNA around the ICL without removal of the lesion.
When the high fidelity polymerase P stalls at the adducted oligo site, signalling to the
RAD6 pathway occurs, leading to monoubiquitination ofPCNA at K164. A
polymerase switch to polymerase C, a B- family polymerase known to replicate
through a variety of lesions, then occurs (Sarkar et al. 2006). Translesion synthesis
and re-initiation of replication downstream of the lesion follows. An interplay
between the predominant NER pathway and the translesion bypass pathway helps to
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bypass ICL during G1 of the cell cycle in yeast. If this pathway is important in higher
organisms remains to be elucidated.
Xu et al. (1998) found homologues of human ERCC1 and yeast RADIO in several
plant genera, including lily. These homologues were able to correct mitomycin C
induced lesions in Chinese hamster ovary cells, pointing to existing NER and
recombination mechanisms in plants. These results have since been further
confirmed and other NER factors similar to XPF have been found in Arabidopsis
flower tissue (Liu et al. 2000).
1.11 ERCC1 deficiency in mice
With approximately 99% of the mouse genes having a homologue in the human
genome, mice are a convenient model to investigate genetic disorders (Mouse
genome sequencing consortium 2002). Mice have been used for biomedical research
for a long time, and with the rediscovery ofMendel's law of inheritance in the
beginning of the last century and the start of gene mapping, knowledge about the
mouse genome has been extended (Mouse genome sequencing consortium 2002).
Gene targeting has become a useful tool making it possible to alter particular genes
and study the functional consequences of these alterations. The main principle of
gene targeting is based on homologous recombination of a vector carrying, for
example, a specific gene and a chromosomal locus that is targeted by the vector
(Melton 2002).
Mouse models have increased the understanding of the mechanisms ofERCC1
deficiency during the past decade. Erccl has been knocked out in strains of mice and
consequences ofErccl loss have been extensively studied. Erccl knockout mice
were reported to suffer from several abnormal features. They were runted at birth,
died before weaning because of liver failure and displayed severe liver abnormalities
(McWhir et al. 1993, Weeda et al. 1997). Liver cells were found to contain nuclei
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with variable sizes and were polyploid with a development towards severe
aneuploidy by three weeks of age (McWhir et al. 1993).
Polyploidisation is a general mechanism occurring in all cell types in mammals and
is seen as a general physiological process. By providing duplicated genes,
polyploidisation fuels long- term diversification and evolutionary success (Comai
2005). Advantages of polyploidisation include gene redundancy, which leads to a
protective effect against deleterious recessive mutations in a bottleneck population.
In addition, an increased performance of polyploids compared to inbred parents
might occur as the fixation of a divergent parental genome is possible, leading to a
more diverse genetic background which could adapt more easily to environmental
changes (Comai 2005). On the other hand, a dosage imbalance could occur when the
nucleus- cytoplasm ratio changes with increased polyploidy, causing a change in the
relationship of tri- and bi-dimensional compartments of the cell to each other which
could be of disadvantage. In addition, difficulties in meiosis might arise and an
increase in abnormal chromosome segregation might be apparent (Comai 2005).
The onset ofpolyploidisation of the liver is associated with late foetal development
and postnatal maturation and progresses with age (Gupta 2000). It is therefore seen
as a sign of terminal differentiation and senescence of hepatocytes. Hepatocyte
polyploidy in vivo is also associated with an increase in cell size and cytoplasmic
complexity and an accumulation of lipid peroxidation products such as lipofuscin, an
end product of intracellular oxidation, and a decrease in cell division potential (Gupta
2000). Polyploidy along with increased cytoplasmic density lead to a decline in cell
division in vivo (Gorla et al. 2001). Liver polyploidy in humans is associated with an
increase in age. Hepatocytes are mostly diploid in newborns with an increase in
tetraploidy in adolescents and the onset of octaploidy in adults occurring with age
(Biesterfeld et al. 1994). In mice, polyploidisation shows a similar pattern with the
livers of foetal and suckling animals containing mainly diploid hepatocytes and
tetraploidy being apparent in the majority of hepatocytes in young adult liver (Gupta
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2000). Polyploidy is usually observed in older animals with nuclei being up to 16n
towards their maximum life span.
The basis for polyploidisation is thought to be acytokinesis (Guidotti et al. 2003).
Mononucleate cells have been shown to abort cytokinesis leading to a population of
binucleate cells. Polyploidisation can occur when the two nuclei of a binucleate cell
fuse. Alternatively, binucleate cells can give rise to two tetraploid cells during cell
division with all chromosomes replicating once. Guidotti et al. (2003) showed that
the latter is the case in hepatocyte cultures.
Liver polyploidy is normally seen in ageing hepatocytes and might have a protective
role against DNA damage. The liver is naturally a target for many toxic agents and in
order to deal with genetic damage, polyploidisation might occur to compensate for
cellular losses (Weeda et al. 1997). Apart from being a protective mechanism,
polyploidisation is also regarded to be a natural sign of ageing.
p53 levels were elevated in Erccl- deficient liver, kidney and brain as p53 is
involved in monitoring DNA damage. Further studies revealed changes in cell cycle
and p21 involvement. p21 is one of the major downstream targets for p53, but can
also be upregulated independently from p53. p21 acts as a cyclin-dependent kinase
inhibitor, resulting in cell cycle arrest at Gl/S and G2/M checkpoints, as well as a
mediator in cell differentiation and senescence (Weeda et al. 1997). Overexpression
of a p21 transgene in the liver produced a similar phenotype to that ofErccl
deficiency (Wu et al. 1996), giving additional support to the idea that p21 is involved
in ERCC1-dependent cross-link repair (Weeda et al. 1997). Moreover, arrest in G2
has been observed in hepatocytes deficient in Erccl (Melton et al. 1998). The cell
cycle arrest is thought to occur through misregulation of p21 as a result of
uncoupling of S-phase and mitosis. DNA replication and normal binucleation events
also seem to be reduced in Erccl - deficient liver. This has been shown to be due to a
protective role for p53 in ERCC1 deficient cells. It was suggested that p53 ensures
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that cells with DNA damage do not proceed through replication or binucleation to
reduce the risk of fixation ofmutations and formation of chromosomal aberrations
(Nunez et al. 2000).
The following model has been proposed to explain the growth arrest and early
senescence in Erccl- deficient rodent cells: ERCC1 is not essential for homologous
recombination repair in rodents but seems to stimulate chromosome exchange in S-
phase on a UV- damaged template during single strand annealing (Melton et al.
1998). Accumulation of DSB occurs where single strand annealing fails because of a
defect in the Erccl gene. This leads to upregulation of p53 although the main
features of the observed phenotype are probably independent of it. Elevated levels of
p21 arise because of the damage, where p21 seems to be independently induced in
these cells. Increase of p21 results in G2 cell cycle arrest instead of arrest in Gl/S
(Nunez et al. 2000). Cells are therefore able to replicate and increase their DNA
contents through rounds of endoreduplication without cell division or binucleation
(Nunez et al. 2000). Genome instability and a rise in mutation frequency can be
observed because of an increase in DSB and the lack ofNER. In Erccl- deficient
liver, these events could be triggered by endogenous oxidative DNA damage, rather
than by UV irradiation.
As Erccl knockout mice die early after birth it is very difficult to study further
consequences later during life such as cancer susceptibility and effects on tissues
other than liver. Correction of liver dysfunction has recently been achieved through
an Erccl transgene, resulting in new opportunities to study more long term
consequences of ERCC1 deficiency (Selfridge et al. 2001). A transgene was created
under the control of a transthyretin (TTR) gene promoter to guarantee liver specific
ERCC1 expression. The lifespan of these animals was extended to 61-88 days which
still is not long enough for cancer susceptibility studies. However, runting was
inhibited and liver function corrected by the transgene. The rise of oxidative damage
along with liver polyploidy was reversed. Instead, polyploidy in the kidney could be
detected and animals died with renal malfunction (Selfridge et al. 2001).
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Prasher et al. (2005) investigated the haematopoietic system ofErccl knockout mice
and found the basal haematopoiesis and the reserve capacity of the system reduced in
those mice. This functional decline of the haematopoietic system is normally found
in humans aged 70 and older, where mild anaemia and reduced neutrophil production
can be observed (Prasher et al. 2005). No such reduction in haematopoiesis could be
noted in Xpa mice which are only malfunctional in NER. The hypersensitivity of
Erccl knockout mice to ICL and the reduced function of the haematopoietic system
highlights similarities to patients with Fancomi anaemia and it has been suggested
that Erccl knockout mice are a model thereof (Prasher et al. 2005).
A mouse line with a truncated form ofErccl, lacking the last 7 amino acids, on one
allele, showed delayed onset of premature aging with an extended life span of 6
months (Dolle et al. 2006). Mutation frequencies were assessed using a lacZ reporter
gene in Erccl truncated livers and were found to be 2- fold increased when
compared to Wt littermates at 28 weeks of age. Point mutations and deletions or
inversions of over 50 bp were found in these livers. In addition, G:C to T:A
mutations, an oxidative damage signature mutation, were the most common form of
no- change mutations (Dolle et al. 2006). The increased genome instability found in
mice with a truncated form ofErccl was thought to be an effect of the impaired
interstrand cross- link repair ability ofErccl rather than its function in NER as livers
ofXpa mice showed a lower mutation frequency and less severe genome
rearrangements. Xpa mice display malfunctional NER pathways only and do develop
spontaneous liver tumours (Ishikawa et al. 2004). Interestingly, only liver was
affected by the truncated form ofErccl with no mutations found in other organs such
as kidney (Dolle et al. 2006). In addition, livers of 3 week old complete Erccl
knockout mice showed no increased genome instability and mutation frequency
when compared to Wt littermates (Dolle et al. 2006). These findings suggest that
mutation frequencies in Erccl- deficient livers rise from weaning onwards, leading
to large genome rearrangements thereafter. These large rearrangements could impact
normal patterns of gene expression in liver and lead to age- related cellular
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degradations and liver failure. Overall, the liver seems to be especially susceptible to
loss ofErccl. Further investigations are required to specify the reason for the
importance ofErccl in liver.
Xpf- deficient mice were created by Tian et al. (2004). Unsurprisingly, Xpf- deficient
mice showed the same phenotype as Erccl- deficient mice. Animals were runted,
died before weaning and displayed an increase in polyploid hepatocyte nuclei. As
ERCC1 forms a functional complex with XPF, these findings underline the
importance of both factors to act simultaneously during NER, homologous
recombination and inter strand cross- link repair.
1.12 Erccl and cancer
A skin- specific Erccl- deficient mouse line has recently been established in our
laboratory using the Cre/loxP technique. In short, mice carrying two loxP sites
flanking exon 3 and 5 of the Erccl gene were created. In Erccl Flox/Null and
Flox/Wt mice, a Cre recombinase under the skin- specific K5 promoter drove the
recombination of the loxP sites, resulting in the excision of exons 3-5 of the Erccl
gene. Erccl Flox/Null mice showed 50-70% recombination in the skin (Doig et al.
2006). When UVB was used as a DNA damaging agent, Erccl Flox/Null mice
showed a high incidence of skin tumours 8- 17 weeks after exposure to UVB with
Wt littermates under the same protocol not showing any carcinogenic changes in the
skin. This study underlines the role ofErccl in cancer protection.
Liver cancer is the fifth most common cancer in men and the eighth most common
cancer in women world- wide (Bosch et al. 2004). Rates of hepatocellular
carcinomas (HCC) are 2-4- fold higher in men compared to women. Risk factors
include hepatitis B and C, alcohol abuse and exposure to aflatoxin. Fautrel et al.
(2005) have shown that ERCC1 is frequently overexpressed in HCC in patients and
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that NER activity is upregulated which might account for the relative resistance of
HCC to chemotherapeutic agents.
ERCC1 has also been implicated in resistance to platinum based chemotherapy in a
variety of cancers and ERCC1 status could be used as a predictive marker for
chemotherapeutic outcome. ERCC1 polymorphisms are known to occur at position
225 and 354 of the ERCC1 gene. At position 225 a G:T substitution takes place and
at position 354 C is substituted by T. Both mutations are silent and occur in
heterozygous or homozygous form (Ford et al. 2000).
However, Yu et al. (2000) suggested that even silent ERCC1 polymorphisms could
lead to diminished mRNA and protein levels in ovarian cancer cell lines with
functional consequences in cisplatin DNA removal capacity. In addition, a
polymorphism in codon 118 in exon 4 leads to a C: T substitution without change in
the polypeptide sequence (Isla et al. 2004).
However, predicted survival for cisplatin treated non- small cell lung cancer patients
decreases when one allele contains the T variant ofERCC1 at codon 118. The same
polymorphism is also associated with decreased overall survival and time to
progression of colorectal cancer on patients receiving chemotherapy (Moreno et al.
2006). Zienolddiny et al. (2006) propose that the 118 transition leads to differential
ERCC1 mRNA levels which might influence repair capacity. Yan et al. (2006)
examined ERCC1- related cisplatin resistance in more detail. The upstream promoter
region around 410 bp of the ERCC1 gene contains a variety of transcription factor
motifs and seems to be responsible for resistance to cisplatin. Upon exposure to
cisplatin, the transcription repressor MZF1 was downregulated followed by ERCC1
upregulation. Similarly, MZF1 overexpression led to lower levels of ERCC1 upon
cisplatin administration, indicating a regulatory function for MZF1 on ERCC1
expression (Yan et al. 2006).
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In addition, human ovarian cancer cell lines and specimens were examined for the
presence of a 42 bp splicing variant ofERCC1 (Yu et al. 2001). The 5'- UTR region
of ERCC1 mRNA includes an untranslated region in exon 1. The loss of the 42 bp
sequence was associated with a rise in ERCC1 mRNA levels in ovarian cancer
specimens, indicating a negative transcriptional regulatory effect of this region of
ERCC1 expression. These findings could not be confirmed in our laboratory when a
variety of human cancer cell lines, including cisplatin resistant cell lines, were
examined and the 42 bp splice variant was found ubiquitously (Winter et al. 2005).
Therefore, the 42 bp splice variant was not cancer related. In general, deregulation of
ERCC1 and silent polymorphisms could give rise to higher incidences of cancer or to
resistance to chemotherapeutic agents.
1.13 Objectives
The aim of the current study was to set up a better model for examination ofErccl
deficiency and premature polyploidy in the murine liver and to determine the DNA
lesions responsible for this premature polyploidy. We used the Cre/lox system with
an Adeno virus carrying Cre recombinase to conditionally induce Erccl- deficiency
and to reduce ERCC1 levels in adult murine hepatocytes in vitro and in liver in vivo.
In addition, livers from simple Erccl knockout mice were further characterised,
examining their reactive oxidative species content and the occurrence of
malondialdehyde adducts. Real- time RT-PCR was used to determine differences in
expression of cell cycle regulation and survival genes between Erccl- deficient and
control livers. Moreover, lipid content was examined in Erccl- deficient livers and in




2.1 Laboratory reagents and suppliers
Ambion: RNase free water
Amersham Biosciences: Redivue (a-32P)- dCTP (3000 Ci/mMole, 10 mCi/ml),
Dextran sulphate, NICK column, ECL- plus Western Blotting detection system,
Percoll, Bromodeoxyuridine (BrdU)
Applied Biosystems: 2x TaqMan©PCR mix, 20x Assays on demand Assay mix
(containing Real- time PCR primers)
BDH ltd: Hydrochloric acid, Acetic acid
BioRad: Kaleidoscope pre- stained standards, Lowry protein assay, 96 well PCR
plates, Coomassie brilliant blue R- 250
Greiner Bio: Petri dishes, 24- well plates
Fisher Scientific: 10% Sodium dodecyl sulphate (SDS), Boric acid,
Ethanediaminetetraacetic acid (EDTA), Isoamyl alcohol, Sodium chloride (NaCl),
Sodium citrate , Sodium hydroxide (NaOH), Potassium disulphite, Isopropanol,
Methanol, Chloroform, Potassium chloride (KC1), Tri- sodium citrate
Fluka: Glucose oxidase (GO)
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Invitrogen: 25 mM deoxyribonucleotides (dNTP), EcoRI, lOx Digestion Buffer for
EcoRI, lx Phosphate buffered saline (PBS), Oligo dT, Moloney murine leukaemia
virus (MMLV) reverse transcriptase enzyme, RNase H, Dithiothreitol (DTT),
Phenol, Low melting point agarose, Perfusion medium, modified Chee's medium,
lOx Hanks buffered saline solution (HBSS), Insulin- Trans- Sel- G (ITS), Tris, L-
glutamine, ~/-(2-hydroxyethy1)-1 -piperazincethanesul fonic acid (HEPES),
Gentamicin, 100 bp DNA marker ladder, 5-(and-6)-chloromethyl-2',7'-
dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA)
Millipore: Immobilon-P transfer membrane
LabTek: 2- well chamber slides, 4- well chamber slides
Oxford Technologies: anti BrdU antibody
Oswell: Polymerase chain reaction (PCR) primers
Packard Biosciences: Ultima Gold scintillation fluid
Perkin Elmer: Genescreen Plus hybridisation transfer membrane
Pfizer: Rimadyl, Halothane
Premier International foods: Marvel
Promega: lOx PCR buffer, 25 mM Magnesium chloride (MgCE), Taq DNA
polymerase, DNA Polymerase I large fragment
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Qiagen: RNeasy mini kit, DNase
Roche: DNase I
Virapur: AdenoCre virus
Sacura FineTek: OCT compound
Santa Cruz: Goat anti- rabbit IgG antibody
Severn Biotech: Acrylamide
Sigma: Carbon tetrachloride, Tamoxifen citrate, 4- hydroxytamoxifen, 20 mg/ml
Proteinase K, RNase A, Trypsin, Trypsin inhibitor, Ribonuclease A, Propidium
iodide (PI), Leibowitz 15 medium, Dulbecco's modified Eagle medium (DMEM),
Mitomycin C (MMC), Sunflower oil, Electrophoresis grade agarose, Collagenase IV,
Glasgow medium, Trichloroacetic acid (TCA), Tween 20, New- born calf serum
(NRS), rabbit anti- rat Horseradish peroxidase (HRP) conjugated, Diaminobenzidine
(DAB) solution, Cedarwood Oil, Propylene glycol, Hydrogen peroxide (H2O2),
Fibronectin, Insulin, Linoleic acid (BSA), Epidermal growth factor (EGF),
Dexamethasone, Tween 20, Lipid Lin-Trol Set, Dimethylsulphoxide (DMSO),
Ethidium bromide, Glycerol, Herring sperm DNA, Formaldehyde, Triton X- 100,
NP- 40, Bromophenol blue, (3- mercaptoethanol, Feulgen's grade fuchsin,
Ribonuclease inhibitor, Glycerine, N,N,N', N'- Tetramethylethylenediamine
(TEMED), Ammonium persulphate (APS), Sucrose, activated Charcoal
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Thermo Spectronic Corporation: ThermoTrace Triglyceride standard,
ThermoTrace Triglyceride reagent
formamidopyrimidine- DNA- glycosylase (FPG) enzyme was a gift to Dr S. Prost.
2.2 Solutions
Bouin's fixative: 425ml Methanol, 25 ml glacial Acetic acid, 50 ml 40% formalin
Blocking solution (BrdU stain): PBS, 20% (v/v), normal rabbit serum (NRS),
0.05% Tween 20 (v/v)
Chloroform- isoamyl alcohol solution (CA): 24 parts chloroform (v/v), 1 part
isoamyl alcohol (v/v)
Citrate Buffer: 8.55% sucrose (w/v), 5% DMSO (v/v), 40mM tri- sodium citrate
(w/v), pH 7.6
Coomassie blue: 0.2% Coomassie (w/v), 7.5% Acetic acid (v/v), 40% Methanol
(v/v)
Denaturing buffer (Southern blot): 0.5M NaOH, 1.5M NaCl
Electrophoresis solution (Comet assay): 0.3M NaOH, ImM EDTA
Enzyme buffer (Comet assay): 40mM Hepes, 0.1M KC1, 0.5mM EDTA, 0.2 mg/ml
BSA, pH 8.0
Fluorescence activated cell scanning (FACS) stock solution: 3.4M tri- sodium
citrate, 0.5M Tris- HC1, 1% NP40, 0.52mg/ml spermine tetrahydrochloride, pH 7.6
FACS solution A: 30pg/ml trypsin in stock solution
FACS solution B: 0.5 mg/ml trypsin inhibitor, 0.1 mg/ml ribonuclease inhibitor in
stock solution
FACS solution C: 0.42 mg/ml propidium iodide, 1 mg/ml spermine
tetrahydrochloride in stock solution
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Formalin: 10% (v/v) formaldehyde in phosphate buffered saline
Hybridisation buffer (Southern): 1 mg dextran sulphate, 10% SDS, 20x SSC,
denatured sperm DNA and DDW
5x Loading buffer (gel electrophoresis): 20% (v/v) glycerol, lOOmM EDTA, 0.1%
(w/v) bromophenol blue
4x Lower Buffer (for lower, separating Western gel, 12%): 1.5M Tris- HC1, 0.4%
SDS (v/v), pH8.8
Lower gel (Western): 12% Acrylamide (w/v), 0.006 % (w/v) APS, 0.002% (w/v)
TEMED, 25% (v/v) Lower buffer
Lysis buffer 1 (Comet assay): 2.5M NaCl, 0.1M EDTA, lOmM Tris, 1% Triton X-
100 (v/v), pH 10
Lysis buffer 2 (Comet assay): 2.5M NaCl, 0.1M EDTA, lOmMTris, pH 10.0
Lysis buffer (Western): lOOmM Tris, 2% SDS (v/v), pH 8.2
Marvel solution: 5% Marvel (w/v), TBST
Neutralising buffer (Southern blot): 3M NaCl, 0.5M Tris- E1C1, pH 7.0
Neutralising buffer (Comet assay): 0.4M Tris, pH to 7.5 with HC1
Solution A (Oligo labelling buffer): 1.25M Tris- HC1 pH 8.0, 0.125M MgCl2,
25mM p- mercaptoethanol, 0.5mM each of dGTP, dATP, TTP
Solution B (Oligo labelling buffer): 2M Hepes buffer adjusted to pH 6.6 with
NaOH
Solution C (Oligo labelling buffer): Random hexadeoxyribonucleotides;
90 OD26o nm units/ml in TE, 50 pg/ml DNA equals OD260nm= 1
Definition OD260nm unit: One optical density (OD) unit equals the amount ofDNA
that gives an absorbance reading of 1.0 at 260nm for a sample dissolved in 1 ml total
volume of double distilled water.
Oligo labelling buffer: 50pl solution A, 125pil solution B, 75pl solution C
Percoll: 9 parts Percoll to 1 part lxHBSS (v/v)
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Phenol- chloroform- isoamyl alcohol (PCA) solution: 25 parts redistilled phenol,
24 parts chloroform, 1 part isoamyl alcohol
4x Protein sample buffer: 250 mM Tris- HC1, 2% SDS (v/v), 20% P-
mercaptoethanol (v/v), 40% glycerol (v/v), 0.5% bromophenol blue (v/v), pH 6.8
5x RT buffer: 250mM Tris- HC1 pH 8.3, 30mM MgCl2, 200mM KC1, 5mM DTT
Schiff s reagent: 2.5g Feulgens grade Fuchsin, 5 g Potassium disulfite, 10ml 10%
HC1, 2g activated charcoal
20x Standard saline citrate (SSC): 3M NaCl, 0.3M tri- sodium citrate, pH 7.0
Swelling buffer: 0.01M HEPES, 1.5 mM MgCl2, pH 7.4
Tail lysis buffer: 400mM NaCl, lOmM Tris- HC1, 3mM EDTA, 1% (w/v) SDS
lOx Tris- Borate- EDTA (TBE): 0.9M Tris- HC1, 0.9M boric acid, 20mM EDTA,
pH 8.3
lOx Tris buffered saline (TBS): 1M Tris base, 1M NaCl, pH 7.5
Tris buffered saline with Tween (TBST): 0.005% Tween 20 (v/v) inlx TBS
20% Trichloroacetic acid (TCA): Trichloroacetic acid in DDW (w/v)
Tris- EDTA (TE) buffer: lOmM Tris- HC1, ImM EDTA, pH 8.0
Transfer Buffer (Western): 3 g TRIS, 14.4 g Glycine in 1 liter double distilled
water (DDW)
4x Upper buffer (for upper, stacking Western gel): 0.5M Tris- HC1, 0.4 % SDS
(v/v), pH 6.8
Upper gel (Western blot): 4% Acrylamide (w/v), 0.006% (w/v) APS, 0.002% (w/v)
TEMED, 33% (v/v) Upper buffer
2.3 Cell culture media and conditions
Liver perfusion medium was obtained and 50 pg/ml gentamicin added to each 500ml
bottle ofmedium.
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Digestion medium consisted of 500 ml Leibowitz 15 medium to which 50 pg/ml
gentamicin, 4 mM L- glutamine, 0.14 mM dexamethasone, 1.7 mM insulin and 50
mM Hepes were added. The pH was adjusted with 1M NaOH until pH 7.5 was
reached. Before perfusion, 25 mg of collagenase IV and 600 mg DNase I were filter
sterilised and added to 120 ml digestion medium.
Plating medium consisted of 500 ml DMEM to which 50 pg/ml gentamicin, 4 mM
L- glutamine, 0.14 mM dexamethasone, 1.7 mM insulin was added. The pH was
adjusted with 1M NaOH until pH 7.5 was reached.
Cell culture medium consisted of 500 ml modified Chee's medium to which 50pg/ml
gentamicin, 4 mM L- glutamine, 0.14 mM dexamethasone, 0.1 ng/ml ITS and 12.5
ng/ml EGF, made up in lx BSA, was added. The medium itself contained high
amounts of amino acids to help proliferation in culture. The pH was adjusted with
1M NaOH until pH 7.5 was reached.
Hepatocyte cultures were maintained at 37°C in a 5% CO2 atmosphere in a Sanyo
incubator.
2.4 Primers
All primers are listed in Table 0. Conventional PCR primers were obtained from
Oswell. Their sequence and the product size are indicated for all PCR assays. Real¬
time PCR primers were obtained from Applied Biosystems. The exact positioning
and the sequence of those primers could not be obtained as Applied Biosystems does
not provide this information. Instead, approximate positions and exon boundaries are
given. The product size is indicated for each Real- time PCR assay. Real- time PCR
primers are usually located around exon boundaries and PCR products are small to
ensure amplification of cDNA only.
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Table 0: PCR and RT Real- time PCR primers. Primer sequences for forward and reverse
primers are indicated for ail conventional PCR primers. The exon location of primers are
given for RT Real- time PCR primers. The product size is given in base pairs (bp).
PCR assay Forward Primer Reverse Primer Product size
(standard) (bp)
TTRCre 5'- ATGAAATGCAA 5'- TCTAGAAGGAT 1350
GAACGTGGTACCC-3' CATATTCAGAATAG-3'
Erccl KO 5'-GGTTCGAAATGA 5-CGAAGGGCGA 800
CCGACCAAGCG-3' AGTTCTTCCC-3'
500 (Flox)
Erccl Flox Wt 5'-TGCAGAGCCTG 5'- TCAAAGTATG and
GGGAAGAACTTCGC-3' GTAGCCAAGGCAGC-3' 1050 (Wt)
Recombination 5'-TGTCTCCCTGG 5-TCAAAGTATG 250
CTCTGGATCTGAC-3' GTAGCCAAGGCAGC-3'














TTRCre mice were obtained from Mireille Vasseur-Cognet, Institut Cochin
U567, Departement de Genetique, Developement et Physiopathologie Moleculaires,
INSERM U567, 24 rue du Faubourg Saint Jacques, 75014 Paris, France. The mice
were hemizygous for the transgene and were on a mixed background. We crossed
TTRCre mice with our own Erccl knockout stock (Erccl Wt/Null) which was on a
mixed genetic background. Erccl Wt/Null animals containing the TTRCre transgene
were then crossed with Erccl Flox/Flox mice to obtain Erccl Flox/Null and Flox/Wt
animals with and without TTRCre transgene. For the AdenoCre experiments, Erccl
Wt/Null animals were crossed with homozygous Erccl floxed animals to obtain
Erccl Flox/Null and Flox/Wt mice.
2.5.2 Animal husbandry
All animal procedures were carried out under the Home Office Animals (Scientific
Procedures) Act 1986. All mice were maintained in accordance with established
animal care guidelines (Poole 1989). Animals were kept at standard conditions with a
12 hour light cycle and an average temperature of 21°C. Water and food were given
ad libitum. After weaning, animals were separated into single sex cages. Tail
biopsies of less than 1 cm distal tail for genotyping were obtained after exposure to
the analgesic rimadyle, and the anaesthetic halothane. At the same time each
individual animal was marked with coded ear markings. In all experiments,
littermates are used as experimental and control animals.
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2.5.3 Tamoxifen injections
4-Hydroxytamoxifen was prepared in 50% ethanol to obtain a 40 mg/ml stock
solution. All further dilutions were carried out in sterile sunflower oil until a final
concentration of 10 mg/ml was reached. 1 mg of this solution was given i.p. to one
group ofmice once and subsequently to all other animals on 5 consecutive days.
In addition, tamoxifen citrate was prepared in 50% ethanol to obtain a 40 mg/ml
stock solution. All further dilutions were carried out in sterile sunflower oil until a
final concentration of 20 mg/ml was reached. 1 mg of tamoxifen citrate in solution
was given to each animal i.p. daily for 5 consecutive days. All animals were 6-8
weeks old.
2.5.4 Carbon tetrachloride injections
Carbon tetrachloride was diluted in sterile sunflower oil to obtain a 23 mg/ml, 51
mg/ml and 102 mg/ml solution. 1 pl/g body weight (BW), which corresponds to 23,
51 and 102 pg/g body weight of solution, was injected i.p. into each mouse using a
Hamilton glass syringe. Mice varied in age from 6-8 weeks.
2.5.5 AdenoCre injections
Sterile lx PBS was added to the AdenoCre virus to obtain a pfu of lxl09 and 4xl09
in a 200 pi volume. Mice were restrained in a plunger and the tail vein warmed with
37°C water. 200 pi of diluted virus was given i.v. to 6 week old male and female
animals. Animals were sacrificed 1 and 3 weeks after AdenoCre injections.
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2.5.6 Short term in vivo study
6 week old male Erccl Flox/Null and Flox/Wt mice were injected i.v. with lxl09and
4xl09 pfu AdenoCre virus. 51pg/g BW of CCI4 solution was given i.p. the next day
once to one group of animals and weekly for three consecutive weeks to another
group of animals. Animals were sacrificed 7 or 14 days after the last CCI4 injection.
2.6 Tissue processing
2.6.1 DNA extraction
DNA from tail and tissue was extracted using phenol, together with chloroform,
which separates nucleic acid from protein. Tail tips were incubated in 0.6 ml tail
lysis buffer and 300 pg proteinase K solution on a shaker (Gallenkamp) at 37°C and
200 rpm over night. All centrifugation steps were done on a Mikro 20 centrifuge
(Hettich) at 1300 rpm for 5 minutes. Separation of the solution and remains of hair
was done by spinning. The samples were carried over into a fresh epppendorf tube
and 0.6 ml Phenol- chloroform- isoamyl alcohol (PCA) was added to the samples to
extract DNA. All sample tubes were attached to a Rotatest flatbed shaker (Stuart) at
80 rpm for 15 minutes. After an additional centrifugation step, the aqueous phase
was carried over to a fresh eppendorf tube adding 0.75 ml of chloroform- isoamyl
alcohol (CA) to eliminate any remaining phenol. Mixing was achieved through
attachment of the tube to the rotatest flatbed shaker as above. The aqueous phase was
carried over to a fresh eppendorf tube after a third centrifugation step using 0.75 ml
propan-2-ol to precipitate the DNA. Samples were left at room temperature for 10
minutes and spun down to pellet the DNA. After washing the pellet in 70% ethanol,
the DNA was dried and re- suspended in lOOpl sterile water.
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Isolation ofDNA from mouse tissues was done as above using 5 ml tail lysis buffer
and 2500 jug proteinase K solution as well as 5 ml PCA and CA respectively.
Resuspension was done in 1ml DDW for liver DNA and 0.8 ml DDW for all other
tissues.
2.6.2 Estimation of DNA concentrations
Concentration ofDNA samples was estimated using spectrophotometry. The
absorbance of diluted DNA was measured at 260 and 280nm using the Biomate 3
spectrophotometer (Thermo Spectronic). Double stranded DNA with a concentration
of 50pg/ml equals an OD260nm=l-0. In addition, the ratio of OD260nm/OD280nm is an
indication of nucleic acid purity with a ratio of 1.8 indicating no significant
contamination with protein.
2.6.3 Agarose gel electrophoresis
Agarose gel electrophoresis relies on the principle that negatively charged DNA
moves towards a positive electrode. Agarose is used to create a porous gel to allow
for DNA separation by size. Agarose gels were prepared using lx TBE and
electrophoresis grade agarose. 0.5pg/ml ethidium bromide, which intercalates with
DNA and fluorescences under UV light, was added to each gel to visualise the PCR
products. A 1 OObp DNA ladder was added to each gel for size comparison. TTRCre,
Erccl Null, Flox and Wt PCR products were run on a 1% agarose gel (w/v) for 1
hour at 100 V using 20pl of sample and 5pi of 5x loading buffer. The recombination
PCR products were run out on a 2% gel (w/v) for 2 hours at 100 V using 20 pi of
sample and 5 pi of 5x loading buffer.
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All gel electrophoresis was carried out using a BioRad powerpack Junior. All
samples were visualised on a Gel Doc 2000 from Biorad using the Quantity One
software.
2.6.4 PCR assays
All PCR assays were carried out in 50pl volumes, using 5pl lOx PCR buffer, 2pl 25
mM MgCb, 1 pi 25 mM dNTP and 2.5 units of Taq DNA polymerase. All primers
were used at 300 ng per reaction. To obtain 50pi of solution for the PCR assay,
DDW was added accordingly. Typically, 100 ng ofDNA were added to each
reaction. All primer sequences are summarised in Table 0. All reactions were run on
a Thermocycler (Biometra).
The TTR-Cre transgene was detected by PCR with the forward primer being Cre-
derived and the reverse primer being MER- derived (see Figure 3). PCR conditions
were as followed: 94°C for 5 minutes, 94°C for 1 min followed by 60°C for 1 minute
and 72°C for 2 minutes for 30 cycles, 72°C for 10 minutes. The expected product
size was 1350 bp.
For detection of the Erccl Null allele, a PCR was performed using forward primer
M4956 and reverse primer 035M (see Figure 2). The PCR reaction was run at 94°C
for 5 minutes, 35 cycles of 94°C, 68°C and 72°C for 1 minute each and 72°C for 10
minutes. The expected band size was 800 bp.
For detection of the Flox and Wt alleles forward primer 432E and reverse primer
F25732 were used to detect a 500 bp band for the Flox allele and a 1050 bp band for
the Wt allele (see Figure 2). The PCR conditions were 94°C for 5 minutes, 35 cycles
of 94°C and 63°C for 1 minute and 72°C for 2 minutes 30 seconds, 72°C for 10
minutes.
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Recombination was visualised by PCR with the forward primer being F25731 and
the reverse primer being F25732, giving a 250bp product (see Figure 2). The PCR
conditions were as follows: 94°C for 5 minutes, 94°C for 1 minute followed by 68°C
for 1 minute and 72°C for 30 seconds for 35 cycles, 72°C for 10 minutes.
For estimation of recombination by PCR, the amounts ofDNA were matched using a
spectrophotometer (Thermo Spectronic Biomate 3). In addition, EcoRI digestion (see
Southern blotting below) was performed on all samples to further match the amounts
ofDNA used per sample for PCR. Under the above recombination PCR cycle
conditions, the amount of PCR product is directly related to the input ofDNA, giving
this PCR assay a semi- quantitative quality. Densitometry was used to estimate the
amounts of recombination between samples. Pictures were taken with the Quantity
One software. The individual recombination PCR products were marked and the
band intensities of the samples compared to the band intensity of the recombination
control. The recombination levels in all samples were expressed as percentage of
recombination compared to the control.
2.6.5 Histology
Liver samples were fixed in 10% formalin buffered in PBS and processed to obtain
haematoxylin and eosin (H&E)- stained slides using standard histological methods.
Histology was carried out by Mr Robert Morris. For Oil Red O analysis, liver
samples were frozen in OCT compound and stored at -70°C until cryosections were




Images from slides were taken using an Olympus BX 51 microscope and the
Olympus DP software. To estimate the amount of necrosis after carbon tetrachloride
treatment, several pictures of the same liver were taken using a 20x objective. All
necrotic islands were marked and the total amount ofmarked area was calculated.
This amount was compared to the total amount of area examined and necrotic area
expressed as a percentage of the total area examined.
2.6.7 Triglyceride assay
Triglyceride content was analysed as described in Morton et al. (2004). 100 mg liver
was used per sample. Samples were homogenised using a hand- held Fisher
homogeniser in a glass test tube in 2 ml isopropanol, taking care not to lose any fluid.
The test tubes were covered and shaken in a flatbed shaker (Stuart) for 45 minutes to
extract the lipids. Centrifugation (Sigma 4 k 15) at 3000rpm for 10 minutes was
followed by assaying the supernatant. To 10pi of supernatant 1ml ThermoTrace
Triglyceride reagent was added and all samples were incubated in a water bath
(Grant) at 37° C for 5 minutes, allowing triglycerides to be recovered from all
samples. A ThermoTrace Triglyceride standard was diluted with lx PBS to obtain a
standard curve. The absorbance of all samples was read on a Biomate 3
spectrophotometer (ThermoSpectronic) at 500nm. All calculations were performed in
Microsoft Excel. The standard curve method was used to estimate the triglyceride
content per liver sample. Before each run, a machine calibration check for
linearity/limits of assay was performed using the Lipid Lin-Trol Set.
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2.6.8 Malondialdehyde analysis
The immunoslot blot method is an antibody based approach to visualise DNA
adducts in a variety of tissues. Malondialdehyde adducts were determined using the
immuno slotblot technique with assistance ofDr R. Singh. 1 pg ofDNA was used per
sample and the procedures followed as described by Singh et al. (2001). In short,
single stranded DNA was prepared and pipetted onto a nitrocellulose filter. A 5%
Marvel solution was used to block non- specific binding of antibodies before
exposure to the primary deoxyguanosine malondialdehyde antibody. A horseradish
peroxidase- conjugated secondary antibody was used to visualise the deoxyguanosine
malondialdehyde adducts when exposed to a chemiluminescent reagent in
combination with a X- ray hyperfilm. The band intensity was calculated using image
analysis software. All samples were run in triplicate. A malondialdehyde-
deoxyguanosine standard was created and used for comparison. The mean and the
standard deviation were calculated for all samples using Microsoft Excel.
2.6.9 Reactive oxygen species (ROS) assay
Erccl Null and Wt livers were sampled and cut into small pieces. Collagenase IV
treatment of the cells was performed using 10 mg of collagenase in 120 ml of plating
medium ex- vivo. The dissected liver pieces were re-suspended in lx HBSS and a
centrifugation step at 500 rpm using Percoll (see below) performed to separate live
from dead hepatocytes. Viability of the cell suspension was estimated using trypan
blue and the hepatocytes were plated into 24 well plates at a density of 1.3 xl 06 live
cells/ml. CM-HbDCFDA, a cell permeable diacetate ester which fluoresces green
upon reaction with ROS, was used to determine the amount ofROS in Erccl Null
and Wt hepatocytes obtained from animals aged 5-21 days. CM-KfDCFDA was
diluted in DMSO to give a lOOpM stock solution. A lOpM solution ofCM-
H2DCFDA was obtained by adding lx HBSS. This solution was added to Erccl Null
and Wt hepatocytes. In addition, 100pU Glucose oxidase (GO) was added Wt
58
hepatocyte wells as a positive control. DMSO and lx HBSS were added to Wt
hepatocyte wells as a negative control. All samples were run in triplicate. The
amount ofROS activated fluorescence was measured every minute over 1 hour at
37°C using a Synergy HT Fluorimeter (BioTek) with KC 4 software (BioTek). The
excitation laser was set to 485 nm and the fdter was set to 510 nm. The amount of
ROS was normalised to the amount of protein in each well determined using the
Lowry protein assay (BioRad). Cells were lysed in 100 mM Tris and 2% SDS and
the manufacturer's instructions were followed. The amount of protein was
determined using a MRX spectrophotometer (Dynex technologies) at an absorbance
of 630nm. The mean and the standard deviation were calculated using Microsoft
Excel.
2.7 Laboratory based methods
2.7.1 Southern blotting
To estimate the level of recombination in hepatocyte cultures and liver a Southern
blot was carried out. Southern blotting was invented by E. M. Southern in 1975. This
method can help with the determination of the molecular weight of a restriction
fragment and the measurement of relative amounts in different samples (Alberts
1994). In short, genomic DNA is digested with a restriction enzyme and separated by
gel electrophoresis. DNA samples are then transferred from an agarose gel onto a
membrane which is then incubated with a single-stranded DNA probe. This probe
will form base pairs with its complementary DNA sequence and bind to form a
double-stranded DNA molecule. Before hybridisation of the membrane the probe is
labelled with radioactive material or with an enzyme such as HRP. Detection of the
probe is achieved by directly exposing the membrane to X-ray film or by
chemiluminescent methods. 15pg ofDNA was added to 80 units ofEcoRI in 10 pi
of lOx Digestion Buffer, 6 units ofRNase A and 10 pg of lOx BSA. The solution
was made up to lOOpl with double distilled water (DDW). The digestion was carried
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out at 37°C in a Grant water bath overnight. 50 pi of digested samples were run out
onto a 0.8 % gel at 45 V overnight. The gel was denatured for 30 minutes in
denaturing buffer on a Rotatest flatbed shaker (Luckham). The Genescreen Plus
Hybridisation Transfer Membrane was soaked in DDW and denaturing buffer. The
gel was then blotted onto the membrane in denaturing buffer overnight. The
membrane was neutralised in neutralisation buffer for 20 minutes. The membrane
was baked in a vacuum oven (Gallenkamp) at 80°C for 4 hours and prehybridised in
10 ml hybridisation buffer, containing 3.5 mg of denatured herring sperm DNA, in
an incubator (Hybaid) at 65°C for 2 hours. The probe to detect the recombined and
Wt allele was a 600 bp product spanning exon 1 and 2. The probe was denatured and
labelled with 32 P using lOpl of Oligo labelling buffer, 20 pg of lOx BSA, 2 units of
DNA polymerase I large fragment and 50 pCi of (a-32 P)- dCTP. The cleaning of the
probe from unincorporated nucleotides was done through chromatography using a
NIKK column. The column was equilibrated with 400pl of TE prior to use and 400pl
of TE was added to the probe twice. 4.5 mg of denatured herring sperm DNA was
then added to the flow through and used to hybridise the membrane in the rotator
oven at 65°C overnight. The membrane was washed at room temperature in 2x SSC
for 5 minutes twice and then washed in 2x SSC and 1% SDS in the rotator oven at
65°C for 2x 30 minutes. The last washing step was done in O.lx SSC at room
temperature twice. The membrane was sealed and exposed onto film (Kodak) at
-70°C overnight. The Hyperprocessor (Amersham Biosciences) was used to develop
the film. Alternatively, phosphoimagery was performed to visualise the Southern blot
products. The membrane was exposed to a storage phosphor screen (Molecular
dynamics) at room temperature overnight and signals visualised on a phosphoimager
(Molecular dynamics). Data were analysed with the ImageQuant software. A titration
curve of levels of recombination from 100%- 0% was obtained by diluting varying
amounts of a cell culture sample with 100% recombination into genomic Flox/Flox
DNA so that the total amount ofDNA in each of the titration curve samples was
15pg. The 5.5 kb fragment is produced from the Wt, Null and non- recombined Flox
alleles (this region on the gene is identical in these three alleles) and the 3.05 kb
fragment is from the recombined Flox allele. Southern blotting was performed with
assistance from Dr J. Selfridge.
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2.7.2 Western blotting
Western blotting is an antibody based method that allows for determination of
relative amounts of the protein between samples. Briefly, samples are homogenized
in a buffer that protects the protein of interest from degradation. Separation of the
proteins is achieved using SDS-PAGE (SDS polyacrylamide gel electrophoresis).
The proteins are then transferred from the gel onto a membrane. The membrane is
incubated with a blocking protein which binds to any remaining sticky places on the
membrane. A primary antibody is added binding to the target protein. A secondary
antibody, which can be visualised, recognizes the primary antibody, helping with the
location of the protein in question. Cells were lysed with lysis buffer. 60 pg of total
cell protein was subjected to SDS/PAGE. 4x Protein sample buffer was added to
each sample to protect against denaturing of protein. The samples were loaded onto a
12 % acrylamide gel and run at 140V for 2 hours to separate proteins of different
size. A Kaleidoscope prestained standard was used for comparison. The gel was then
transferred onto an Immobilon-P transfer membrane using the Biorad (Hercules, CA)
Trans-Blot SD semi-dry Transfer Cell at 12 V for 1 hour. Prior to the transfer, the
membrane was soaked in transfer buffer to help protein transfer. In addition, the
membrane was embedded in blotting paper, which was saturated with transfer buffer.
A 5% Marvel solution was used to prevent non- specific antibody binding at 4° C
overnight. The primary antibody was a crude rabbit anti- Erccl antibody used at a
1:1000 (antibody: lx TBST) dilution at 4° C overnight. The secondary goat anti-
rabbit IgG antibody was used at a dilution of 1:200 000 (antibody: lx TBST) at room
temperature for 1 hour. The membrane was washed in lx TSBT for 1 hour in
between incubations. The membrane was exposed to ECL film after the ECL-plus
Western blotting detection system was used to visualise the protein bands. The
expected band size was 33 kDa. All amounts of protein were matched by eye using
Coomassie stain to visualise the band intensity on a second gel with similar loading.
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2.7.3 Flow cytometry
Flow cytometry is a method used to determine a single cell's characteristic as it
passes in a fluid stream by a beam of laser light. Depending on the nature of the light
scattered by the cell while passing the laser, cell size, granularity and more specific
characteristics such as DNA content can be determined. The principles of flow
cytometry for determining DNA content were first described by Vindelov (1977).
DNA content was determined in hepatocytes and liver samples. Individual
hepatocyte nuclei were prepared for flow cytometry. Tissue was cut into small pieces
or dishes were scraped and re-suspended in 100 pi of citrate buffer. Cells were
trypsinised for 10 min in 450 pi of solution A. Trypsin was subsequently inhibited by
320 pi of solution B containing trypsin inhibitor and ribonuclease A to degrade
cellular RNA. Cells were incubated in 250 pi of solution C containing propidium
iodide at 4°C for 10 min. Propidium iodide is a nucleic acid dye that intercalates in
the DNA double helix. It fluorescences red when exposed to laser light (488nm).
Depending on the DNA content, the extent of the fluorescence captured by the
FACScan varies. Typically, 10 000 nuclei per sample were analysed on the Coulter
Epics XL machine using Expo 32 (Beckham Coulter) and Multi cycle (Phoenix Flow
Systems) software.
2.7.4 RNA isolation
Total RNA for RT Real- time PCR was isolated using the Qiagen RNeasy kit. The
manufacturer's instructions were followed. In short, samples were stored at -80 °C in
RNAlater until processed. RNA was extracted from ca.10 mg of liver sample. The
tissue was homogenised in 300 pi Buffer RTL using a hand- held homogeniser
(Fisher). Buffer RTL contains guanidine isothiocyanate and (1- mercaptoethanol
ensuring denaturing of the tissue and inactivation ofRNases. Ethanol was then added
to the lysate, helping selective binding of total RNA to the silica- gel membrane. In
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addition, samples were treated with 2 units DNase to remove any DNA
contamination. All samples were re-suspended in 80 pi ofDDW and stored at-70°C.
2.7.5 Estimation of RNA concentrations
Concentration ofRNA samples was estimated using spectrophotometry. The
absorbance of diluted RNA was measured at 260 and 280nm using the Biomate 3
spectrophotometer (Thermo Spectronic). 40pg/ml ofRNA represents an
OD260nm=l-0. In addition, the ratio of OD260nm/OD280nm is an indication of nucleic
acid purity with a ratio of 2 indicating no significant contamination with protein.
2.7.6 Reverse Transcription (RT)- PCR
cDNA for Real- time PCR was obtained using RT- PCR. MMLV reverse
transcriptase was chosen as its cDNA synthesis rate is up to 40 times greater than
that of avian myeloblastosius virus (AMV) reverse transcriptase (Bustin 2004). In
addition the choice of a random oligo dT primer, which anneals to the
polyadenylated 3' (poly- A) tail found in most mRNAs, rather than a specific primer,
allows the amplification of a number of different mRNA from the same cDNA.
RNase free water and 50 ng oligo dT was added to 3 pg ofRNA to give a total
volume of 11 pi and incubated at 70 °C for 10 minutes. The samples were
subsequently chilled on ice. 4 pi of 5x synthesis buffer, 10 mM dNTP mix, 0.1M
DTT and 200 units ofMMLV reverse transcriptase enzyme was added to each
sample. All samples were incubated for 10 min at room temperature. The tubes were
heated to 37 °C for 60 minutes to allow cDNA synthesis. The reaction was finally
terminated by heating to 90 °C for 10 minutes. After chilling the tubes on ice for 10
minutes, 1 unit ofRNase H was added to the reaction followed by 20 minutes
incubation at 37 °C to ensure elimination of remaining mRNA. All samples were
stored at -70 °C.
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2.7.7 Real-time PCR
Real- time PCR requires a specific, fluorescence probe for detection of cDNA levels.
In the TaqMan assay, a probe longer than the primers contains a fluorescent dye on
the 5' base along with a quenching dye on the 3' base. In the intact probe, the energy
of the excited fluorescent dye is transferred to the quencher rather than resulting in
detectable fluorescence. TaqMan probes are designed to anneal to an internal region
of a PCR product. During PCR amplification, the 5'- 3'- exonuclease activity of Taq
DNA polymerase separates the fluorphore and the quencher leading to an increased
fluorescent signal. This fluorescent signal increases with each cycle proportional to
the rate of probe cleavage. Real- time PCR exploits the characteristics of a PCR
reaction where 4 phases can be distinguished: the 1st phase consists of an exponential
amplification of fluorescence hidden under the background fluorescence level. In the
2nd phase, an exponential amplification can be detected above the background which
then increases during the 3rd step where the fluorescence intensity is linear to the
amplification efficiency. A plateau is then reached in the 4th step (Bustin 2004). The
amount of amplified target is known to be directly proportional to the input amount
of target during the exponential phase of the PCR amplification. Therefore, selection
of the threshold should be placed within this region. All sample cDNA was diluted
1:9 in RNase free water. A standard curve using Wt liver cDNA was created for each
gene of interest. Serial dilutions were carried out to give 1:1, 1:3, 1:9, 1:27, 1:81, 1:
243 of cDNA in RNase free water. The Taq Man© system with 2x Taq Man©
universal PCR mix and 20x Assays on demand Assay mix was used for all reactions.
The Assay on demand mix contained the primers for each reaction and the probe
with the fluorescent FAM- 490 (Table 0). Each reaction contained lOpl ofPCR mix
and 1 pi ofAssay mix with 9 pi of diluted cDNA. All samples were done in triplicate
and 20pl/reaction was loaded onto a 96 well plate. Each plate contained a no
template control (NTC) without cDNA. RNA only was loaded once per sample to
check for RNA quality. We wanted to exclude the possibility that DNA
contamination, resulting from the RNA isolation procedure, rather than actual
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amplification of cDNA was responsible for the signals obtained. The PCR was
carried out on a Biorad My iO single colour PCR detection system (Biorad). The
PCR protocol used was 2 minutes 50°C, 10 minutes 95°C, and 15 seconds 95°C and
2 minutes 60°C for 40 cycles. All samples were analysed using Microsoft Excel and
the standard curve method following Larionov et al. (2004). The threshold was
selected automatically, a standard curve created and all means and variances were
calculated for the PCR replica using MyiQ software. Tbp and Gapdh were chosen as
reference genes for which the geometric mean was calculated to receive a single
normalisation factor for each sample. Non- normalised values were divided by the
normalisation factor. The final results were expressed as the ratio between Erccl
Null and Wt samples, showing the mean of two different plates and the standard
error of the mean.
2.8 Cell culture methods
2.8.1 Hepatocyte isolation
A two-step perfusion protocol was established to isolate hepatocytes from mice.
9-4- • _
Livers were perfused with a Ca - free Perfusion medium to allow opening of
desmosomes and removal of blood from the liver. This step was followed by a
second perfusion step with 120 ml Leibowitz 15 medium containing 25 mg
collagenase for enzymatic separation of hepatocytes. Collection of hepatocytes was
achieved through a centrifugation step at 270 rpm, followed by a second
centrifugation using Percoll at 340mOsm/kg to eliminate dead hepatocytes. Percoll is
composed of colloidal silica coated with polyvinylpyrrolidone and forms a density
gradient upon high speed centrifugation. Its low viscosity, its compatibility with
living cells and its impermeability into biological membranes helps to isolate dead,
lighter cells from live, heavier cells. Cell viability was determined using the trypan
blue exclusion method. Cells were plated at a density of 0.13xl06 cells/ml on
fibronectin- coated 60 mm2 petri dishes or 2- well chamber slides in DMEM
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containing AdenoCre virus for 2.5hrs (see below). Uninfected control dishes
received DMEM only for the same amount of time. Medium was changed twice to
stop further infection of the virus and all cells were cultured in modified Chee's
medium.
2.8.2 Tamoxifen in culture
Tamoxifen citrate was diluted in 50% ethanol to obtain a 5 mM solution. All other
dilutions were performed in Chee's medium until a final concentration of 500 nM
was reached. Medium was aspirated and the tamoxifen solution was then added to
the cultures for a period of 24 hours. Aspiration ofmedium was followed by two
washes with lxPBS and replacement with Chee's medium only until cells were
harvested.
2.8.3 AdenoCre in culture
AdenoCre virus was diluted in plating medium to obtain a multiplicity of infection
(MOI) factor of 10. This infection medium was added to petri dishes or chamber
slides and left in the incubator at 37°C and 5% CO2 for 2.5 hours. Plates were then
washed with modified Chee's medium twice and subsequently cultured in modified
Chee's medium.
2.8.4 Thymidine incorporation
Dishes were rinsed with serum- free Glasgow- modified Eagle's medium and
incubated with serum- free medium containing 1 pCi/ml 3H- Thymidine at 37°C for
3 hrs. Cells were rinsed with PBS and lysed with 1% SDS at room temperature. 20%
cold TCA was added and stored for 90 min at 4 °C to precipitate nucleic acid
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polymers longer than 20 nucleotides and to separate radioactively labelled
nucleotides from unincorporated label. All samples were fdtered using 10% TCA.
The filters were dried and then read in the scintillation counter Tri Carb 2100 TR
(Packard) in Ultima Gold fluid (Packard Biosciences).
2.8.5 BrdU staining
For BrdU staining DNA replication is used to replace thymidine with BrdU in the
DNA structure of dividing cells both in vitro and in vivo (Gage et al. 2000).
Hepatocytes were incubated in 40pM BrdU for 6 hours at 37°C allowing BrdU
incorporation. Cells were fixed in 80% ethanol at 4°C overnight and rinsed in PBS
for 10 mins. All slides were incubated in 5M HC1 for 45 mins on a rocker at room
temperature and washed with PBS. Slides were then incubated in 1% H2O2 for 10
mins to block any intrinsic peroxidase activity and washed twice with PBS. Slides
were covered in blocking solution for 10 mins at room temperature and incubated in
anti- BrdU antibody diluted 1:100 with blocking solution for 1 hour. After a wash
with PBS, slides were covered with rabbit anti- rat FIRP diluted 1:100 with blocking
solution for 30 mins at room temperature. Another wash with PBS was followed by
incubation with DAB solution at room temperature, visualising the BrdU
incorporation in each nucleus. Slides were rinsed in water, counterstained with 0.1%
haematoxylin (w/v) and 0.1% light green (w/v) and mounted in cedarwood oil.
2.8.6 Feulgen staining
Slides were fixed overnight in Bouin's fixative at 4°C and then incubated in
denaturing solution made of 5M HC1 for 45 mins at room temperature. All slides
were washed in water and stained with Schiff s reagent for 1 hour at room
temperature. Slides were thoroughly washed in water until pink colour developed
67
and counterstained with 0.1% light green (w/v). All slides were mounted in
cedarwood oil and stored at 4°C in the dark.
2.8.7 Comet assay
The comet assay is a single cell gel electrophoresis method that was introduced in
1984 by Ostling and Johanson to measure DNA damage in individual cells. This
method was subsequently further developed by Singh et al. (1988) who used a more
versatile alkaline based method to measure DNA strand breaks with high sensitivity.
In summary, cells are embedded in agarose and nuclei are lysed to remove cellular
protein. DNA unwinding is done under alkaline conditions and separated by gel
electrophoresis. Finally, DNA is stained with a fluorescent dye to visualise the
broken or damaged DNA that, during gel electrophoresis, migrated away from the
nucleus. The extent ofDNA liberated from the head of the comet is directly
proportional to the DNA damage. Intact hepatocyte nuclei were prepared for the
comet assay. 0.13xl06 cells were rinsed in ice- cold PBS, followed by a 5 min
incubation of 1.4 ml swelling buffer to help hepatocytes detach from the fibronectin-
coated slides. 140pl lysis buffer 1 was then added to the hepatocytes and cells were
incubated on ice for 5 min under intermittent shaking. Aliquots of 2x700 pi were
prepared per dish and centrifuged on a layer of 700 pi 0.6 M sucrose in TE buffer at
4°C and 4000 rpm for 5 min. All pellets were gently dispensed in 100 pi PBS and
140 pi 1.5% low melting point agarose was added. By placing a coverslip over 70 pi
of agarose and nuclei suspension on agarose- coated slides, a gel was formed at 4°C.
The extracted nuclei were then incubated in lysis buffer 2 for 5 min, followed by 3
washes in cold enzyme buffer. Half of the aliquots were incubated with
formamidopyrimidine- DNA- glycosylase (Fpg) at 37°C for 1 hour and the other half
with buffer only. Alkaline unwinding in electrophoresis solution was done for 10 min
and nuclei were subjected to electrophoresis at 300mA for 10 min. Samples were
washed with neutralising buffer and stained with propidium iodide. All nuclei were
analysed using a fluorescence microscope (Olympus) and the Komet software
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(Kinetic Imaging Ltd., Liverpool). 50 nuclei per sample were analysed at random and
the mean and standard deviation calculated.
2.8.8 Oil Red O stain on slides
Cytoplasmic lipids were stained red with Oil Red O to examine the amount of lipid
accumulation in hepatocytes. Slides were incubated in 100% propylene glycol for
3x5 mins on a flatbed shaker (Stuart) at room temperature. Oil Red O stain was
dissolved in 100% propylene glycol and filtered before use. Slides were incubated in
Oil Red O solution for 1 hour on a flatbed shaker (Rotatest) at room temperature and
subsequently washed in 85% propylene glycol for 5 mins. Slides were rinsed in
DDW and cells were counterstained with 0.1% haematoxylin (w/v). Slides were
mounted using glycerol.
2.8.9 DNA damaging agents
Three days after plating and infection, hepatocytes were challenged using three
different DNA damaging agents. Glucose oxidase, an oxidative damage inducer, was
given at 1, 5, 10, 50 and 100 pU in lxHBSS per dish. Cells were incubated at 37°C
for one hour, washed with PBS and fresh Chee's medium was added. For UVC
irradiation, which induces lesions repaired by NER, medium was aspirated off all
dishes and a small amount of PBS was added before irradiation. Cells were given 50
J/m2, 20 J/m2, 10 J/m2, 5 J/m2 and 2 J/m2 ofUVC irradiation using a UVGL-58
Miniregalight lamp (Ultra- Violet Prod. Inc.). Hepatocytes were incubated in 10
pg/ml, 5 pg/ml, 2 pg/ml and 1 pg/ml ofMitomycin C, an interstrand cross- link
inducer, in Chee's medium for 24 hrs. Cells were washed with PBS and fresh Chee's
medium was added.
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3. Use of Erccl floxed TTRCre mice to create a conditional,
liver- specific knockout mouse model in vivo and in vitro
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Erccl knockout mice die before weaning at 3 weeks of age (McWhir et al. 1993),
making it difficult to characterise the liver phenotype and to determine the lesions
responsible. We therefore decided to establish a liver- specific, conditional Erccl
knockout mouse to enable us to control the onset ofErccl- deficiency in liver only.
We decided to use a tamoxifen inducible Cre recombinase- loxP system as a similar
system had already proven successful in our laboratory where a skin- specific Erccl
knockout was created (Doig et al. 2006).
Our Cre recombinase, with a mutated murine oestrogen receptor (MER) fused to
both terminals was linked to the liver- specific transthyretin (TTR) promoter (Verrou
et al. 1999, Tannour- Louet et al. 2002). The TTR gene sequence consists of 3 kb of
regulatory sequence, exon 1, intron 1 and part of exon 2 with all potential ATG start
codons in exon 1 and 2 being mutated (Figure 3).
A mutation in the oestrogen receptor at amino acid 525 leads to the replacement of a
glycine with an arginine (Danielian et al. 1993). The mutated oestrogen receptor has
lost its ability to bind to 17 P- oestradiol and can only be activated when the
oestrogen receptor antagonist tamoxifen is present. Introduction of the transgene into
mice results in liver- specific expression of Cre recombinase (Tannour-Louet et al.
2002).
In the cytoplasm, the chimeric Cre is complexed by the heat shock protein 90
(hsp90), leaving the chimeric Cre recombinase in an inactive state (Figure 4). Upon
tamoxifen administration, the hsp90 is released from the Cre recombinase, resulting
in a translocation of chimeric Cre into the nucleus. Once in the nucleus, Cre
recombinase can detect the loxP sites and excise the Erccl region between exons 3-5
(see Figure 4). This results in a loss of function for Erccl in the liver.
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3.1 Breeding of TTRCre Erccl Flox animals
TTRCre mice were obtained from Dr M. Vasseur-Cognet (Tannour-Louet et al.
2002) and crossed onto animals that were heterozygous for Erccl deficiency (Erccl
Wt/Null) (Figure 1). TTRCre Erccl Wt/Null heterozygotes were then mated with
Erccl Flox/Flox animals. This cross resulted in TTRCre Erccl Flox/Null
experimental animals and TTRCre Erccl Flox/Wt animals which we used as
controls.
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TTRCre Erccl Wt/Wt Erccl Wt/Null
I
I I




TTRCre Erccl Flox/Null TTRCre Erccl Flox/Wt Erccl Flox/ Null Erccl Flox/Wt
Experimental Control
Figure 1: Breeding scheme for the production of TTRCre Erccl Flox/Null and TTRCre
Erccl Flox/Wt mice. In both generations, the ratios of offspring are
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3.2 PCR assays for detection of TTRCre transgene, Erccl Null, Wt,
recombined and Flox alleles
A PCR protocol for detection of the Erccl knockout allele was set up (Figure 2). The
Erccl knockout was originally achieved by introducing a NEO cassette into exon 5
of the Erccl gene (McWhir et al. 1993). Primers were located in the NEO cassette
(M4956) and in exon 5 (035M) to give an 800 bp long product specific for the Erccl
knockout allele. The Flox allele was detected by placing one primer in exon 5
upstream of the 3' loxP site (432E) and another primer 3' of the loxP site in intron 5
(F25732). A 500 bp band indicates the Flox allele. In addition, a 1050 bp band for
the Wt allele is detectable with the same primer pair (Figure 2). The difference in
PCR product size of the Flox and Wt alleles results from the deletion of several
hundred base pairs of intron 5 during loxP introduction, giving a shorter band for the
Flox allele.
Recombination of the Flox Erccl locus could be detected by placing primers
immediately upstream of the 5' loxP site (F25731) and immediately downstream of
the 3' loxP site (F25732) (Figure 2). No PCR product can be produced when the
locus is not recombined as the primers are too far apart. Upon recombination, the
exon 3-5 region is excised, the primers become located close to each other and a 250
bp band can be detected by PCR.
A PCR assay for detection of the TTRCre transgene in my animals was established.
The primers were located in the Cre recombinase sequence (Cre) and the murine
oestrogen receptor (Mer) sequence of the TTRCre transgene (Figure 3). The resulting
PCR product was 1350 base pairs (bp) long. Figure 4 illustrates the TTRCre Erccl
floxed model and the recombination event itself in detail.
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Figure 2: Schematic of the central region of the Erccl Wt, Flox, Null and recombined loci
(A) Erccl Wt and Erccl Flox loci. Exons are numbered and shown as boxes. LoxP sites are
marked as large arrow heads. Location of the primers is represented by small arrows and
PCR band size is indicated. A gel with the PCR products for primers 432E and F25732 is
shown for Flox/Null and FloxA/Vt. The difference in size between Wt and Flox bands results
from partial deletion of intron sequence during introduction of the loxP site. (B) Erccl
knockout (KO) locus. The NEO cassette was inserted into exon 5, leading to a disabled
Erccl allele. The PCR product for primers M4956 and 035M is shown for the Erccl Flox/Null
sample and a lack of product is shown for Erccl Flox/Wt. (C) Erccl recombined locus. Upon
recombination of the Flox allele, the distance between primers F25731 and F25732 narrows




TTR I - II MER Cre MER
3 kb 318 bp 1050 bp 318 bp
Expected PCR product: -1350 bp
Transgene
Figure 3: Schematic of the TTRCre transgene. Cre recombinase (Cre) is flanked by two
ligand- binding domains of the murine oestrogen receptor (MER). A mutation at amino acid
525 (G525R) ensures that the MER receptor is only responsive to tamoxifen. Upstream of
the MERCreMER construct, the 3 kb regulatory region containing the murine TTR promoter,
exon 1 and intron 1 and most of exon 2 are used to drive liver specific transcription.
Location of the primers is marked with small arrows and the band size indicated. A gel with
the PCR products is shown for TTRCre and Wt livers.
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(A) TTR driven Cre recombinase
I TTR TT1—Ull MERCreMER
(B> Cre activation
MJx
Tamoxifen 1 + <MERCreMER/
<c) Floxed Erccl
1 2 toxP 3 4 5 foxP 6 7 8 9 10
^ [Tamoxifen!—iMERCreMERl
Recombined Erccl Gene
1 2 loxP 6 7 8 9 10IOX
Figure 4: Schematic of Cre recombinase activation and the recombination event. (A)
TTRCre transgene. (B) Cre recombinase activation upon tamoxifen administration. In the
cytoplasm, chimeric Cre is complexed by the heat shock protein 90 (hsp90). In the presence
of tamoxifen, the chimeric Cre is released from hsp90 and translocated into the nucleus
where the Cre recombinase drives the recombination event upon recognition of loxP sites.
(C) Schematic of the Flox and recombined Erccl loci. Activation of Cre recombinase is
initiated by tamoxifen administration. The Cre recombinase recognises the loxP sites and
recombines the Flox Erccl allele, leading to an excision of the Erccl region spanning exons
3-5.
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3.3 Establishment of primary hepatocyte cultures
I established a two- step perfusion protocol for primary hepatocyte cell culture to
investigate the role ofErccl in vitro. Yield of primary hepatocytes was improved
from lxl 06 to 16.3xl06 by reducing the amount of collagenase used during the
perfusion from 75 mg to 25 mg (Table 1, isolations 2 and 5). In addition, viability
improved from 45% to 80%. I reduced the centrifugation speed from 600 rpm to 500
rpm as this seemed to be a milder treatment during hepatocyte isolation, although no
clear effect could be seen on yield and viability. The perfusion time was increased
from 8 min to 10 min and an improvement in yield and viability could be seen when
comparing isolations 5 and 6 in Table 1. The effect of Percoll on the hepatocyte
cultures was investigated. Without using Percoll during the second centrifugation
step, the yield improved from 5.18xl06to 12.5xl06, but the overall viability was
compromised (isolations 3 and 4, Table 1). The effect of Percoll was further
examined by subjecting Percoll treated and untreated hepatocyte populations to flow
cytometry (Figure 5). Large amounts of apoptotic material and/or cell debris can be
seen in isolations done without using Percoll when compared to Percoll treated
isolations. Typically, a yield of 29x106 and a viability of 88% were achieved by using
25 mg collagenase for 10 min, spinning the cells at 500 rpm and including the use of
Percoll in the second spin. This protocol was used for establishment of subsequent
cultures.
I went on to determine basic hepatocyte parameters ofmy Wt cultures looking at
apoptosis, S-phase, development of tetraploidy and H- thymidine incorporation from
day 0 to day 9 (Table 2). S-phase was low initially with a peak of 4% at day 3 and a
subsequent stabilisation to a rate of 2% in older cultures. Wt hepatocyte replication,
as determined by 3H- Thd incorporation, increased steadily from day 1 in culture
with a peak at day 5 and subsequent lower levels in older cultures. In addition, cells
showed low levels of apoptosis immediately after plating with a peak of 24% at day
3 and only slightly lower levels of 16-19% in older cultures. No change in polyploidy
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was detected in any of the cultures over time. Thus, a basic hepatocyte cell culture
system was established for use on Erccl Flox/Wt and Flox/Null hepatocytes.
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Table 1: Summary of the conditions used for hepatocyte isolation. + indicates the use of
Percoll and - the absence of Percoll during the second spin. Best yield and viability were












1 75 8 + 600 1x106 29
2 75 8 + 500 1x106 45
3 50 8 + 500 5.18x10® 80
4 50 8 - 500 12.5x10® 48
5 25 8 + 500 16.3x10® 80




Without Percoll Wth Percoll
Figure 5: Flow cytometry profiles showing the effect of Percoll during hepatocyte isolation.
Cell cultures were set up from isolations made with and without using Percoll. DNA content
is shown at day 3 after plating. The different cell populations are labelled.
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Table 2: Basic hepatocyte parameters obtained from wild type hepatocyte cultures over 9
days. Apoptosis, S-phase and tetraploidy values were obtained by flow cytometry. Apoptosis
is shown as percentage of all cells. S-phase and tetraploidy are expressed as the
percentage of all viable cells. Tritium labelled thymidine (3 H- Thd) incorporation was
measured on three different dishes for each time point. The mean CPM (counts per minute)
and SEM (standard error of the mean) are shown.
Parameters Dav 0 Dav 1 Dav 3 Dav 5 Dav 7 Dav 9
Apoptosis
(% of all cells)
0.5 15 24 19 16 17
S-phase
(% of viable cells)
0.6 3 4 2 2 2
Tetraploidy
(% of viable cells)
38 31 26 33 29 27
3H-Thd












3.4 Tamoxifen citrate treatment of primary hepatocyte cultures
Tamoxifen citrate was brought into solution by addition of absolute ethanol. All
further dilutions were done with modified Chee's medium until a tamoxifen
concentration of 500 nM was obtained. This solution was added to TTRCre Erccl
Flox/Null hepatocytes. Control dishes received Chee's medium only. DNA samples
were taken 24, 48 and 72 hours after tamoxifen citrate addition. DNA content was
matched by spectrophotometry and a semi- quantitative recombination PCR was
performed. DNA from a cell line with 100% recombination was used for
comparison. A faint band could be seen 48 hrs after tamoxifen treatment, but not at
other time points (Figure 6). When a TTRCre transgene PCR was done on the same
samples, all samples showed a strong transgenic band, indicating that the DNA was
of sufficient quality. When I repeated this experiment using Flox/Wt and Flox/Null
cultures, no recombination could be seen at any of the time points (data not shown).
When higher doses of tamoxifen citrate were given to the cultures, hepatocytes
showed high levels of cell death (data not shown). I was therefore unable to achieve
high levels of recombination in vitro by tamoxifen administration to TTRCre Erccl
Flox/Null or Flox/Wt hepatocyte cultures.
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Recombination PCR
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Figure 6: Recombination PCR on TTRCre Erccl Flox/Null hepatocyte cultures. 500nM of
tamoxifen citrate was added to hepatocyte cultures and DNA taken at 24, 48 and 72 hrs afte
tamoxifen addition. Recombination could only be detected at 48 hours. A control cell line with
100% recombination is shown for comparison. A TTRCre PCR was performed on all
samples to determine DNA quality. Positive controls are indicated as + and negative controls
as -. An untreated control hepatocyte culture is shown for comparison.
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3.5 4- Hydroxytamoxifen (4-OHT) treatment in vivo
To test the TTRCre inducible system in combination with our Flox Erccl gene as
soon as possible, we mated TTRCre mice with Erccl Flox/Null mice when the
transgenics from France were still in the isolator. Initially, 4- hydroxytamoxifen was
used for induction of recombination in vivo which was in accordance with Tannour-
Louet et al. (2002). As a pilot experiment, 1 mg of 4-OHT was injected i.p. into each
of two TTRCre ErcclFlox/Null animals on two days, leaving 48 hours for recovery
between injections. In addition, two Erccl Flox/Null animals without theTTRCre
transgene were treated in a similar manner and used as controls. DNA was extracted
from liver, kidney and tail. DNA content of all samples was matched by
spectrophotometry and a semi- quantitative recombination PCR was performed. A
faint band could be detected in the liver of TTRCre Erccl Flox/Null mice indicating
low levels of recombination (Figure 7, only one pair of animals shown). In the
absence of the TTRCre transgene, no recombination could be detected in the liver of
Erccl Flox/Null animals after 4-OHT treatment. We estimated the level of
recombination in our TTRCre Erccl Flox/Null livers by densitometry to be around
10% using a cell line with 100% recombination for comparison. The experiment was
repeated giving 6 doses of tamoxifen to one male animal and 9 doses of tamoxifen to
one female animal with an injection every second day. Again, low levels of
recombination could be seen in the liver (data not shown). However, we judged the
levels of recombination to be insufficient to generate high levels ofErccl- deficient
hepatocytes in vivo and decided to switch to tamoxifen citrate as inducer following
recommendations of the French group. Tamoxifen citrate is easier to keep in solution
and we hoped that it would enable us to achieve higher amounts of recombination in




Flox/ Null + TTRCre
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250 bp
recombination band
Figure 7: Recombination PCR on Erccl Flox/Null mice with and without TTRCre transgene.
Liver, kidney and tail samples were analysed. A sample with 100% recombination was used
for comparison. In addition to the 250 bp recombination band, an unspecific band of 200 bp
can be detected in liver, irrespective of the presence of the TTRCre transgene.
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3.6 Tamoxifen citrate treatment of TTRCre Erccl Flox/Wt and Flox/Null
animals
Tamoxifen citrate injections were given to TTRCre Flox/Wt and Flox/Null animals
of both genders. 1 course of tamoxifen citrate consisted of i.p. injections of 1 mg of
tamoxifen citrate for 5 consecutive days.
After 1 and 2 courses of tamoxifen citrate and 5 days of recovery, I could detect low
levels of recombination in Flox/Wt animals number 2, 3 and 4 (Table 3). The
amounts ofDNA were matched by spectrophotometry and recombination levels were
detected by semi-quantitative PCR, using a cell line showing 100% recombination
for comparison. The levels of recombination were estimated to be around 10-25% by
densitometry with animal number 3 showing the highest levels of liver- specific
recombination.
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Table 3: Summary of levels of recombination and DNA content in TTRCre Erccl Flox/Null
and Flox/Wt mouse livers after tamoxifen citrate injections. One course of tamoxifen (tamox.)
comprises of i.p. injections on five consecutive days. The time before sacrifice is shown,
starting from the day of the first injection. Approximate levels of recombination (recomb.)
were estimated via PCR using a cell line with 100% recombination for comparison.
Recombination levels of samples 1 to 6 were further determined in the Southern blot shown
in Figure 9. DNA content was determined by flow cytometry. A flow cytometry profile of
samples 5 and 6 is shown in Figure 8. Amounts of ploidy and S-phase are given as the
percentage of viable cells. Apoptosis levels are given as percentage of all cells.
S;
Genotype Sex ID Recomb. Tamox. Time 2n 4n 8n Apoptosis phase
(# (to
(#) (%) courses) sacrifice) (%) (%) (%) (%) (%)
Erccl Flox/Null m 1 0 1 5 days 67.9 23.4 - 4.7 1.8
TTR
Ercc/Flox/Wt f 2 10 1 5 days 73.6 21.8 - 2.1 0.6
TTR
ErcctFlox/Wt f 3 25 2 5 days 69.1 20.1 0.3 9.9 1.1
TTR
Ercc 1 Flox/Wt f 4 2 2 5 days 62.3 24.4 - 1.8 1.9
TTR
ErcctFlox/Null m 5 0 2 3 weeks 34.4 39.3 20.4 11.6 1.7
TTR
Ercc'/Flox/Wt m 6 0 2 3 weeks 58.2 30.6 2.6 5 1.2
TTR
ErcclFlox/Null m 7 0 2 4 weeks 78.4 32.9 6.9 37 3.2
TTR
Erccl Flox/Wt m 8 0 3 5 weeks 77.7 39.8 4.5 41.3 5
TTR
Erccl Flox/Null m 9 0 2 6 weeks 56.8 37.8 3.3 7 1.4
TTR
Erect Flox/Null m 10 0 2 6 weeks 58.5 37.4 2.3 7.5 1.3
TTR
Erect Flox/Null m 11 0 2 6 weeks 54.1 35.8 8 6.7 1.4
TTR
Ercc7Flox/Wt m 12 0 2 6 weeks 63.8 33.5 - 4.6 0.5
TTR
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When 2 courses of tamoxifen citrate were given to male animals of both genotypes
and the recovery period extended to 3 weeks, high levels of ploidy and apoptosis
were apparent by flow cytometry in TTRCre Erccl Flox/Null animal number 5 when
compared to the TTRCre Erccl Flox/Wt control animal number 6 (Table 3 and
Figure 8). The tetraploid peak consists of tetraploid nuclei in G1 phase and diploid
nuclei in G2. Throughout this thesis, I refer to this peak as the tetraploid peak as the
majority of nuclei will be tetraploid. Despite the changes in DNA content, no
recombination could be detected by PCR in either animal (Table 3). No consistent
genotype- dependend changes in polyploidy, apoptosis or S-phase were seen in any
of the other animals given 1 or 2 courses of tamoxifen citrate.
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Figure 8: Flow cytometry profiles showing the DNA content of TTRCre Erccl Flox/Null (# 5)
and Flox/Wt (# 6) livers after two courses of tamoxifen citrate and three weeks recovery. The
different cell fractions are labelled. Apoptosis is given as a percentage of the total amount of
cells. Diploid, tetraploid and octaploid fractions are given as the percentage of viable cells.
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I decided to allow longer recovery periods in the recently injected male animals and
to extend the amount of tamoxifen citrate given from 2 to 3 courses in animal
number 8 in order to increase the chance of development of polyploidy and high
levels of recombination. However, I was unable to detect any recombination or
polyploidy in male animals of either genotype, irrespective of treatment (Table 3).
Initially, we suspected a female bias towards success of recombination as only
female animals had shown recombination of the liver (animals 2, 3 and 4 Table 3).
We therefore injected males and females of both genotypes with several courses of
tamoxifen citrate and varied the length of recovery as before. We were unsuccessful
in seeing any recombination, higher levels of ploidy or apoptosis in livers of either
gender (data not shown).
To determine recombination levels more accurately, a Southern blot was performed
on animals number 1 -6. A titration curve was created by spiking DNA from a cell
line with 100% recombination with DNA from an Erccl Flox/Flox liver in various
dilutions (Figure 9). We were able to detect levels of recombination as low as 10% in
our titration curve. In contrast, no recombination could be detected by Southern
blotting in any of our samples. Therefore, the actual recombination levels of livers 2,
3 and 4 are below 10%, showing that our semi-quantitative PCR system leads to an
over-estimation of the amounts of recombination in liver.
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Figure 9: Liver specific recombination of the Erccl Flox allele. (A) Schematic of Erccl Flo>
and recombined alleles. All Erccl exons are numbered and represented by a line. The loxP
sites are shown as small arrow heads. The location of the probe is indicated by a grey box
The 5.5 kb fragment is produced from the Wt, Null and non- recombined Flox alleles (this
region on the gene is identical in these three alleles) and the 3.05 kb fragment is from the
recombined Flox allele. (B) Southern blot indicating the levels of recombination in TTRCre
Erccl Floxed/Null and Floxed/Wt livers after treatment with tamoxifen citrate and recovery. A
titration curve was obtained by spiking varying amounts of DNA from a cell line showing
100% recombination into DNA from an Erccl Floxed/Floxed liver. Lanes:
1) Floxed/Wt liver #6,2 courses of tamoxifen citrate and 3 weeks before sacrifice;
2) Floxed/Null liver # 5, 2 courses of tamoxifen citrate and 3 weeks before sacrifice;
3) Floxed/Wt liver #3,2 courses of tamoxifen citrate and 5 days before sacrifice;
4) Floxed/Wt liver # 4, 2 courses of tamoxifen citrate and 5 days before sacrifice;
5) Floxed/Wt liver # 2, 1 course of tamoxifen citrate and 5 days before sacrifice;
6) Floxed/Null liver# 1, 1 course of tamoxifen citrate and 5 days before sacrifice.
92
In conclusion, using 4- OHT or tamoxifen citrate to induce recombination in TTRCre
Erccl Flox/Wt or Flox/Null livers and hepatocytes, led to insufficient levels of
recombination to induce Erccl- deficiency. A phenotype, consisting of the typical
polyploidisation of the liver seen in complete Erccl knockout livers, was only seen
occasionally, but no recombination could be seen in these animals. Consequently,
because of the low levels of recombination observed and the irreproducible effects
on the phenotype of the mice, we decided to use a different system to induce
recombination in our Erccl Flox animals.
3.7 Discussion
The establishment of hepatocyte primary cultures was a first step to ensure that in
vitro experiments could be conducted on Erccl- deficient hepatocytes. One issue
with all primary cultures is the viability of cells. Primary hepatocytes do not survive
for more than 2 weeks in culture (Mitaka 1998). My hepatocytes showed some
apoptosis in culture shortly after isolation and cells did not survive beyond 10 days
of culture, limiting experimental time. In addition, hepatocytes do not divide readily
in culture and even upon stimulation with mitogens such as EGF and insulin, DNA
synthesis is usually increased, but without subsequent cell division. It is estimated
that hepatocytes undergo approximately one cycle of cell division in culture (Mitaka
1998). A way to improve cell division in hepatocytes is to co-culture hepatocytes
with non-parenchymal cells such as Stellate and Kupfer cells. Tateno et al. (2000)
have shown that large hepatocytes grow and form colonies when cultured with
fractions ofKupfer and Stellate cells. However, the grade of hepatocyte maturity, the
amount of granulation and the state of polyploidy all determine the ability for DNA
synthesis and cell division of primary hepatocytes (Tateno et al. 2000). S-phase and
growth potential have been shown to decrease with increased granularity, maturity
and polyploidy in vivo (Tateno et al. 2000). Non- parenchymal cells in my
hepatocyte cultures are mostly separated from my primary cells during the Percoll
step. This could explain the shorter life-span ofmy primary hepatocyte cultures when
compared to the literature. Another issue with hepatocyte culture is the maintenance
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of the differentiated state in the liver. It is now widely accepted that hepatocyte
differentiation is primarily controlled at the transcription level, emphasising the
importance of transcription factor and protein synthesis (Mitaka 1998). There are two
major ways to ensure hepatocyte maintenance, one being the addition of
nicotinamide to improve hepatocyte survival and cell growth. In addition, nutrient-
rich media containing high concentrations of amino acids and lower amounts of
vitamins and trace metals help to stimulate protein synthesis and cell survival
(Mitaka 1998). Our modified Chee's medium contains amino acids, vitamins and
trace metals. It should therefore be suited to help with primary hepatocyte survival.
In general, from our data on Wt hepatocyte cultures it seems that using H- Thd
incorporation as a measurement ofproliferation is the better choice ofmethod
compared to flow cytometry, where only a slight increase in S-phase was observed in
Wt hepatocyte cultures. In contrast, 3H-Thd analysis showed much bigger range of
DNA replication in culture. Maybe flow cytometry is not sensitive enough to pick up
slight changes in S-phase in a whole liver or even cell culture system.
Tamoxifen is an anti-oestrogen with complex pharmacology and is known to lead to
species and tissue specific responses upon administration
(http://l 93.51.164.1 l/htdocs/monographs/vol66/tamoxifen.html 2005). Tamoxifen is
readily absorbed and attains maximum plasma levels about 5 hours after
administration in humans. The drug is extensively metabolised into N-
desmethyltamoxifen and 4- hydroxytamoxifen (http://www.ncbi.nlm/nih.gov/books
2005). Both metabolites display a high affinity to the ER. Zhang et al. (1996) found
that 4-OHT shows a 10-100x higher affinity to the hormone binding domain ofMER
than tamoxifen itself. We anticipated that using the metabolite 4-hydroxytamoxifen
in our experimental setting should result in hepatocyte- specific Cre recombinase
activation in vitro and in vivo. Similar protocols with the same TTRCre transgene
have been used extensively, resulting in the desired recombination of different loci in
animal models (Tannour- Louet et al. 2002, Wirth et al. 2003). However, in our
animal model, 4-OHT was unable to induce high levels of recombination. We
decided to switch to a more highly purified and concentrated form of tamoxifen,
94
tamoxifen citrate. Tamoxifen citrate is a nonsteroidal triphenylethylene derivative. It
has been used in humans and is normally readily absorbed and metabolised in vivo.
The change to tamoxifen citrate initially led to low, but sporadic levels of
recombination in vitro and in vivo. None of those results could be repeated. The
success of the system regarding recombination levels does not seem to be dependant
on the form of tamoxifen used to induce Cre recombinase expression. The acute
toxicity of tamoxifen in experimental animals is low, but long term treatment with
tamoxifen is associated with onset of hepatocellular carcinoma in rats (Hirsimaki et
al. 1993). A single dose of tamoxifen in rats produces DNA adducts in liver, with 10-
15 fold differences compared to controls after six tamoxifen injections (Han and
Liehr 1992). Suzme et al. (2001) showed that tamoxifen citrate doses of 10-20mg/kg
resulted in high levels ofploidy. Levels ofproliferation were estimated as a
percentage of cells in S- phase using flow cytometry and remained the same when
compared to untreated Wt animals. We could not detect an increase in ploidy in our
animals when using tamoxifen on Flox/Wt animals after one or several courses of
tamoxifen. Furthermore, changes in S-phase in our experimental animals could not
be readily noted by flow cytometry which is in accordance to Suzme et al. (2001).
This suggests that the doses of tamoxifen we are using do not have a significant,
direct toxic effect on hepatocytes.
The route of tamoxifen administration and local levels of tamoxifen could be a
contributing factor to the low levels of recombination that we see in our system in
vivo. However, when using a cell culture system, where administration of the drug is
not a limiting factor, recombination could only just be detected at a very low level. In
fact, using 4-OHT did not give any successful recombination at all. When using
tamoxifen citrate only low levels of recombination could be detected in vitro. It is
therefore unlikely that the route of administration plays a major part in the failure to
see recombination in our experimental settings.
The TTRCre construct consists of different parts which are all equally important for
a functional transgene. One problem with our system could result from a dysfunction
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of the murine oestrogen receptor (MER) part of the transgene, leading to a failure to
respond to tamoxifen. However, the use of the mutated ER receptor has been widely
tested in embryonic stem (ES) cells and mice. A mutated form of the human
oestrogen receptor was first found by Fawell et al. (1990). They found that the
oestrogen binding domain of the receptor is encoded by exon 7 and 8 in the
conserved C-terminal region. Furthermore, a G to R mutation at amino acid 525 led
to DNA binding with high affinity and dimerisation of the receptor without steroid
binding. In contrast, tamoxifen was still able to induce a transcriptional response in
this mutated receptor. In fact, it seems that the mutated form showed a higher DNA
binding affinity compared to the Wt form of the receptor. The system was further
developed by Feil et al. (1996) when Cre recombinase was fused to the mutated form
of the human oestrogen receptor under the control of the CMV promoter. Murine ES
cells and transgenic mice showed excision of the tkneo gene after a dose of 1 pM 4-
OHT in vitro and 1 mg of4-OHT i.p for 5 days in vivo in all tissues. As the
expression of the CMV promoter varies in different tissues, recombination levels
were found to vary from 40-50% in spleen, kidney and skin to 30% in liver.
The same G525R mutation was introduced into the murine oestrogen receptor (MER)
by Zhang et al. (1996). The system was further exploited by fusing a single mutated
MER to the Cre recombinase sequence in ES cells. A dose of 8-10 pM 4-OHT
resulted in full recombination of the lacZ gene after 3-4 days in vitro. Higher doses
of tamoxifen lead to toxicity in the cell cultures. This is in accordance with my own
findings in hepatocyte cultures. The tamoxifen doses and the timing I used in vitro
were similar to those used by Zhang et al. (1996), so that an insufficient
concentration of tamoxifen or an insufficient incubation time can be excluded as a
reason for the low levels of recombination seen in cultures after 48 hours. As the use
of a single MER receptor showed moderate levels of background recombination after
8-10 weeks in culture, Zhang et al. (1996) fused a second MER to the other terminus
of the Cre recombinase sequence. When tested in ES cells by staining for B-
galactosidase after lacZ expression, this new construct showed complete
recombination after 48 hrs in one clone and after 72 hrs in another clone without
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significant background in long term cultures (Verrou et al. 1999). The crystal
structure for the Cre recombinase reveals a catalytic unit in the centre of the enzyme
with the N- and C- termini being relatively free. Fusion of two receptors to either
end should therefore not be a problem.
Three different groups subsequently reported on using the Cre recombinase system
with the mutated human or mouse ER in combination with liver specific promoters.
Levels of recombination seem to be varying in the different systems. Imai et al.
(2000) reported 40-50% recombination of the tkneo gene in mouse liver carrying the
transgene under the liver specific human al - antitrypsin promoter after tamoxifen
injections. Mosaic expression of Cre ERt was found by Imai et al. (2000) in about
40-50% of hepatocytes which correlated with mosaic transgene expression of the
promoter. Mosaic recombination is a widely known problem with the Cre
recombinase system (Ryding et al. 2001). This could be one contributing factor to
why our system hardly shows any recombination at all. If the transgene is only
expressed in a minority of the cells, then the overall effect after tamoxifen injection
will be very small and could in fact be masked by the majority of normal
hepatocytes. Another system used the liver specific albumin promoter and enhancer
in combination with the a- fetoprotein enhancer to mimic the normal genomic
organisation around a liver- specific gene (Kellendonk et al. 2000). Transgenic lines
showed liver specific recombination of the glucocorticoid receptor after tamoxifen
injections. A third group used the same albumin enhancer and promoter to excise the
glucokinase gene after tamoxifen injections (Prostic and Magnusson 2000). 80%
recombination was detected in 8 week old mice. However, it was noted that the
recombination levels differed with time. 1 day old animals showed 40%
recombination with a rise to 60% one week after birth and high levels after weaning.
Clearly, the timing of recombination initiation is an important factor as expression of
Cre recombinase may change with age. We are using young animals that are 6-8
weeks of age in which Cre recombinase expression is driven by the TTR promoter. It
is possible that Cre recombinase is not expressed in our hepatocytes due to
malfunction of the TTR promoter or mice being of the wrong age for maximal Cre
97
recombinase expression. The end point of the experiment might also play a role as
the translocation of the Cre recombinase into the nucleus and subsequent
recombination has been shown to take about 2-3 days after tamoxifen treatment
(Metzger and Chambon 2001). We looked one day after tamoxifen treatment and up
to 6 weeks after the treatment ended and could not find high levels of recombination
as detected by PCR. In conclusion, although it seems that timing of recombination
initiation and choice of promoter can lead to differences in recombination efficiency,
I am confident that choosing the end point of the experiment was not a limiting factor
in our case.
We decided to use a system with a transthyretin promoter driving liver specific Cre
recombinase expression. Tannour- Louet et al. (2002) reported 50% recombination
of the Rosa and Ampk genes using the TTRMERCreMER construct after 5 i.p.
injections on consecutive days, with 80% recombination being detectable after
multiple rounds of injections. This system was later used by Wirth et al. (2003) to
delete the Apc2 gene in liver, where 40% recombination was detected after one round
of tamoxifen injections. The recombination we see in our system is below 10% as
established by Southern blotting. This could depend on the location and accessibility
of the loxP sites. Depending on how easily Cre recombinase can access the loxP
sites, recombination efficiency should differ. The size of the deleted region might
also play a role. The commonly used lacZ gene was excised using loxP sites that are
only 950 bp apart. This amount ofDNA should be more easily excised than a region
spanning exon 3-5 of the Erccl gene which consist of around 2.3 kB. However,
Ryding et al. (2001) report that regions up to 2cM have been demonstrated to be
excised in vivo. In addition, when using the Flox Erccl alleles with a skin-specific
Cre recombinase system, high levels of recombination are obtained regularly (Doig
et al. 2006). This shows that the loxP sites in our Erccl Flox cells are accessible and
that the exon 3-5 region is not too big a region to be excised successfully.
It is possible that strain dependence is responsible for the low levels of
recombination in our mice. Tannour-Louet et al. (2002) used a cross between
98
B6D2H and C57BL mice and Wirth et al. (2003) carried their experiments out in
C57BL animals. Both groups found differences in recombination levels in liver when
using the same TTRCre construct and tamoxifen regime. Our animals are on a mixed
background derived from 129/Ola, C57BL and B6D2H and the genetic variation in
our animals is therefore expected to be high. This could lead to complex interaction
on a genomic level and explain the lack of recombination seen in our animals.
Although we first suspected a female bias toward successful recombination, we
discarded that possibility after more extensive experimentation. After animals of both
genders were exposed to different amounts of tamoxifen, we were still unable to
detect anything other than low levels of recombination in our mouse livers and
hepatocytes regardless of gender. Furthermore, no such gender bias is reported in the
literature using a similar tamoxifen inducible Cre recombinase system in mice. The
only report on gender specificity is based on skin specificity of Cre recombinase
being transferred through the father rather than the mother (Ramirez et al. 2004).
When females were carrying the skin specific transgene, recombination in all organs
could be detected. Ramirez et al. (2004) suggested that Cre expression in late stage
oocytes and persistence into the developing embryo was responsible for the
recombination detected. This pattern could not be detected in our mice as
recombination, if it occurred, was always liver specific.
Another possibility might be that Erccl is so essential in the liver, that Erccl
deficient cells have a survival disadvantage. This could be especially true after
tamoxifen injections, as tamoxifen has been shown to have an effect on liver,
producing DNA adducts after one injection only (Han and Liehr 1992). This in
combination with the defect in NER and other major repair pathways due to Erccl-
deficiency might be an explanation for the lack of recombination seen in our animals
and hepatocytes. As shown previously, Erccl- deficient animals die of liver failure at
three weeks of age (McWhir et al. 1993). We did detect higher levels of apoptosis by
Flow cytometry in Erccl Flox/Null liver after 2 courses of tamoxifen compared to
Flox/Wt injected animals (Figure 8). However, no recombination could be detected
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in either of those animals. These findings could be taken to support the view that
Erccl- deficiency is incompatible with hepatocyte survival when further challenged
with tamoxifen. However, if this was the case we would only expect it to apply to
Erccl Flox/Null animals, where high levels of recombination could lead to Erccl-
deficient hepatocytes. High levels of recombination in Erccl Flox/Wt animals would
produce hepatocytes with 50% of the normal levels of ERCC1 protein. This should
not affect viability since Erccl Wt/Null heterozygotes have normal livers and
viability and high levels of recombination were not seen in either genotype.
One obvious explanation for the lack of recombination is that the TTRCre transgene
is not expressed in our mice. We tried to address this issue by using Northern and
Western blotting. Patterns of TTRCre transgene expression on the mRNA and
protein level were inconsitent using either approach in TTRCre Erccl Flox/Wt and
Flox/Null animals. In addition, the results obtained were irreproducible and were
therefore not included in this thesis. We can not exclude the possibility that a lack of
TTRCre expression is responsible for the results obtained in this chapter. However,
as only low and irreproducible levels of recombination were detected in vivo or in
vitro with no consistent biological effects, we decided to switch to an approach using
the loxP system in combination with an AdenoCre virus.
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4. Conditional Erccl knockout approach using AdenoCre virus
in vitro
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After extensive investigation of a liver specific, tamoxifen inducible conditional
knockout system using TTRCre mice, we needed another way of inducing
recombination in our mice in vivo and in hepatocytes in vitro. One relatively easy
way of achieving recombination of loxP sites is the use of a virus which delivers the
Cre recombinase. We chose to use an Adenovirus that was derived from a human
type 5, replication deficient vector with an integrated Cre recombinase from PI
(Anton and Graham 1995). The human CMV promoter, an immediate-early
promoter, drives Cre recombinase expression. It has been shown that Cre
recombinase is expressed in replication permissive 293 cells and non-permissive
minimal residual cancer cells (MRC) cells (Anton and Graham 1995). In general,
AdenoCre integrates rarely into the eukaryotic genome making it ideal for in vitro
and in vivo long- term use. The AdenoCre virus was tested in murine primary
hepatocyte cultures, where recombination of the Rb locus could be detected 24 hours
after infection (Prost et al. 2001). In addition, Rb protein levels were undetectable 48
hours after the infection (Prost et al. 2001). Furthermore, no chromosomal
abnormalities, cell death or p53 stabilisation could be detected in those cultures.
However, addition of AdenoCre virus led to an increase in proliferation as measured
by BrdU incorporation 48 hrs after infection. In addition, hepatocytes displayed a
shortened G1 and hastened into S-phase (Prost et al. 2001). We felt that the
properties of the virus along with an easy route of administration in vitro via addition
to the culture medium made this approach suitable to achieve recombination of the
Erccl loxP sites in hepatocytes.
4.1 Detection of recombination levels via PCR and Southern blotting
For all experiments, Erccl Flox/Null and Flox/Wt hepatocyte cultures were set up
and infected with AdenoCre virus. In addition, uninfected Flox/Null cultures were
used as controls for effect of virus.
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Recombination levels were assessed in all cultures 24, 48 and 72 hrs after infection.
A semi-quantitative recombination PCR was conducted on infected Flox/Wt cultures.
DNA was matched by spectrophotometry and a cell line with 100% recombination
was used for comparison. Strong bands were seen by PCR in all lanes, with an
increase in band intensity from 24 hours after AdenoCre infection up to 72 hours
post- infection (Figure 10 (A)). For further quantification of recombination in
AdenoCre infected Flox/Wt cultures, a Southern blot was performed. A titration
curve showing 100, 75, 50, 10 and 0 % recombination was achieved by spiking DNA
from a cell line with 100% recombination with DNA from a Flox/Flox liver. All
amounts ofDNA were matched by spectrophotometry. Only a faint Wt band could
be detected in our hepatocyte samples 24, 48 and 72 hours after AdenoCre infection,
probably pointing to a certain amount ofDNA degradation which would have a
greater effect on the larger Wt band (Figure 10 (B)). The Southern blot indicates that
recombination levels in AdenoCre infected Flox/Wt samples are very high from 24
hours after infection onwards (Figure 10 (B)). This shows that in vitro deletion of the
floxed locus is achieved at an early stage after AdenoCre infection.
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Figure 10: Recombination levels in hepatocyte cell cultures 24, 48 and 72 hours after
AdenoCre virus infection. (A) Recombination PCR gel showing PCR products from Flox/Wt
hepatocytes and from a cell line with 100% recombination for comparison. The amounts of
DNA were matched by spectrophotometry. The negative control contained water only. (B)
Southern blot showing recombination in AdenoCre infected Flox/Wt hepatocyte cultures.
DNA amounts were matched by spectrophotometry. A titration curve was obtained by spiking
DNA from a cell line with 100% recombination with Flox/Flox liver DNA. Samples were taken
24, 48 and 72 hours after AdenoCre infection and show high levels of recombination.
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4.2 Determination of protein levels via western blotting
ERCC1 protein levels were determined in Flox/Null hepatocyte cultures 24, 48 and
72 hours after AdenoCre infection using western blotting. Erccl Wt/Wt, Null/Null
livers and an uninfected Flox/Null hepatocyte sample were used as controls. ERCC1
protein was visible as a 33 kDa band in our western blot in Wt liver and in the
uninfected Flox/Null control (Figure 11). In addition, a complete lack of protein
could be seen in Erccl- deficient liver. A reduction of ERCC1 protein levels was
visible in Flox/Null hepatocytes 48 hours after AdenoCre infection, with a complete
lack of the protein 72 hrs after infection. A cross- reacting band was detected in all
lanes, irrespective of genotype or treatment. In conclusion, the recombination of the
Erccl locus in Flox/Null mice led to ERCC1 protein levels being reduced with a
complete lack of the protein after 3 days in culture. Our cell culture system could





Figure 11: Western blot determining ERCC1 protein levels after AdenoCre virus infection.
Flox/Null hepatocyte cultures are shown 24, 48 and 72 hours after infection. Protein content
of one uninfected Flox/Null culture is shown for comparison. The positive control represents
Wt ERCC1 liver and the negative control represents ERCC1- deficient liver. A non- specific
cross reacting band can be seen just above the 33 kDa ERCC1 protein band in all lanes
irrespective of genotype and is used as loading control. Amounts of protein were matched,
but with the 72 hour time point being slightly underloaded.
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4.3 Feulgen staining to assess the amount of apoptotic, necrotic and normal
cells in culture
Feulgen staining was performed to distinguish between apoptotic, necrotic and
normal cells in AdenoCre infected Flox/Wt and Flox/Null and in uninfected
Flox/Null hepatocyte cultures (Figure 12).
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Apoptotic Normal
Figure 12: Apoptotic, necrotic and normal hepatocytes in AdenoCre virus infected Flox/Null
cultures. Hepatocytes were Feulgen stained and a picture taken with a 20x objective. Arrows
point to the different types of cell which are labelled accordingly.
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500 cells were counted in duplicate cultures 1, 2, 5 and 7 days after AdenoCre
infection. The mean frequency from two independent experiments is given along
with the standard error of the mean (Figure 13). There was a trend towards an
increase in the frequency of necrotic cells with increased time in culture, but this was
not correlated with genotype or viral infection. One day after AdenoCre infection no
differences in the frequency of apoptotic cells between samples could be detected.
However, from day 2 onwards, the levels of apoptosis rose and were higher in
infected Flox/Null cultures compared to infected Flox/Wt and uninfected Flox/Null
(Figure 13). The p values below are for the null hypothesis that there was no
difference between levels of apoptosis in infected Flox/Null and infected Flox/Wt or
uninfected Flox/Null cultures by a x2 test.
Day 1: Infected Flox/Null 5.1 %; infected Flox/Wt 5.8 % (p= 0.92); uninfected
Flox/Null 3.8 % (p= 0.19)
Day 2: Infected Flox/Null 9.8 %; infected Flox/Wt 5 % (p= 0.0008); uninfected
Flox/Null 3.3 % (p= 0.00002)
Day 5: Infected Flox/Null 23 %; infected Flox/Wt 6.6 % (p< 0.000001); uninfected
Flox/Null 11.8 % (p< 0.000001)
Day 7: Infected Flox/Null 34.3 %; infected Flox/Wt 9 % (p< 0.000001); uninfected
Flox/Null 9.1 % (p< 0.000001)
At 7 days post- infection 34.3 % of cells in infected Flox/Null cultures were
apoptotic, more than 3- fold higher than in corresponding infected Flox/Wt and
uninfected Flox/Null cultures. In conclusion, levels of apoptosis increased with time
in culture from 2 days to 7 days post- infection in Flox/Null hepatocytes and were















































































Figure 13: Apoptotic and necrotic cell death in AdenoCre virus infected hepatocyte cultures.
Infected Erccl Flox/Wt, Flox/Null and uninfected Flox/Null hepatocyte cultures were scored
1, 2, 5 and 7 days after infection. For each culture 500 Feulgen stained cells were counted in
two separate chambers. Data shown represent the mean of two different experiments. The
SEM is indicated with error bars. All values are expressed as percentage of counted cells.
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4.4 Identification of DNA content via flow cytometry
DNA content was measured using flow cytometry at different time points after
infection and in different experiments. Apoptosis levels, S-phase as well as ploidy
changes were monitored. All results are summarised in Table 4. Uninfected
Flox/Null and Flox/Wt hepatocytes showed low levels of S-phase and apoptosis
before plating. Diploid, tetraploid and a small population of octaploid cells could be
detected in both genotypes before plating (Table 4 group 6 and 9). However, after
plating and AdenoCre infection, the amount of cells in S-phase and undergoing
apoptosis increased independent of time point. Feulgen staining detected
significantly increased levels of apoptosis in infected Flox/Null hepatocyte cultures
compared to the two controls. While a similar elevation was observed by flow
cytometry in some experimental groups (7 and 8), this was not a consistent overall
finding. Viral infection, irrespective of genotype, resulted in an increase in levels of
S-phase in some groups (2, 3, 8, 11, 12), but again this was not a consistent finding.
No clear difference in ploidy status could be observed between infected Flox/Null
cultures and both controls over time. This differs from the higher ploidy seen in the
livers ofErccl- deficient animals compared to controls (McWhir et al. 1993).
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Table 4: DNA content of AdenoCre infected hepatocyte cell cultures as determined by flow
cytometry. Flox/Wt, Flox/Null and uninfected (uninf.) Flox/Null hepatocyte cultures are shown
before plating and 2, 3, 4, 5 and 7 days after infection. Apoptosis is displayed as percent of
all cells. Ploidy status and S-phase are shown as percent of viable cells. Data from 4
different experiments are shown.
Exd. Group Sample Time 2n 4n 8n 16n Apoptosis S-ohase
(#) (#) (days) (%) (%) (%) (%) (%) (%)
1 1 Flox/Wt+Cre 2 32.8 30.4 3.4 14.5 13.3
Flox/Null+Cre 2 32.8 23.9 3.8 11.4 17.2
2 Flox/Wt+Cre 3 23.8 27 2.9 20.1 17.5
Flox/Null+Cre 3 25.6 28.2 5.2 15.4 15.7
Flox/Null uninf. 3 42 32 1.5 13.5 8.4
3 Flox/Wt+Cre 7 11.9 29.4 16.1 13.8 13.9
Flox/Null+Cre 7 12.2 20.6 16.2 3.5 13.8 13.8
Flox/Null uninf. 7 38 41.9 1.7 7.2 7.7
2 4 Flox/Wt+Cre 2 40 33.2 4.4 7.3 8.6
Flox/Null+Cre 2 21.9 21.2 8.4 32.8 12.8
5 Flox/Wt+Cre 5 25.6 37.9 9.3 6.8 10.1
Flox/Null+Cre 5 14.7 19.7 11.1 23 16.5
Flox/Null uninf. 5 17.2 26.4 7.4 25 13.4
3 6 Flox/Wt+Cre 0 46.5 38.7 11.8 0.1 1
Flox/Null+Cre 0 51.6 27.3 8.6 0.1 1.3
7 Flox/Wt+Cre 2 24.5 36 10.5 3 10.2
Flox/Null+Cre 2 27.9 31.5 8.5 10.4 13.5
Flox/Null uninf. 2 30.8 33.7 13.1 4.6 10.5
8 Flox/Wt+Cre 5 12.6 22.6 17 3.5 17.9
Flox/Null+Cre 5 15.7 12.5 7 14.6 24.8
Flox/Null uninf. 5 18.9 40.6 12.1 3 12.2
4 9 Flox/Wt+Cre 0 45.6 15.4 12.8 0.3 3.6
Flox/Null+Cre 0 38.1 34.6 8.7 1.1 2.3
10 Flox/Wt+Cre 2 54.5 30.1 2.4 1.3 6.4
Flox/Null+Cre 2 32.9 43.3 6.9 1.3 5.8
Flox/Null uninf. 2 35.1 37.9 5 1.7 7.8
11 Flox/Wt+Cre 3 41.2 25.2 2.8 2.9 16.1
Flox/Null+Cre 3 26.6 27.2 4.8 3.2 16.4
Flox/Null uninf. 3 32 36.1 6.9 1.7 8.1
12 Flox/Wt+Cre 4 36.8 38.9 6.2 1.6 9.9
Flox/Null+Cre 4 29.8 40.2 7.5 2.4 14.1
Flox/Null uninf. 4 44.6 42.7 2.9 1.3 5.8
13 Flox/Wt+Cre 5 28.6 36.8 7.6 2.3 9.6
Flox/Null+Cre 5 26.5 33.5 7.6 2.4 13.5
Flox/Null uninf. 5 25.9 24.5 3.7 3.7 21.5
14 Flox/Wt+Cre 7 25.7 42.8 11.1 1.2 7.5
Flox/Null+Cre 7 30.7 32.8 7.4 3.2 13.2
Flox/Null uninf. 7 34.9 39.4 5.7 2 8.6
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4.5 Frequencies of mono- and binucleate cells in vitro
Binucleation is a normal part of liver development with reduced levels of
binucleation being apparent in Erccl- deficient liver (Nunez et al. 2000). The ratio of
mononucleate and binucleate cells was assessed in all AdenoCre infected Flox/Null
and Flox/Wt cultures and in uninfected Flox/Null hepatocytes. Cells were stained
and 500 cells were counted in duplicate cultures 2, 5 and 7 days after infection. No
difference in the mononucleate to binucleate ratio could be seen between the three
cultures. Around 80% of hepatocytes were already binucleate after 2 days in culture
(Figure 14). The amount of binucleate cells did not change with time in culture in
any of the genotypes. This differs from the lower frequencies of binucleate cells





Figure 14: Frequency of binucleate and mononucleate cells in infected hepatocyte cultures.
Hepatocytes were scored 2, 5 and 7 days (d) after plating. 1000 cells of AdenoCre infected
Flox/Wt, Flox/Null and uninfected Flox/Null cultures were counted for each genotype.
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4.6 Measurement of 3H- Thymidine incorporation to determine replication
potential
To estimate the amount of replication in our Flox/Null and Flox/Wt cultures
3FI-Thymidine (3H- Thd) incorporation was measured 1, 2, 3, 4 and 5 days after
"3 ... .
AdenoCre infection in duplicate cultures. In addition, H-Thymidine incorporation
was determined in uninfected Flox/Null cultures at the same time points. Lower
levels of replication were apparent in uninfected Flox/Null cultures at all time points
T ... .
(Figure 15). Infected Flox/Wt cultures showed a peak of H-Thymidine incorporation
3- 4 days after infection. Levels of incorporation were lower at the equivalent stage
in infected Flox/Null cultures, but the high level of variability for each genotype
meant that this difference was not significant.
Furthermore, BrdU incorporation was measured in culture using
immunohistochemistry. The uninfected Flox/Null cultures always showed few
labelled nuclei compared to the infected Flox/Null and Flox/Wt cultures which had
similar staining frequencies. No clear difference in amount of stained nuclei could be
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Figure 15:3H-Thymidine incorporation in AdenoCre infected hepatocyte cultures.
3H-Thymidine incorporation was measured as counts per minute (CPM) in infected Flox/Wt,
Flox/Null and uninfected Flox/Null hepatocyte cultures 1, 2, 3, 4 and 5 days after infection.
All samples were counted three times. Data shown represent the mean of three different
experiments. The SEM is given for all data points.
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4.7 Assessment of oxidative damage in vitro using the comet assay
The comet assay is an assay primarily examining the levels of oxidative lesions and
DNA strand breaks (Wheelhouse et al. 2003). DNA migration is measured as a
function of size and number of broken ends ofDNA which is expressed as the Olive
tail moment. The amounts of oxidative damage and strand breaks were assessed in
AdenoCre infected Flox/Wt and Flox/Null cultures 1 day after infection (Figure 16).
Infected Flox/Null hepatocytes exhibited a mean and standard deviation of 23.6 % ±
13.6 tail DNA compared to 29.7% ± 17.6 in Flox/Wt without addition of enzyme. A
paired t-test revealed a just significant difference between AdenoCre infected
Flox/Wt and Flox/Null cultures (p=0.049), indicating, counterintuitively, more
accumulation of damage in infected Flox/Wt compared to Flox/Null hepatocyte
cultures. The enzyme formamidopyrimidine- DNA- glycosylase (Fpg) is known to
recognise and process a variety of oxidative DNA adducts, leading to strand breaks
which can then be detected in the comet assay. When Fpg was added to both
preparations, infected Flox/Null hepatocytes showed a mean and standard deviation
of 31.2% ±13.5 tail DNA and Flox/Wt cells a mean and standard deviation of
28.9% ± 19 of tail DNA. No significant difference could be detected between the two
genotypes after treatment with enzyme when a paired t-test was performed (p= 0.48).
Comparison of genotypes at later time points did not reveal a difference between the
genotypes (data not shown). In conclusion, there was no evidence for elevated levels
of oxidative DNA damage in infected Flox/Null cultures.
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Figure 16: Comet analysis in AdenoCre infected hepatocyte cultures. The percentage of tail
DNA in infected Erccl Flox/Wt and Flox/Null hepatocyte cultures was scored 24 hours after
infection. Data shown represent both genotypes with and without addition of the Fpg
enzyme. The mean of 50 counted comets is given. The standard deviation is indicated by
error bars.
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4.8 Oil Red O stain to visualise lipid accumulation in hepatocyte cultures
AdenoCre infected Flox/Null and Flox/Wt and uninfected Flox/Null hepatocytes
were stained with Oil Red O for lipid detection 5, 7 and 9 days after infection.
Lipid accumulation increased gradually in Erccl- deficient cultures from day 5 after
infection with higher levels at days 7 and 9. Much lower levels of lipid were detected
in both control cultures and then only from day 7 onwards (Figure 17). When the
pattern of lipid accumulation in primary hepatocyte cultures was examined at higher
power, it was observed that AdenoCre infected Flox/Null cultures contained many
microvesicles accumulating throughout the cytoplasm compared with fewer
microvesicles in both controls (Figure 18).
119
Flox/Null+ Cre 5 days Flox/Null+ Cre 7 days Flox/Null + Cre 9 days
Flox/Null uninfected 5 days Flox/Null uninfected 7 days Flox/Null uninfected 9 days
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Flox/Wt + Cre 5 days Flox/Wt + Cre 7 days Flox/Wt + Cre 9 days
Figure 17: Lipid accumulation in AdenoCre infected hepatocyte cultures. Infected Erccl
Flox/Wt, Flox/Null and uninfected Flox/Null hepatocyte cultures were stained with Oil Red O
5, 7 and 9 days after plating. Images taken with a 10x objective show the amount of lipid
accumulation overall. Lipid vesicles are stained in red and cytoplasm and nuclei are stained
in blue. Round apoptotic cells stain intensely red.
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7 days
Flox/WT + Cre Flox/Null Uninfected Flox/Null + Cre
Figure 18: Detail of lipid accumulation in AdenoCre infected hepatocytes. Infected Erccl
Flox/Wt, Flox/Null and uninfected Flox/Null hepatocyte cultures were stained with Oil Red O
7 days after plating. The 40x objective highlights the small droplets of lipid accumulated in
infected Flox/Null cultures. Lipid vesicles are stained in red and cytoplasm and nuclei are
stained in blue. Round apoptotic cells stain intensely red.
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4.9 Feulgen staining to assess apoptotic, necrotic and normal cells after UV
irradiation, Glucose oxidase and Mitomycin C treatment
AdenoCre infected Flox/Wt and Flox/Null and uninfected Flox/Null hepatocyte
cultures were challenged with UVC, Glucose oxidase and Mitomycin C to examine
their impact on cell status. 3 days after infection, cells were challenged with different
doses of the damaging agents and Feulgen staining was performed 2 days later. 500
cells were counted in duplicate cultures. The mean and standard error of the mean of
two different experiments is shown for UVC (Figure 19) and Glucose oxidase
(Figure 20). A single experiment for Mitomycin C exposure is shown in Figure 21.
UVC irradiation- induced DNA damage is repaired by the nucleotide excision repair
pathway which is abrogated in infected Flox/Null cultures. In infected Flox/Null
cultures, apoptosis increased with UV dose and, at all doses, levels of apoptosis were
significantly higher in infected Flox/Null cultures when compared to the two controls
(Figure 19). The p values below are for the null hypothesis that there was no
difference between levels of apoptosis in infected Flox/Null and infected Flox/Wt or
uninfected Flox/Null cultures by a %2 test.
2J/m2: infected Flox/Null 4.5 %; infected Flox/Wt 1.7 % (p< 0.000001); uninfected
Flox/Null 3.3 % (p= 0.00005)
10J/m2: infected Flox/Null 11.2 %; infected Flox/Wt 6 % (p= 0.0059); uninfected
Flox/Null 4.1 % (p= 0.0011)
20J/m2: infected Flox/Null 21.8 %; infected Flox/Wt 4.8 % (p< 0.000001);
uninfected Flox/Null 7.2 % (p< 0.000001)
50J/m2: infected Flox/Null 66.5 %; infected Flox/Wt 15.5 % (p< 0.000001);
uninfected Flox/Null 39.6 % (p< 0.000001)
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Levels of necrosis were low for all samples. At 20J/m2 21.8 % of cells in infected
Flox/Null cultures were apoptotic, more than 3- fold higher than in corresponding
infected Flox/Wt and uninfected Flox/Null cultures. In conclusion, significantly
higher levels ofUV- induced apoptosis were observed in infected Flox/Null

























































Figure 19: Apoptotic and necrotic cell death in AdenoCre virus infected hepatocyte cultures
after UVC. Infected Erccl Flox/Wt, Flox/Null and uninfected Flox/Null hepatocyte cultures
were scored 2 days after UVC irradiation. The doses of UVC varied from 2 J/m2to 50 Jim2.
Non- irradiated controls are shown for all genotypes. For each culture 500 cells were
Feulgen stained and counted in two separate chambers. Data shown represent the mean of
two different experiments. The SEM is indicated with error bars.
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Glucose oxidase is a potent oxidative damage inducer. Some forms of oxidative
DNA damage are repaired by the nucleotide excision repair pathway which is
abrogated in infected Flox/Null cultures. Infected, untreated Flox/Null hepatocytes
showed higher levels of apoptosis when compared to infected, untreated Flox/Wt
(p=0.00004) and uninfected, untreated Flox/Null cultures (p=0.02). This is in
accordance with our previous findings examining spontaneous levels of apoptosis in
Erccl- deficient cultures when compared to controls. In infected Flox/Null cultures,
apoptosis increased with GO dose and, at low doses, levels of apoptosis were
significantly higher in infected Flox/Null cultures when compared to the two controls
(Figure 20). The p values below are for the null hypothesis that there was no
difference between levels of apoptosis in infected Flox/Null and infected Flox/Wt or
uninfected Flox/Null cultures by a y2 test.
lpU GO: infected Flox/Null 11.7 %; Flox/Wt 1.2 % (p< 0.000001); uninfected
Flox/Null 3.9 % (p= 0.000002)
5 pU GO: infected Flox/Null 15 %; Flox/Wt 1.6 % (p< 0.000001); uninfected
Flox/Null 8.1 % (p= 0.00052)
lOpU GO: infected Flox/Null 18.2 %; Flox/Wt 2.6 % (p< 0.000001); uninfected
Flox/Null 10.2 % (p= 0.00028)
50 pU GO: infected Flox/Null 23.5 %; Flox/Wt 5.3 % (p< 0.000001); uninfected
Flox/Null 17 % (p= 0.015)
100 pU GO: infected Flox/Null 28.7 %; Flox/Wt 18.1 % (p= 0.00012); uninfected
Flox/Null 22.7 % (p=0.086)
Levels of necrosis were low in all samples. At a dose of 1 pU GO 11.7% of infected
Flox/Null hepatocytes were apoptotic, 3- fold higher than in corresponding infected
Flox/Wt and uninfected Flox/Null cultures. In conclusion, at low levels ofGO,
significantly higher levels ofGO- induced apoptosis could be detected in infected





Figure 20: Apoptotic and necrotic cell death in AdenoCre virus infected hepatocyte cultures
after Glucose oxidase exposure. Infected Erccl Flox/Wt, Flox/Null and uninfected Flox/Null
hepatocyte cultures were scored 2 days after treatment with GO. The doses given varied
from 1pU to 100 pU. Untreated controls are shown for all genotypes. For each culture 500
cells were Feulgen stained and counted in two separate chambers. Data shown represent
the mean of two different experiments. The SEM is indicated with error bars.
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Erccl is involved in the repair of interstrand cros- links. A wide range of doses of
Mitomycin C (MMC), an interstrand cross- link inducer, was tested on hepatocyte
cultures, but no difference in MMC- induced cell death was detected (Figure 21). At
doses above 1 pg Mitomycin C, all hepatocytes showed 5-10% of necrosis,
independent of genotype or treatment. Doses higher than 10 pg resulted in high
amounts of cell death in all genotypes (data not shown).
We further tried to characterise the impact of all three damaging agents by
determining the DNA content of all cultures by flow cytometry. No significant
difference in ploidy could be observed after exposure to the different DNA damaging
agents and between the different genotypes (data not shown).
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Figure 21: Apoptotic and necrotic cell death in AdenoCre virus infected hepatocyte cultures
after Mitomycin C exposure. Infected Erccl Flox/Wt, Flox/Null and uninfected Flox/Null
hepatocyte cultures were scored 2 days after treatment with MMC. The doses of Mitomycin
C varied from 1 pg to 10 pg. Untreated controls are shown for all genotypes. For each
culture 1000 cells were Feulgen stained and counted in two separate chambers.
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4.10 Oil Red O stain to visualise lipid accumulation after UV irradiation
Previously, we had observed lipid accumulation only in old, infected Flox/Null
cultures. However, when hepatocytes were treated with lOJ/m ofUVC, we noticed a
change in lipid accumulation pattern in all cultures. Therefore, AdenoCre infected
Flox/Null and Flox/Wt and uninfected Flox/Null hepatocytes were stained with Oil
Red O 5 and 7 days after infection, which equated to 2 and 4 days after UVC
irradiation. Non- irradiated cultures of all genotypes were used for comparison.
Exposure to UVC led to accumulation of lipids in all genotypes 5 days after infection
(Figure 22). Lipid accumulation in Flox/Null uninfected cultures and in infected
Flox/Wt hepatocyte cultures was subsequently reduced 7 days after infection. As
most infected Flox/Null hepatocytes had undergone apoptosis, I was unable to stain
those cells at the same time point. Control dishes showed lipid accumulation in older,
infected Flox/Null hepatocytes only as seen previously. In conclusion, it seems that
lipid accumulation in hepatocytes is a consequence ofDNA damage and disappears
with time when functional DNA repair mechanisms are present.
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Most cells dead
Flox/Null+Cre 2 days 10J UV Flox/Null+Cre 4 days no (JVC
Flox/Null uninf. 2 days 10J UV Flox/ Null uninf. 4 days 10J UV Flox/Null uninf. 4 days no UVC
Flox/Wt+Cre 2 days 10 J UV Flox/Wt 4 days 10J UV Flox/Wt+Cre 4 days no UVC
Figure 22: Lipid accumulation in AdenoCre infected, UVC- irradiated hepatocyte cultures.
Infected Erccl Flox/Wt, Flox/Null and uninfected Flox/Null hepatocyte cultures were stained
with Oil Red O. 2 and 4 days after 10 J/m2 UVC. Non- irradiated controls are shown for all
genotypes 4 days after irradiation. The objective used was 10x with an inset picture taken
with a 40x objective showing the pattern of lipid stain in more detail. No picture was obtained
for AdenoCre infected Flox/Null cultures 4 days after UVC as the majority of cells were dead.
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4.11 Discussion
Most hepatocytes contain polyploid nuclei, in which recombination can be efficiently
induced by the AdenoCre virus without leading to any major abnormalities in the
hepatocyte cultures. However, Addison et al. (1997) have shown that the human
CMV promoter is less effective in murine cells when compared to its effect on
human cells. Given the recombination efficiency observed by Prost et al. (2001) in
floxed Rb mouse hepatocytes along with the rapid disappearance of protein, using
this AdenoCre virus to induce recombination of the floxed Erccl locus should be
achieved easily. In fact, when recombination efficiency was determined in vitro,
recombination could be readily detected 24 hours after AdenoCre infection, with the
amount of recombination being around 90%. Using the human CMV promoter did
not lead to any complications with recombination efficiency in our system.
Furthermore, ERCC1 protein could no longer be detected 72 hours after AdenoCre
infection, proving that recombination of the loxP sites in Erccl Flox/Null and
Flox/Wt hepatocytes does result in downregulation of ERCC1 protein.
To investigate basic parameters ofErccl- deficiency in AdenoCre infected
hepatocyte cell cultures, replication potential was examined at different time points
after AdenoCre administration. In vivo, hepatocytes do not replicate unless
stimulated by hepatic toxins such as carbon tetrachloride where a peak ofDNA
synthesis can be observed 60 hours after insult (Bellamy et al. 1997). In Erccl-
deficient liver, an indication of lower BrdU incorporation was detected when
compared to Wt, although this finding was not statistically significant (Nunez et al.
2000). In vitro, however, replication is less rare as the perfusion itself seems to
trigger DNA synthesis in cultured hepatocytes forcing the cells from a quiescent
stage into proliferation (Bellamy et al. 1997). I found that uninfected Erccl
Flox/Null hepatocyte cultures showed very low levels of 3H- Thd incorporation
overall, indicating low levels of replication. In contrast, in infected Erccl Flox/Null
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and Flox/Wt hepatocytes cultures higher levels of H- Thd incorporation were
detected. No difference between the infected genotypes was established, indicating
that the addition of AdenoCre virus rather than the perfusion event is responsible for
triggering replication in my cell culture system. These findings are further supported
by the fact that uninfected Flox/Null hepatocytes did not stain for BrdU whilst Erccl
Flox/Null and Flox/Wt cultures showed high amounts of BrdU stain after AdenoCre
infection. The stain intensities varied from nucleus to nucleus, but not between
genotypes. In accordance with my findings, when BrdU incorporation and H-Thd
incorporation was measured in mouse liver at different time points after toxic insult,
no difference in labelling index or intensity of stain could be noted, leading to the
conclusion that both methods are interchangeable (Lanier et al. 1989,
Eldridge et al.l 990). In conclusion, there was no evidence that replication was
affected in infected Flox/Null cultures compared to the infected Flox/Wt controls.
Binucleation is a normal feature of liver development, leading to a majority of
binucleate cells with age (Sheahan et al. 2004). Binucleation in Erccl- deficient liver
has, however, been demonstrated to be inhibited (Nunez et al. 2000). This finding
could not be confirmed in cultures as most hepatocytes were already binucleate 2
days after plating. The rapid binucleation in vitro could be a result of cell fusion or
DNA replication without cytokinesis. The perfusion process itself and culture
methods could encourage binucleation and diminish the difference between Erccl-
deficient cells and Wt hepatocytes. In addition, Mossin et al. (1994) have shown that
the addition of growth hormones such as EGF can induce binucleation in vitro.
Nunez et al. (2000) studied binucleation in 2-3 week old Erccl- deficient animals. In
contrast, animals used for cell culture experiments were 6-8 weeks old. As
binucleation is a feature of older livers, high amounts of binucleate hepatocyte nuclei
in vitro when compared to in vivo results could be explained by the discrepancy in
age between animals used.
Polyploidisation is a general physiological process seen in all cell types in mammals,
insects and plants (Comai 2005). By providing duplicated genes, polyploidisation
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might fuel long- term diversification and evolutionary success. It is thought to be a
protective mechanism against deleterious recessive mutations when a bottleneck
population is apparent and is also thought to be a response to immediate DNA
damage when repair is impaired (Comai 2005, Me Whir et al. 1993). In hepatocytes
polyploidisation is part of the normal maturation process and is associated with late
foetal development (Gupta 2000). Mature hepatocytes display higher levels of
ploidy, increasing cell size and accumulation of lipofuscin and other lipid
peroxidation products (Gupta 2000). In addition, p21 accumulation has been noted in
senescent hepatocytes (Sigal et al. 1999). This hypertrophic change could be
mimicked in vitro when the appropriate growth hormones were added to the cultures
(Gupta 2000). In general, external stimuli seem to induce polyploidisation. Mossin et
al. (1994) noted that an increase in ploidy is correlated with a decrease in
proliferation in vitro independent ofmitogenic stimuli.
These findings have been confirmed in vivo, where diseased liver is associated with
a decrease in DNA synthesis and an increase in the polyploid hepatocyte fraction
(Gupta 2000). It is generally hypothesised that polyploidy arises when DNA
synthesis is completed without cell division or cytokinesis (Gupta 2000). In fact,
Guidotti et al. (2003) showed that binucleation is an intermediate step to higher
ploidy status in vitro. When primary rat hepatocyte cultures were examined, it was
established that about 20% of diploid, binucleate cells aborted cytokinesis after
progression through S-phase to form tetraploid, mononucleate cells.
Polyploidisation is one of the most striking features ofErccl- deficient liver. Before
dying of liver failure at the age of 3 weeks, Erccl- deficient mice have equivalent
levels ofpolyploidy to that normally seen only in 2 year old, normal adults (MeWhir
et al. 1993). This polyploidy could not be observed in infected Erccl Flox/Null when
compared to infected Flox/Wt hepatocytes. One of the factors responsible might be
the limited survival rate in culture not leaving enough time to establish octaploidy in
primary hepatocytes. Another reason for similar levels ofpolyploidy in AdenoCre
infected Flox/Null and Flox/Wt hepatocytes could be the addition of virus and the
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subsequent stimulation of replication in all cultures. The artificial culture
environment might also be responsible for the absence of polyploidy in AdenoCre
infected Flox/Null hepatocytes, not providing all essential stimuli needed for
polyploidisation. In conclusion, a polyploid phenotype similar to that seen in Erccl-
deficient liver in vivo could not be established in in vitro hepatocyte cultures.
Apoptosis and cell proliferation are closely linked events in hepatocytes with many
apoptotic factors being involved in cell cycle and division (Kanzler and Galle 2000).
The liver is an organ with low cell turnover where 1-5 cells/ 10 000 cells undergo
apoptosis at any given time point (Kanzler and Galle 2000). There are two main
pathways of apoptosis, one being the extrinsic pathway which is initiated by ligand
binding to a death receptor and a direct activation of caspase 8 and 3. The intrinsic
pathway can also be stimulated through activation of death receptors, but it does
need the involvement ofmitochondrial cytochrome c release in order to cleave and
activate caspase 3 (Li et al. 2003). Fas and TNF-a receptors mediate apoptosis in
hepatocytes using similar but not identical pathways. Fas mediated apoptosis leads to
a quick response which does not necessarily involve mitochondrial activation (Hatani
et al. 2000). It is also the most common type of apoptotic induction in hepatocytes
which express high levels of receptor, but not ligand (Guicciardi and Gores 2005). In
contrast, TNF- a mediated apoptosis requires mitochondrial permeability transition
and is therefore generally the slower pathway (Guicciardi and Gores 2005). In both
cases, NFkB activation has been shown to protect primary murine hepatocytes from
apoptosis (Hatano et al. 2000).
Generally, it seems that repair instead of apoptosis is favoured in murine
hepatocytes. This hypothesis is supported by the fact that NER levels in murine
hepatocytes are comparable to those in human fibroblasts with all other murine
organs showing a much lower rate ofNER (Prost et al. 1998). Even when Irf, a gene
thought be involved in DNA damage repair, is absent from hepatocytes, no
difference in apoptosis is noticed when compared to Wt cells, both spontaneously
and after UV irradiation. In contrast, Erccl- deficient hepatocyte cultures show
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higher levels of apoptosis when compared to controls using the Feulgen method. The
addition of AdenoCre virus cannot be responsible for the higher apoptosis levels seen
in Erccl- deficient cultures, as infected Flox/Wt cultures showed low levels of
apoptosis even over a longer period in culture. The results obtained by Feulgen
staining could not be repeated when flow cytometry was used to assess DNA content
and apoptosis. This discrepancy could be explained by the fact that the assay used for
flow cytometry is primarily designed to visualise differences in ploidy, which might
not be sensitive enough to pick up the apoptotic cell fraction in our cultures. A
separate stain could have been used to look at apoptosis levels by flow cytometry.
Also, fragile hepatocyte nuclei do not tolerate flow cytometry well. Nuclear
fragmentation during preparation could make it harder to detect increased levels of
apoptosis associated with Erccl deficiency. However, we felt confident that the
Feulgen stain method was powerful enough to reveal differences in normal apoptotic
and necrotic cell fractions in vitro. In conclusion, apoptosis is uncommon in
hepatocytes so the defect caused by Erccl- deficiency must be severe given that a
strong apoptotic response is triggered. Therefore, Erccl seems to play a crucial role
in murine liver and hepatocytes seem to be unable to survive without Erccl in
prolonged in vitro culture.
The possibility of oxidative DNA damage contributing to the induction of apoptosis
in Erccl- deficient hepatocytes was further explored using the comet method. When
we compared the Olive tail moment ofAdenoCre infected Flox/Null and Flox/Wt
hepatocyte cultures 24 hours after infection a slight difference between the genotypes
could be established. One of the reasons for the, counterintuitively, higher amount of
DNA strand breaks in Flox/Wt hepatocytes could be due to the isolation procedure
which has been shown to lead to additional DNA damage (Wheelhouse et al. 2003).
When DNA strand breaks were also introduced at oxidative lesion sites by using the
enzyme Fpg, no difference in Olive tail moment was observed between genotypes.
The lack ofmore DNA damage in infected Flox/Null hepatocytes could be due to
ERCC1 protein still being present in sufficient concentration to deal with DNA
repair at 24 hours after infection. However, even at later time points, when the levels
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of ERCC1 protein had decayed, no differences between AdenoCre infected Flox/Null
and Flox/Wt cultures could be found. The overall amount of spontaneous oxidative
damage and strand breaks in our cultures might not be high enough to reveal a
difference in Olive tail moment between genotypes. Alternatively, other repair
pathways such as BER and error- prone post- replication repair (PRR) could be
responsible for dealing with the lesions caused in culture, masking the lack ofNER.
However, when considering the increased, spontaneous levels of apoptosis in Erccl-
deficient hepatocytes, the likelihood of other repair pathways efficiently dealing with
the lesions caused by a defect in NER is low.
To further strengthen the hypothesis that Erccl is crucial to hepatocyte survival and
to examine the lesions that may be responsible for the phenotype seen in Erccl-
deficient liver, experiments were conducted using UVC which induces DNA damage
repaired by the NER pathway, Glucose oxidase which induces oxidative DNA
damage and Mitomycin C which is responsible for the formation of interstrand cross¬
links. The main DNA adducts after UVC irradiation are cyclobutanepyrimidine
dimers and (6-4) photoproducts (Dunkern et al. 2001). In Erccl- deficient Chinese
hamster ovary (CHO) cells, apoptosis can be detected 24 hours after irradiation with
a dose- dependent increase of apoptosis up to 85% at 20 J/nr. Necrosis levels were
low and peaked at about 15% throughout time in culture (Dunkern et al. 2001). In the
same experiment, activation of caspase- 8, 3 and 9 was demonstrated as early as 10
hours after UVC. Bel 2, an anti- apoptotic factor, was subjected to more rapid
degradation after UVC, increasing the likelihood for Erccl- deficient CHO to
undergo apoptosis as a result of unrepaired DNA damage (Dunkern et al. 2001). In
addition, UVC- induced apoptosis has been demonstrated to be higher in Erccl-
deficient, immortalised murine fibroblasts (Melton et al. 1998). This is in accordance
with my findings that UVC induces high levels of apoptosis in Erccl- deficient
hepatocyte cultures. UV- induced apoptosis in Erccl- deficient cultures suggests that
a malfunction ofNER is responsible for the induction of apoptosis and that a lack of
Erccl leads to a survival disadvantage of hepatocytes in culture after UVC-
irradiation. When Dunkern et al. (2001) treated CHO cells with ionising radiation,
136
no such increase in apoptosis could be found, showing that Erccl- deficient CHO
cells are not generally sensitised to DNA damaging agents, but react specifically to
UVC. Of course, UV- induced DNA damage is not responsible for the phenotype in
Erccl- deficient liver. However, some forms of oxidative DNA damage are repaired
by NER and elevated levels of oxidative DNA damage in Erccl- deficient liver could
be contributing to the phenotype.
In primary hepatocytes, mild sensitivity to oxidative damage could also be
demonstrated when low doses ofGlucose oxidase were given, leading to a stronger
apoptotic response in Erccl- deficient hepatocytes when compared to controls.
Glucose oxidase, an enzyme oxidising glucose, is responsible for production of
hydrogen peroxide during the oxidation process (Mueller et al. 2001). In our cell
culture system a constant production of hydrogen peroxide induces oxidative damage
in hepatocytes. Accumulation of oxidative DNA damage has several severe
consequences for the hepatocytes. After induction of a wide range of oxidative stress,
mutations and replication fork blockage has been observed, along with increased
microsatellite instability and changes in intracellular signalling due to altered gene
expression after reactive oxygen species (ROS) production (Cooke et al. 2003).
Therefore, multiple repair pathways have evolved to deal with oxidative lesions, the
most prominent ofwhich is BER with its main substrate being 8-oxo-guanine (Cooke
et al. 2003). However, oxidative damage triggers a moderate, apoptotic response
when Erccl is absent in culture. It has been suggested that oxidative damage in the
liver contributes to the premature polyploidy observed in vivo (Mc Whir et al. 1993).
This suggestion is supported by the elevated levels of 8-oxo-G levels observed in
Erccl knockout liver (Selfridge et al. 2001) and by my observations of greater
sensitivity to glucose oxidase in Erccl- deficient hepatocytes in vitro.The absence of
a more drastic response in hepatocyte cultures can be explained by the rapid
degradation of hydrogen peroxide by hepatic catalases and glutathione peroxidase,
protecting the primary hepatocytes from extensive damage (Mueller et al. 2001).
When higher doses of Glucose oxidase were added to the cultures, extensive cell
death could be observed in all cultures independent of genotype. This could be
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explained by an imbalance of hydrogen peroxide concentration compared to catalase
and glutathione peroxidase activity, leading to an overall toxicity in vitro and cell
death.
In vitro, both NER and oxidative damage repair properties ofErccl seem to play a
role in hepatocyte maintenance. A combination ofDNA lesions arising due to
different roles ofErccl could contribute to the premature ploidy seen in vivo and the
extensive apoptotic response in vitro. In addition, the lack of development of
polyploidy which could protect Erccl- deficient hepatocytes from apoptosis is not
apparent in our cell culture system, possibly exposing those hepatocytes to higher
amounts of cellular stress and increasing the likelihood of apoptotic cell death.
Psoralen inter- strand cross links (ICL) in yeast are dealt with by several repair
pathways: The error- free pathway involves NER in which NER proteins induce
DSB around the lesion upon replication to be repaired by homologous recombination
(HR). On the other hand, the error- prone post- replication repair (PRR) pathway
ensures the bypass of the lesion (Saffran et al. 2004). Mitomycin C (MMC) induces
ICL, leading to a block of the replication fork and DSB. By linking two sister
chromosomes together, MMC interferes with the ability of the chromosomes to
separate during cell division. In addition, pyrimidine dimers and tandem base
substitutions can be observed upon MMC administration (Nohmi and Masumura
2005). As a result of the complexity of the lesion and the inability of chromosomes
to segregate during cell division, inter- strand cross links are known to be very
cytotoxic and rodent cells have been shown to be hypersensitive to ICL. (Lan et al.
2004). Mitomycin C exposure has been shown to result in higher levels of apoptosis
ofErccl- deficient Chinese hamster ovary cells and immortalised embryonic mouse
fibroblasts when compared to Wt cells (McWhir et al. 1993, Melton et al. 1998)
probably acting through caspase 8 activation (Dunkern et al. 2001). Interestingly,
immortalised embryonic mouse fibroblasts seemed to be less sensitive to Mitomycin
C than CHO cells, suggesting that there might be a second pathway in the mouse to
deal with interstrand cross-links. This is in accordance with my findings that
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Mitomycin C does not readily induce apoptosis in primary, Erccl- deficient
hepatocytes. Another possible explanation could also be lack of cell division in my
hepatocyte cultures. As mentioned above, the cytotoxicity ofMMC results from
cross linking two sister chromosomes which lose the ability to separate during cell
division. If cell division is low or lacking in hepatocyte cultures, exposure to MMC
would have no effect on hepatocyte survival.
In general, lower levels of apoptosis could be seen in control untreated cultures
during the DNA damaging experiments at 5 days after plating when compared to the
original estimation of spontaneous apoptosis in cultures at the same time point.
Levels of apoptosis were found to be around 23 % in infected Erccl Flox/Null
hepatocyte cultures at day 5 after plating. Infected Erccl Flox/Null control cultures
in the DNA damaging experiments at the same time point showed 3-7 % of
apoptosis. This discrepancy could be explained by a different batch of virus that was
used to assess spontaneous apoptosis and when cultures were challenged with DNA
damaging agents.
One of the more striking features of our Erccl- deficient hepatocyte cultures is the
accumulation ofmicrovesicular lipids in older cultures. Lipid accumulation is
generally a sign of diseased liver and occurs rapidly after insult. A progression from
microvesicles to the formation of macrovesicles is usually noticed with time (D.
Harrison, personal communication). Lipid accumulation is a sign of insufficient
hepatic mitochondrial (3- oxidation of free fatty acids, leading to a conversion of
excess fat to, for example, triglycerides which are stored in the cytoplasm (Patrick
2002). Mitochondrial (3- oxidation produces reactive oxygen species as part of the
normal metabolism in mitochondria. ROS can in turn initiate lipid peroxidation of
stored triglycerides in the cytoplasm (Patrick 2004). The production of reactive
aldehydes such as 4- hydroxynoneal or malondialdehyde can lead to damage in
mtDNA and nuclear DNA (Fromenty et al. 2004). Another reason for cytoplasmic
lipid accumulation can be found when lipogenesis is increased or when microsomal
cytochrome P450A co - oxidation is impaired (Videla et al. 2004). Lipid
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accumulation and mitochondrial dysfunction have been shown to lead to apoptosis or
necrosis, depending on the energy status of the cell (Fromenty et al. 2004). My
findings of lipid accumulation in liver point to a malfunction of mitochondria caused
by Erccl- deficiency. In addition, the increased levels of apoptosis in Erccl-
deficient cells might be partly responsible for the high amounts of lipids observed in
these cultures. No direct involvement ofNER in mitochondrial DNA repair has been
found in mammalian cells or yeast to date with BER mechanisms being operational
in mitochondria instead (Larsen et al. 2005). However, DNA damage that arises in
the nucleus in a situation of absent NER could lead to alterations in nuclear gene
expression and cause a disruption ofmitochondrial lipid metabolism indirectly.
Lipid accumulation in all cell culture dishes independent of genotype was apparent
after UVC irradiation, showing that accumulated DNA damage in the liver can lead
to a malfunction of lipid oxidation pathways (D. Harrison, personal communication).
In general, lipid accumulation is known to be a feature of diseased liver and is
common in models of alcoholic liver injury (Deaciuc et al. 2000). It seems that in
control dishes, where DNA repair is functional, normal lipid oxidation can take place
once the DNA damage is repaired and lipids no longer accumulate. In Erccl-
deficient liver lipid accumulation persists as a result of unrepaired DNA damage in
the hepatocytes.
In conclusion, Erccl- deficient primary hepatocyte cultures helped to further
characterise Erccl- deficiency in liver. We observed that absence ofNER led to high
rates of apoptosis in hepatocytes. In addition, it was established that the DNA lesions
most likely to be found in Erccl- deficient liver and implicated with the phenotype
observed is oxidative DNA damage. A possible disruption of lipid metabolism, as
indicated by hepatic lipid accumulation, could further contribute to damage in
hepatocytes and liver failure in Erccl- deficient animals in vivo. The liver phenotype
in Erccl- deficiency was further tested using AdenoCre virus in Erccl Flox/Null and
Flox/Wt animals.
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5. Conditional Erctf knockout approach using AdenoCre virus
in vivo
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5.1 Determination of recombination via PCR and Southern blotting
Six week old Erccl Flox/Null and Flox/Wt animals were i.v. injected with lxlO9 or
4xl09 pfu ofAdenoCre virus to determine short term consequences ofErccl-
deficiency in vivo. Animals of each group consisted of littermates and were
sacrificed 1 and 3 weeks after virus injection. DNA was prepared from liver. All
amounts ofDNA were matched and samples were subjected to a semi- quantitative
recombination PCR using a tissue sample with 200% recombination for comparison.
A faint 250 bp recombined band could be detected in all liver samples. The Erccl
Flox/Wt sample receiving 4xl09 AdenoCre virus showed the highest amount of
recombination 3 weeks after injection with levels being estimated at around 25%
(Figure 23, ID # 14 in Table 5).
Southern blotting was performed on samples receiving lxlO9 pfu AdenoCre virus 1
and 3 weeks after infection to determine the amounts of recombination more
accurately. A titration curve was obtained by spiking varying amounts ofDNA from
a cell line showing 100% recombination into DNA from an Erccl Flox/Flox liver.
The 3.3 kb recombined band could be detected in samples showing down to 25%
recombination in the titration curve, indicating the lower level of sensitivity for this
blot. In the infected Erccl Flox/Null and Flox/Wt samples, no recombined band
could be detected 1 or 3 weeks after infection. This result suggests that
recombination levels after AdenoCre infection in our fircc/Flox/Null and Flox/Wt
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Figure 23: Liver specific recombination of the Erccl floxed allele after AdenoCre virus
administration. (A) Semi- quantitative PCR showing a 250 bp recombined band in Erccl
Flox/Null and Flox/Wt liver 1 and 3 weeks after i.v. AdenoCre administration. Virus
concentrations varied from 1x109 to 4x 109 pfu per animal. An Erccl Flox/Flox tissue sample
showing 200% recombination (two floxed alleles, each with 100% recombination) was used
for comparison. All DNA was matched by spectrophotometry. (B) Southern blot indicating the
levels of recombination in Erccl Flox/Null and Flox/Wt livers after AdenoCre virus
administration. A titration curve was obtained by spiking varying amounts of DNA from a cell
line showing 100% recombination into DNA from an Erccl Flox/Flox liver. Erccl Flox/Null
and Flox/Wt livers show no recombined band 1 and 3 weeks after AdenoCre infection.
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5.2 Characterisation of the liver phenotype after AdenoCre virus injection
using histology
H&E slides were prepared from Erccl Flox/Null and Flox/Wt liver samples after
administration of 4xl09pfu AdenoCre virus 3 weeks after infection. Large, polyploid
hepatocyte nuclei could be detected in all samples independent of genotype
following a random distribution throughout the liver (Figure 24). We anticipated a
possible accumulation of polyploid nuclei around sinusoids in Erccl Flox/Null liver
as sinusoids are likely to be one of the main routes of entry for the virus. No such
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Figure 24: Histology of AdenoCre virus infected Erccl Flox/Null and Flox/Wt livers. Liver
sections were taken 3 weeks after i.v. infection with 4x109pfu AdenoCre virus. Sections were
H&E stained and pictures taken with a 10x objective. Hepatic veins and sinusoids are
labelled accordingly. Black arrow heads indicate large hepatocyte nuclei in all slides.
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5.3 Determination of DNA content after AdenoCre virus injection using flow
cytometry
Flow cytometry was used to determine the DNA content of lxl 09pfu AdenoCre
infected Erccl Flox/Wt samples 24 and 72 hours after injection (Table 5, ID #1 and
2). No clear difference in any of the parameters measured could be detected in
infected samples when compared to an uninfected littermate Flox/Wt control (ID #3).
lxl09 and 4xl09 pfu AdenoCre infected Erccl Flox/Null and Flox/Wt samples,
which were used for recombination determination by PCR, were subjected to flow
cytometry 1 and 3 weeks after infection. One week after infection, Erccl Flox/Null
samples showed higher levels of polyploidy (8n) when compared to the Flox/Wt
livers, independent of the total amount of virus given (Table 5, ID # 4 compared to 5;
10 compared to 11). Higher levels of ploidy were also detected in Erccl Flox/Null
livers 3 weeks after administration of 4x109 pfu AdenoCre virus when compared to
the infected Flox/Wt control (Table 5, ID # 14 compared to 15). A rise in octaploidy
could also be detected in lxlO9 pfu AdenoCre injected Flox/Null livers 3 weeks after
injection when compared to 1 week after injection (Table 5, ID # 5 compared to 8).
However, the total amounts of polyploidy were smaller in Erccl Flox/Null livers
when compared to Flox/Wt controls 3 weeks after lxl09 AdenoCre administration
(Table 5, ID # 7 compared to 8). Levels of polyploidy were low in uninfected
Flox/Wt control and Flox/Null control littermates (Table 5, ID # 6, 9, 12, 13). In
conclusion, in three out of four pair wise comparisons the level of polyploidy (8n)
was more than 2- fold higher in infected Erccl Flox/Null livers than in Flox/Wt
controls. The low levels ofpolyploidy in uninfected Erccl Flox/Wt (ID #6, 12,
Table 5) and uninfected Flox/Null (ID #9, 13, Table 5) livers indicate that the
increased ploidy in infected Erccl Flox/Null livers is a consequence of viral
infection and partial loss ofErccl.
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Apoptosis levels were low in general with sample Flox/Wt # 14 showing the highest
amount of apoptosis. This same sample also displayed the highest amount of
recombination as detected by PCR. Levels of S-phase were also low, with no clear
relationship with genotype, viral infection or time after infection.
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Table 5: DNA content of Erccl Flox/Null and Flox/Wt livers after AdenoCre virus
administration. Virus was given at 1x109 and 4x109 pfu. Control animals were littermates that
did not receive virus. Animals were sacrificed as indicated by the time after AdenoCre
infection. Age is given at the time of sacrifice. Apoptosis is given as a percentage of the total
amount of cells. Diploid, tetraploid, octaploid and S-phase fractions are given as the
percentage of viable cells. Individual samples are given ID numbers.
Virus S-
Genotype ID Age conc. Time 2n 4n 8n Apoptosis phase
(after
(#) (weeks) (Pfu) injection) (%) (%) (%) (%) (%)
Flox/Wt 1 7 1x109 24hrs 53.2 35.8 1.5 1.4 2.3
Flox/Wt 2 7 1x109 72hrs 61.1 34 0.6 1.1 1.4
Flox/Wt 3 7 0 72hrs 52.1 38.1 0.9 1.1 1.8
Flox/Wt 4 7 1x109 1 week 53.7 36 1.5 1.1 1.5
Flox/Null 5 7 1x109 1 week 49.7 41.2 5.2 0.7 0.9
Flox/Wt 6 7 0 1 week 58.9 34 2.5 0.8 1.4
Flox/Wt 7 9 1x109 3 weeks 44.8 38 11.5 1.2 1.3
Flox/Null 8 9 1x109 3 weeks 49.7 35.8 8.4 0.8 1.8
Flox/Null 9 9 0 3 weeks 58.8 32 2.8 0.7 1
Flox/Wt 10 7 4x10® 1 week 69 20.6 0.8 1.1 2.9
Flox/Null 11 7 4x10® 1 week 47.8 30.4 12.5 0.9 3
Flox/Wt 12 7 0 1 week 61 29.7 1.3 0.8 1.3
Flox/Null 13 7 0 1 week 58.3 29.6 2.7 0.7 0.7
Flox/Wt 14 9 4x10® 3 weeks 61.5 25.3 3.8 3.2 0.9
Flox/Null 15 9 4x10® 3 weeks 53.7 33 7.5 1.4 1.8
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5.4 Lipid accumulation visualised by Oil Red O staining
Liver sections of 6 week old Erccl Flox/Null and Flox/Wt animals injected with
4x109 pfu virus were taken 1 and 3 weeks after injection. Cryosections were cut and
then stained for lipids using Oil Red O. Pictures were taken with a 40 x objectives.
Erccl Flox/Null livers showed a large number of cytoplasmic macrovesicles
containing lipids when compared to Flox/Wt livers which only showed very small
amounts ofmicrovesicular lipid accumulation in the cytoplasm 1 week after virus
infection (Figure 25). Small amounts of lipid accumulation persisted 3 weeks after
AdenoCre injection in Flox/Null livers and to a lesser extent in Flox/Wt livers
(Figure 25). In conclusion, cytoplasmic lipid accumulation is initially induced in
Erccl Flox/Null livers, disappearing with time after infection.
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1 week after injection
Flox/Null+Cre Flox/Wt+Cre
3 weeks after injection
Flox/Null+Cre Flox/Wt+Cre
Figure 25: Lipid accumulation in AdenoCre infected liver. Erccl Flox/Null and Flox/Wt livers
were taken 1 and 3 weeks after infection with 4x109pfu AdenoCre and stained with Oil Red
O. The objective used for the pictures is 20x with an inset picture taken with a 40x objective.
Lipids and apoptotic cells are stained in red and hepatocytes and nuclei are stained in blue.
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5.5 Induction and characterisation of necrosis using carbon tetrachloride
(CCI4)
We reasoned that a greater difference between AdenoCre infected Erccl Flox/Null
and Flox/Wt livers might be apparent if the livers were stimulated to replicate. Liver
does not readily replicate unless hepatocytes are challenged by damaging agents. To
stimulate replication in the liver, we decided to use CCI4 which induces necrosis of
the liver and subsequent recovery. Necrosis ofErccl Flox/Wt liver and subsequent
regeneration was induced in 6 week old animals. At a single dose of 51 mg/ml,
which corresponds to 51 pg per g ofmouse, CCUand 1 day after injection necrotic
islands could be detected around hepatic sinusoids when stained with H&E (Figure
26). Signs of necrosis with small nuclei and lighter stain remained around sinusoids 5
days after CCI4. Complete regeneration of the liver had occurred 7 days after
injection with hepatocytes showing normal sized nuclei throughout. The amount of
necrosis in CC14 treated livers was further determined using the Olympus DP
software. Nine littermates were injected with 51 mg/ml CCI4 and sacrificed 1, 5 and
7 days after injection and amounts of necrosis were estimated. One day after CCI4
treatment, 25% of liver tissue was classified as necrotic, decreasing to around 15% 5
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Figure 26: Histology of carbon tetrachloride (CCI4) treated Erccl Flox/Wt livers. Animals
were sacrificed 1, 5 and 7 days after i.p. injection with 51 mg/ml CCI4. Sections were stained
for H&E and pictures taken with a 40x objective. Necrotic and normal hepatocytes are







Figure 27: Levels of necrosis in Erccl Flox/Wt livers after CCI4 treatment. Animals were
sacrificed 1, 5 and 7 days after i.p. injection with 51 mg/ml CCI4. Sections were stained for
H&E and pictures taken with a 10x objective. The amount of necrosis was estimated for each
slide using the Olympus DP software.The mean of three different mouse livers is shown for
each time point. The SEM is indicated with error bars.
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Flow cytometry was further used to characterise DNA content of liver samples after
23, 51 and 102 mg/ml CCI4 was given to the animals. Those doses corresponded to
23 pg per g ofmouse, 51 pg per g ofmouse and 102 pg per g ofmouse. Different
time points after injection were chosen as time of sacrifice. A dose of 23 mg/ml of
CCI4 led to an increase in octaploidy in all treated Erccl Flox/Wt livers when
compared to uninjected Flox/Wt littermates (Table 6, ID # 16- 23). The highest
amounts ofpolyploidy in these samples could be noted 3 and 5 days after treatment
(Table 6, ID # 18 and 20). Apoptosis and S-phase levels were low in all samples.
Erccl Flox/Null animals were treated with 51mg/ml CCI4 to determine the effect of
an increased dose of agent on a different genotype. 2 and 3 days after 51mg/ml CCI4
administration an increase in octaploidy was seen in treated animals when compared
to an untreated littermate control (Table 6, ID # 25 and 27 compared to 26). A high
level of apoptosis was seen in an Erccl Flox/Null liver 1 day after 51 mg/ml CCI4
when compared to an uninjected control (Table 6, ID # 24 compared to 26). This
level decreased with time. Levels of S-phase were increased 2 days after 51 mg/ml
CCI4 treatment when compared to an untreated control (Table 6, ID # 25 compared to
26).
We decided to increase the dose of CCI4 to 102 mg/ml in an attempt to see a more
pronounced effect on replication. Levels of octaploidy were increased in most treated
Erccl Flox/Null and Flox/Wt livers when compared to an untreated Flox/Wt
littermate (Table 6, ID # 28- 33 compared to 34). In addition, CCI4 treated Flox/Null
samples showed higher amounts ofploidy when compared to CCI4 treated Flox/Wt
samples 2 and 3 days after injection. An increase in apoptosis could be detected in
injected samples in the same experiment when compared to the uninjected control
(Table 6, ID # 28-33 compared to 34). An increase in S-phase could be noted in all
livers after 102 mg/ml CCI4with Erccl Flox/Null liver # 31 displaying up to 5 % of
cells in S-phase.
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Table 6: DNA content of Erccl Flox/Null and Flox/Wt livers after CCI4 administration. A
single dose of CCI4 was given i.p. at 23, 51 and 102 mg/ml. Control animals were littermates
that did not receive CCI4. Animals were sacrificed as indicated at the time after CCI4
administration. Apoptosis is given as a percentage of the total amount of cells. Diploid,
tetraploid, octaploid and S-phase fractions are given as the percentage of viable cells. All
samples are labelled with individual ID numbers.
Genotype ID CCI4 treatment Time 2n 4n 8n Apoptosis S-phase
(#) (mg/ml) (days) (%) (%) (%) (%) (%)
Flox/Wt 16 23 1 62 29 4.5 0.7 1.3
Flox/Wt 17 0 1 58 29.7 2.7 0.8 2
Flox/Wt 18 23 3 59.7 24 10.4 1.3 2
Flox/Wt 19 0 3 56.4 32.6 3.7 1.1 1.5
Flox/Wt 20 23 5 57.3 29.6 8 0.9 1.6
Flox/Wt 21 0 5 58.9 34 2.5 0.9 1.4
Flox/Wt 22 23 7 51.7 38.6 5.1 0.8 1.1
Flox/Wt 23 0 7 52.9 36 4.1 0.8 1.7
Flox/Null 24 51 1 64.5 23.9 0 5.2 3.1
Flox/Null 25 51 2 66 21.4 3 1.5 4.9
Flox/Null 26 0 2 74.5 17.3 2 1.7 3
Flox/Null 27 51 3 55 31.5 5.3 2.1 2.5
Flox/Wt 28 102 1 63.8 22.7 4.5 2.6 2.6
Flox/Null 29 102 1 60.7 28 3.1 1.2 2.1
Flox/Wt 30 102 2 58.6 31.4 1.8 2.6 3.1
Flox/Null 31 102 2 59.5 26 4.1 0.9 5.1
Flox/Wt 32 102 3 64.9 16.7 9.4 1.3 3.6
Flox/Null 33 102 3 54.5 25.7 12.4 0.7 2.6
Flox/Wt 34 0 3 69 24 2.7 0.6 1.8
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In summary, carbon tetrachloride stimulates necrosis from day 1 after injection with
liver regeneration being completed 7 days after injection. A general increase in
ploidy was apparent in treated samples when compared to untreated controls.
Irrespective of genotype, small increases in S-phase could be noted after higher doses
ofCCI4. Overall, the highest amounts of octaploidy and apoptosis were detected in
injected Flox/Null livers.
Additional pilot studies using multiple injections of 51 mg/ml CCI4 showed sufficient
induction of replication without harming the animals on a long term basis (results not
shown). We therefore decided to use 51mg/ml CCI4 to induce liver regeneration and
replication in our short term study ofErccl deficiency in an attempt to exaggerate
the possible consequences ofErccl loss in the liver.
5.6 Short term consequences of AdenoCre infection and carbon tetrachloride
injections
Previously, AdenoCre infection resulted in higher levels of octaploidy in Erccl
Flox/Null compared to Flox/Wt livers. We now wished to investigate whether this
difference could be exacerbated by CCI4 treatment. 6 week old animals received
lxlO9 or 4xl09 pfu AdenoCre virus followed by 51 mg/ml CCftonce weekly. An
untreated littermate was used as control. For characterisation Erccl Flox/Null and
Flox/Wt livers were subjected to flow cytometry. High levels of octaploidy were
apparent in all samples when compared to an uninjected control littermate with
Erccl Flox/Null sample #38 displaying up to 22% of octaploidy (Table 7). When
lxl 09 virus was given, treatment with CCI4 resulted in higher levels of octaploidy in
Flox/Null livers when compared to treated Flox/Wt livers 1 week after AdenoCre
virus injection (Table 7, ID # 35 compared to 36). In addition, one week after virus
injection higher levels of apoptosis and S-phase were seen in Erccl Flox/Null
compared to the Flox/Wt animal. These differences were not noticed 3 weeks after
injection with lxl09 pfu.
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Table 7: DNA content of Erccl Flox/Null and Flox/Wt livers after AdenoCre virus infection
and CCI4 administration. AdenoCre virus was given i.v. at a pfu of 1x109 and 4x109. CCI4 was
given i.p. at 51 mg/ml weekly. One control animal was a littermate that did not receive virus
or CCI4. Animals were sacrificed as indicated at the time after AdenoCre administration,
leaving 6 days of recovery after the last CCI4 injection. Age is given at the time of sacrifice.
Apoptosis is given as a percentage of the total amount of cells. Diploid, tetraploid, octaploid























Flox/Wt 35 7 1x109 51 1 50.9 38.5 6.9 0 1.6
Flox/Null 36 7 1x109 51 1 46.1 30.7 14.3 3.1 2.7
Flox/Wt 6 7 0 0 1 58.9 34 2.5 0.8 1.4
Flox/Wt 37 9 1x109 51 3 47.5 24.5 19.7 1.2 1.3
Flox/Null 38 9 1x109 51 3 46 23.6 22.4 0.8 1.8
Flox/Null 9 9 0 0 3 58.8 32 2.8 0.7 1
Flox/Wt 39 7 4x109 51 1 51.5 29.8 8.3 2.2 3
Flox/Null 40 7 4x10® 51 1 57.3 27.2 7.6 1.1 2.9
Flox/Wt 12 7 0 0 1 61 29.7 1.3 0.8 1.3
Flox/Null 13 7 0 0 1 58.3 29.6 2.7 0.7 0.7
Flox/Wt 41 7 0 0 1 61 29.7 1.3 0.7 1.3
Flox/Wt 42 9 4x10® 51 3 59.1 27.3 10.9 0.9 0.5
Flox/Null 43 9 4x10® 51 3 60.8 22.8 9.1 1.4 2.5
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Use of CCI4 at a virus concentration of4xl09pfudid not lead to a clear difference in
octaploidy between treated Erccl Flox/Null and Flox/Wt animals (Table 7, ID # 39,
40, 42, 43). Similarly, there were no clear genotype differences when levels of
apoptosis and S-phase were compared.
In conclusion, the polyploidy in regenerating liver induced by CCI4 treatment
reduced rather than increased the ploidy differences observed following AdenoCre
infection ofErccl Flox/Null and Flox/Wt livers.
5.7 Diethyl nitrosamine (DEN) induction of liver cancer in Erccl Flox/Wt mice
A pilot liver cancer induction experiment was conducted prior to designing an
experiment to investigate the effect of loss ofErccl on susceptibility to liver cancer.
One male Erccl Flox/Wt mouse was injected with 1 pg/g body weight (BW) DEN
i.p. at 14 days of age. The animal was regularly examined for signs of discomfort and
sacrificed at 39 weeks of age. A picture was taken of the whole liver and F1& E
sections were taken from tumour nodules and surrounding normal tissue. Figure 28
shows several tumour nodules accumulating throughout the liver. 19 small and 2
larger nodules were sampled in total. Histology of the tumours revealed that the
nodules consisted of hepatocellular adenomas (Dr. David Brownstein, personal
communication, data not shown).
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Tumour Normal tissue
Figure 28: Liver of Flox/Wt mouse 37 weeks after diethyl nitrosamine (DEN) injection. 8 pg
DEN was i.p. injected into a 2 week old male animal. Healthy liver tissue is intensely red.
White nodules comprise tumours of different size and pathology.
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5.8 Discussion
AdenoCre virus was i.v. injected into Erccl Flox/Null and Flox/Wt animals to
determine short term consequences ofErccl- deficiency in vivo. Low levels of
recombination were detected in all liver samples by PCR 1 and 3 weeks after
AdenoCre infection using two different titers of virus. To quantify the levels of
recombination, a Southern blot was performed including a titration curve. The lower
limit of detection was 25%. No recombination in AdenoCre injected samples was
detected by Southern blotting, indicating that the level of recombination was below
25%. The route of administration could be one reason for the low levels of
recombination seen in the liver. The virus is delivered by i.v. injection with no liver
specific receptor being targeted. Akagi et al. (1997) and Wang et al. (1996) reported
recombination levels to be around 50% in liver after i.v. injection ofAdenoCre virus
with lower levels of recombination being found in spleen and all other tissues. After
lxl09pfu AdenoCre virus infection, 80% of hepatocytes showed recombination of
the lacZ locus (Akagi et al. 1997). Therefore, the route of administration and the
concentration of virus used in our study should be sufficient. However, 90% of the
viral DNA was lost 60 days after injection, indicating extensive liver regeneration
after AdenoCre injection leading to an elimination of infected hepatocytes. Akagi et
al. (1997) suspected an increase in galactosidase activity, triggered by
recombination of the lacZ locus, rather than the virus itself as being responsible for
the extensive immune response observed. Stec et al. (1999) also found an
inflammatory response after injection of AdenoCre virus which was indicated by an
enlargement of the spleen. Although the immune system was clearly activated, it did
not affect the study results. An activation of the immune system and a clearance of
virally infected recombined hepatocytes could be responsible for the low levels of
recombination seen in our animals. In addition, Erccl- deficient hepatocytes might
be more prone to undergoing apoptosis in the liver as indicated by the high levels of
apoptotic cells in Erccl- deficient hepatocyte cultures in vitro. Interestingly, the
Erccl Flox/Wt liver sample showing the highest amounts of recombination after
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4xl09 AdenoCre infection also showed the highest amounts of apoptosis, indicating
that there might be a link between amounts of viral infection and rate of elimination
of virally infected hepatocytes.
Clusters of infected hepatocytes were noticed by Stec et al. (1999), but no such
patterns were seen when liver sections were assessed for clusters of polyploid
hepatocytes around sinusoids. Polyploidy is, of course, only an indirect indicator of
viral activity and a lack of polyploid clustering need not mean that viral infection is
evenly distributed in the liver.
Although only low levels of recombination could be detected in Erccl Flox/Null and
Flox/Wt animals after AdenoCre infection, a biological response in the form of
increased levels ofpolyploidy and cytoplasmic lipid accumulation in some of the
livers could be noted when liver samples were subjected to flow cytometry and Oil
Red O staining. Development of premature polyploidy is one of the hallmarks of
Erccl- deficiency and was seen in 6 week old, infected Flox/Null animals 1 week
after viral infection when compared to infected Flox/Wt littermates. In the same
experiment, levels ofpolyploidy in Flox/Null livers continued to be higher compared
to Flox/Wt livers at 3 weeks after 4xl09 pfu AdenoCre virus. Although ploidy
increased in lxl09 pfu AdenoCre infected Flox/Null liver 3 weeks after infection
when compared to the earlier time point, slightly higher levels of ploidy were
observed in the Flox/Wt control. The addition of AdenoCre virus, which stimulates
replication in Erccl Flox/Null and Flox/Wt cultures in vitro, cannot explain the
higher amounts ofpolyploidy seen in all Erccl Flox/Null livers at 1 week after the
infection as infected Flox/Wt littermates show lower levels ofploidy at this time
point. It also cannot be explained by a higher spontaneous level ofpolyploidy in
infected Flox/Null compared to Flox/Wt livers. Instead, Erccl- deficiency, induced
by AdenoCre mediated recombination, could be responsible for the increased levels
ofploidy in the liver of 6 week old animals. Erccl- deficient animals are thought to
undergo premature ageing with ploidy levels in 3 week old animals corresponding to
those of 2 year old Wt animals (McWhir et al. 1993). In normal liver diploid
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hepatocytes are the predominant cell type at birth displaying high amounts of S-
phase. An increase in ploidy and a decrease in mitotic activity occurs after weaning
and continues throughout life (Torres et al. 1999). In the adult liver, hepatocytes are
quiescent but remain with the capacity to re- enter the cell cycle upon toxic insult
(Gupta 2000). This replicative senescence in liver is thought to prolong life span as
telomerase activity is less apparent in mammals after birth, rendering the
chromosome telomeres prone to shortening after cell division (Anantharaju et al.
2002). Polyploidy in the liver, which is exposed to high levels of endotoxins, could
be seen as a protective mechanism where hepatocytes develop multiple copies of the
same gene without undergoing cell division. Partial Erccl- deficiency as observed in
AdenoCre infected Erccl Flox/Null livers led to elevated levels ofploidy indicating
that normal levels of ERCC1 are required for normal liver function. This early
response in our male animals could be mediated by testosterone and 3, 5, 3'-
triiodothyronine which have both been shown to help induce polyploidy in rats
(Torres et al. 1999). The lower levels ofpolyploidy observed in lxlO9 pfu AdenoCre
infected Flox/Null liver 3 weeks after infection could be caused by clearance of the
lower levels of infected hepatocytes with time. In conclusion, higher levels ofploidy
were observed in 6 week old AdenoCre infected Flox/Null livers when compared to
infected Flox/Wt mimicking the premature polyploidy seen in complete Erccl-
deficient liver.
Lipid accumulation is a phenotypic characteristic of ageing liver and is associated
with a rise in mtDNA mutations and deletions (Anantharaju et al. 2002).
Mitochondria are the main source of cellular ROS and at the same time are the main
target for ROS. A decrease in activity of hepatic anti- ROS defence mechanisms such
as Mn- superoxide dismutase (SOD) might be responsible for the accumulation of
oxidative mtDNA damage with age leading to a malfunction of mitochondrial
pathways (Anantharaju et al. 2002). Higher amounts ofmacrovesicular lipids could
be noted in 6 week old AdenoCre infected Erccl Flox/Null liver 1 week after
infection when compared to injected Flox/Wt controls. This lipid accumulation
disappeared 3 weeks after infection in all Flox/Null samples. Clustered lipid
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accumulation might take place in Erccl Flox/Null hepatocytes that have undergone
AdenoCre mediated recombination. Localised Erccl deficiency in those hepatocytes
might lead to cell clearance, which could explain the loss of accumulated,
cytoplasmic lipid in Erccl Flox/Null hepatocytes 3 weeks after AdenoCre infection.
The early lipid accumulation could be caused by mitochondrial malfunction in the
Erccl- deficient hepatocyte population in the liver. Lipid peroxidation, caused by
increased levels of ROS, can destroy the mitochondrial membrane, reducing its
functionality. As lipids that are taken up from the blood are subjected to
mitochondrial P- oxidation, a reduced capacity ofmitochondrial function can lead to
excess fat being stored in the cytoplasm (Patrick 2004). Although no evidence for
direct involvement ofErccl in the mitochondria exists (O'Neil and Melton,
unpublished data), nuclear DNA mutations resulting from Erccl deficiency could
lead to a decrease in supply of nuclear encoded proteins needed to maintain
mitochondrial function. Therefore, Erccl- deficiency could indirectly lead to
mitochondrial malfunction and lipid accumulation. The decrease in accumulated
lipid in Flox/Null livers 3 weeks after infection could be explained by a partial
clearance ofErccl- deficient hepatocytes. Lipid accumulation as a consequence of
mitochondrial membrane disruption has been found by Dirkx et al. (2005). A liver
specific elimination of peroxisomes was achieved using the Cre loxP system, leading
to an alteration in mitochondrial membrane structure and an accumulation of lipid
vesicles in the cytoplasm. It would be interesting to determine the mitochondrial
membrane potential in our Flox/Null AdenoCre infected livers to further strengthen
the hypothesis that the accumulation of lipid observed is linked to a malfunction of
mitochondrial pathways. In general, Erccl Flox/Null livers with increased levels of
polyploidy also showed higher amounts of lipid accumulation compared to Erccl
Flox/Null livers with a lesser response to the AdenoCre virus, indicating that lipid
accumulation might be an early and more subtle response to loss of ERCC1 than
polyploidisation.
Carbon tetrachloride is a liver damaging agent known to cause necrosis of the liver.
CC14 requires metabolic activation in the liver and has been shown to act by
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damaging lipid containing cellular components such as mitochondria, the
endoplasmatic reticulum and the Golgi apparatus (Weber et al. 2003).
Haloalkylation, impairment of lipid metabolism and lipid peroxidation is initiated by
the radical, metabolically active form of CCI4. Lipid accumulation and cell death
occur in several stages after dosing (Weber et al. 2003). Necrosis is first seen 5-6
hours after CCI4 treatment, leading to central zone necrosis after 12 hours and to
massive necrosis 24-48 hours after injection with CCI4 (Weber et al. 2003). High
amounts of necrotic cell death were observed 1 day after injection with CCI4. This is
in accordance with the literature. Signs of necrosis were still apparent 5 days after
insult with a complete recovery 7 days after treatment with CCI4. Animals subjected
to partial hepatectomy (PH) are able to replace the loss of liver mass within 1 week
(Gupta 2000). PH leads to hepatocytes re- entering the cell cycle in a synchronised
manner with a peak ofDNA synthesis 36-40 hours after PH (Taub 2004). As a result
of the liver mass replacement, hepatocytes become more polyploid and binuclear,
limiting further regeneration. CCI4 induces injury to the liver leading to the activation
of similar molecular mechanisms as PH. However, hepatocytes are known to enter
the cell cycle in a non- synchronised manner after CCI4 injections (Taub 2004).
The capacity of the liver to recover from toxic insult results from its ability to re¬
enter the cell cycle and replace damaged hepatocytes (Seglen et al. 1997). Small,
stem cell like hepatocytes are also thought to play a role during liver regeneration
giving rise to a pool of diploid cells that can easily divide after insult (Mitaka et al.
1998). Cell cycle re-entry and subsequent liver regeneration is thought to be
mediated in 2 different steps. Firstly, liver mass is replaced to its original size.
Secondly, the reformation of the normal liver architecture can then be undertaken
(Taub 2004). There are 2 main pathways regulating the restoration of the liver mass,
one being the cytokine dependent pathway and the other being the growth factor
dependent pathway. Cytokine IL- 6 is a key effector of liver regeneration and, upon
binding to its receptor, activates the MAPK pathway, crucial to hepatocyte
proliferation, and PI3K signalling, ensuring cell survival (Taub 2004). The growth
factor mediated pathway promotes DNA replication during liver regeneration using
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the hepatic growth factor (HGF)- Met pathway. DNA replication is induced by HGF
binding to its receptor Met and then activating the PI3K and the MAPK-ERK
pathway (Taub 2004). Stellate cells induce connexin-32 and keratin-8 production
approximately 4 days after PH, helping to maintain the liver architecture by
supplying extracellular matrix to the newly formed hepatocyte clusters. The
termination of liver regeneration is regulated via a feed-back loop where cytokine
suppressors are upregulated upon cytokine induction. In addition, maintenance of
liver function during regeneration is ensured by upregulation of gluconeogenesis,
supplying the organism with sufficient energy (Taub 2004). Cell cycle re- entry in
our animals could be observed by measuring elevated levels of S-phase initially after
treatment with 51 mg/ml and after 102 mg/ml of CCI4 as detected by flow cytometry,
although this increase was not as large as we had anticipated.
In addition to necrosis, higher levels of apoptosis were observed by flow cytometry
when 51 mg/ml and 102 mg/ml of CCI4 were given. Depending on the energy status
of the cell and the damage caused by CCI4, the cellular response can differ between
apoptosis and necrosis (Schulze- Bergkamen 2006). High levels ofATP favour an
apoptotic response in hepatocytes whereas depletion ofATP during mitochondrial
membrane transition favours necrosis. In addition, ROS can activate lysosomal
proteases which, at a low concentration, will cleave caspases and lead to apoptotic
cell death. In contrast, high amounts of lysosomal proteases can induce a necrotic
response (Schulze- Bergkamen 2006). This shows that different cell death patterns
can co-exist in liver. Overall, CCI4 treatment results in clearly increased polyploidy
with small increases in S-phase and apoptotic cells, but no clear difference between
the response in Erccl Flox/Null and Flox/Wt livers.
The combination of AdenoCre virus and treatment with CCI4 in vivo led to higher
levels ofploidy in Erccl Flox/Null livers compared to Flox/Wt samples when lxlO9
pfu virus was given. This difference was apparent 1 week after viral infection and
treatment with CCft, but not after 3 weeks. In addition, no difference in ploidy status
between the two genotypes could be observed when animals were treated with 4xl09
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pfu AdenoCre and CCI4 Furthermore, elevated levels of S-phase were found to be
independent of genotype or virus titer in all treated livers. It seems that the increased
polyploidy in both genotypes resulting from CCI4 treatment is masking the small
increase in ploidy observed as a result ofErccl deficiency induced in Erccl
Flox/Null livers by AdenoCre infection. This model could therefore not be used to
investigate short term consequences ofErccl- deficiency.
Diethyl nitrosamine (DEN) is a known inducer of liver cancer acting through DNA
adduct formation and oxidative DNA damage (Loft et al. 1998). A close correlation
between elevated levels of 8-oxo-G and formation of liver tumours after DEN
administration has been shown in rat liver (Loft et al. 1998). In addition, around 26
weeks after DEN exposure, using similar amounts of carcinogen to ourselves, Wt
male rats displayed high amounts of adenomas with lower tumour frequency being
apparent in female rat livers (Ischiwaka et al. 2001). Kalinina et al. (2003) found an
increase in adenomas in Wt mice 25 weeks after 1 pg/g BW DEN was given with
hepatocellular carcinoma (HCC) appearing at around 42 weeks of age. We found a
high tumour burden in Erccl Wt liver 39 weeks after exposure to DEN. These
tumours were classed as hepatocellular adenomas, showing that hepatocytes rather
than other cell types undergo DEN induced changes. Lim (2002) describes and
characterises a liver cancer model where DEN was used to initiate mutational
damage to hepatocytes followed by weekly injections ofNodularin or Thioacetamide
(TTA), which are similar in action to CCL^ over a 10 week period to promote tumour
formation by stimulating replication and cell division. Fixation of further mutations
then led to hepatocellular carcinoma in rat livers 20 weeks after DEN treatment (Lim
2002). DEN induced p53 protein activation in liver during the initiation step, but no
mutations inp53 could be found during the first weeks after DEN injection.
Exposure to TTA after DEN injections led to a loss ofRb function caused by an
overexpresssion of gankyrin, which has been shown to accelerate the degradation of
Rb (Lim 2002). In addition, although initially pi6 expression was not altered after
TTA treatment, hypermethylation of the promoter DNA led to an inactivation ofpi 6
at later stages during TTA promotion. TGFP receptors were found to be upregulated
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in hepatocytes during the regeneration of the liver after DEN/TTA treatment (Lim
2002). In addition, non- parenchymal cells upregulated TGFP expression, initially
preventing uncontrolled hepatocyte proliferation and promoting apoptosis. However,
during analysis of the HCC tissue a loss of TGFP receptors was apparent in the
tumours, explaining the gradual loss of response to TGFP expression with time.
In skin ofErccl- deficient mice, UVB- induced tumours were apparent in animals 8-
17 weeks after three irradiations per week, with Wt animals not developing tumours
when subjected to the same regime (Doig et al. 2006). Coordinated overexpression of
ERCC1 and XPC has been found to take place in hepatocellular carcinomas when
compared to non-tumour tissue along with an increase ofNER activity (Fautrel et al.
2005). This induction ofERCC1 overexpression and increased activity ofNER has
been linked to EGF- stimulated proliferation in hepatocytes in tumour and normal
livers via the MAPK pathway (Andrieux et al. 2006). In addition, ovarian, gastric
and colon cancers are known to overexpress ERCC1, leading to a resistance to
chemotherapeutic drugs. Thus, a lack as well as overexpression ofERCC1 seem to
have consequences during tumour development. A clear association with ERCC1
deregulation and cancers has been established and it would be of interest to assess
the long- term consequences ofErccl- deficiency in liver. Our AdenoCre based
mouse model using Erccl Flox/Null and Flox/Wt animals is suited to address this
issue, although my data indicate that there is uncertainty about the long term viability
ofErccl- deficient hepatocytes. In fact, a similar protocol to that of Lim (2002)
could be used in a cancer study to determine the effect of partial Erccl- deficiency in
the liver. Unfortunately, limited time did not permit the inclusion of this study in my
thesis.
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6. Changes in the liver of complete Erctf knockout mice
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Originally, we set out to characterise the liver phenotype caused by Erccl deficiency
in a conditional, liver- specific knockout mouse model. However, one of the most
striking features ofErccl loss in the liver, premature polyploidy, was difficult to
replicate in our conditional knockout system in vitro and in vivo. We therefore
resumed examining our original Erccl Null animals in more detail. Premature
polyploidy has been previously characterised by nuclear size change (Chipchase et
al. 2003). We hoped that flow cytometry could further help to examine the
development ofpolyploidy in Erccl Null and Wt animals of different age. In
addition, we wanted to examine whether the lipid accumulation seen in older Erccl-
deficient hepatocyte cultures, after UV in vitro and in AdenoCre infected livers 1
week after infection was also apparent in our complete Erccl knockout animals. In
our conditional hepatocyte culture system it was indicated that both loss ofNER
function and of oxidative repair pathways led to decreased survival in Erccl-
deficient hepatocyte cultures. We set out to examine the lesions responsible for the
premature polyploidy in our Erccl Null livers in vivo in more detail. In addition,
expression changes of selected genes were studied to help understand the changes in
Erccl- deficient livers on a molecular level.
6.1 Histology of Erccl Null and Wt livers
Liver samples from 20 day old littermates were taken and processed for histology.
H&E slides were prepared and pictures taken with a 40x objective. Large, polyploid
nuclei were visible in Erccl Null livers at 20 days of age with smaller nuclei
persisting throughout the liver (Figure 29). Erccl Wt nuclei showed few enlarged,
polyploid nuclei. In conclusion, Erccl Null livers contain polyploid nuclei at 20 days
of age which is in accordance with previous findings (McWhir et al. 1993). We used
flow cytometry to characterise the development of polyploidy in Erccl Null and Wt
livers in more detail.
169
Figure 29: Histology of Erccl- deficient and Wt liver. Liver sections were taken from
littermate pair # 19 at 20 days after birth. All sections were H&E stained and pictures taken
with a 40 x objective. Large hepatocyte nuclei in the Null sample are labelled with small
black arrows.
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6.2 Determination of DNA content in Erccl Null and Wt livers by flow
cytometry
Flow cytometry was used to analyse DNA content ofErccl Null and Wt livers of
different age. The individual ID numbers of littermate pairs are given in Table 8. The
same samples were subjected to multiple analyses in this study. The amount of
apoptosis is given as percent of all cells and the ploidy and S-phase data are
expressed as percent of all viable cells. Erccl Null animals displayed higher amounts
ofploidy in the liver when compared to Wt littermates, even at a young age (Table
8). However, the difference in ploidy between Erccl Null and Wt livers became
more pronounced with age as visualised in a typical flow profile of livers of 20 day
old animals (Figure 30). This increased polyploidy is in accordance with previous
results obtained by McWhir et al. (1993), although no 16n hepatocyte population
could be detected towards the maximum life span of the animals as previously
described. Instead tetraploidy was 2 to 3- fold increased in Erccl Null animals when
compared to Wt littermates from the age of 12 days onwards. Animals were grouped
into 3 different age categories to analyse the onset ofpolyploidisation in more detail.
Erccl Null livers showed no significant difference when compared to Wt littermates
using a paired, two- tailed Student's t- test at the age of 1-5 days (p= 0.2 for 4n, p=
0.16 for 8n) (Table 9). However, Erccl Null livers aged 10-14 days showed
significantly higher amounts of tetraploidy when compared to Wt littermate controls
(p= 0.03, Table 9). The increased levels of octaploidy were borderline significant in
Erccl- deficient livers when compared to Wt control livers (p= 0.057, Table 9).
Increases in both tetra- and octaploidy in Erccl Null livers were significant when
compared to Wt littermate controls in 19-21 day old animals (p= 0.000004 for 4n, p=
0.0002 for 8n, Table 9). Figure 31 summarises the increases in tetra- and octaploidy
in Erccl Null livers in the different age groups and shows typical levels of ploidy for
age matched littermate controls.
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Table 8: DNA content of Erccl- deficient and Wt livers determined by flow cytometry. Data
from littermates of different age are shown for both genotypes. The age is given in days after
birth. Apoptosis is displayed as percentage of all cells. Ploidy status and S-phase are shown
in percent of viable cells.
Littermate S:
Genotype Age Pairs 2n 4n 8n phase Apoptotic
(days) (ID#) (%) (%) (%) (%) (%)
Null 1 20 66.1 9.4 2.9 19.1 2.9
Wt 1 20 70.3 10.5 0.2 17.3 0.8
Null 1 21 67.9 13.5 0.4 16.3 0.6
Wt 1 21 70.3 8.7 0.2 18.9 1.6
Null 4 11 73.9 12.5 0.6 10.8 0.5
Wt 4 11 63.4 13.7 0.4 15.8 0.4
Null 4 12 68.6 17.1 1.2 9.2 0.8
Wt 4 12 72.1 11.5 0.3 13.2 0.7
Null 5 29 75.7 8.5 0.5 14.1 0.7
Wt 5 29 80.9 5.4 0.3 12.8 0.3
Null 10 13 85.8 8.3 0.6 2.2 1.9
Wt 10 13 84.7 6.0 0.2 6.5 0.9
Null 10 14 75.8 15.6 1.1 4.4 1.0
Wt 10 14 83.6 6.5 0.1 7.9 0.6
Null 12 27 71.1 18.0 2.9 4.9 0.2
Wt 12 27 86.3 5.9 0.3 5.7 0.2
Null 14 15 73.8 17.3 2.0 3.1 1.4
Wt 14 15 89.2 6.1 0.3 2.6 0.4
Null 19 17 61.0 25.3 5.9 1.5 0.8
Wt 19 17 75.4 10.6 0.5 2.1 0.4
Null 19 23 79.5 16.2 2.1 0.9 0.2
Wt 19 23 92.5 4.7 0.1 2.3 0.1
Null 19 24 76.4 17.0 2.7 1.6 0.3
Wt 19 24 90.2 7.9 0.2 1.0 0.3
Null 20 19 72.6 17.9 3.7 4.1 0.6
Wt 20 19 88.2 7.3 0.4 2.4 0.5
Null 20 25 69.7 20.7 4.2 2.1 1.1
Wt 20 25 85.6 11.0 0.4 1.5 0.6
Null 21 22 70.1 20.6 4.0 1.4 1.1
Wt 21 22 81.5 8.5 0.4 1.9 0.4
Null 21 26 70.4 21.2 4.5 1.3 0.2













Figure 30: Flow cytometry profile showing the DNA content of 20 day old Erccl- deficient
and Wt liver (pair# 19). The different cell fractions are labelled. Diploid, tetraploid and
octaploid fractions are given as the percentage of viable cells.
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Figure 31: Development of tetra- and octaploidy in Erccl- deficient and Wt livers in different
age groups. Animals were divided into 3 different age groups, ranging from 1-5, 10-14 and
19-21 days after birth. The mean and the SEM is given for each group and genotype.
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Levels of S-phase seemed to be high in all young animals, decreasing with age
(Table 9). Significant levels of haematopoiesis still occur in livers of young animals.
When levels of S-phase in Erccl Null and Wt livers were compared between the 3
age groups, no significant difference was noted between the genotypes (Table 9).
When Erccl Null and Wt livers were grouped according to age, a slight difference in
apoptosis levels between genotypes became apparent (Table 9). 1-5 day and 10-14
day old livers displayed no significant difference in levels of apoptosis in Erccl Null
and Wt livers (p= 0.56 for 1-5 day group, p= 0.1 for 10-14 day group). However, at
the age of 19-21 days, Erccl Null livers showed a borderline significant difference
in apoptosis levels when compared to Wt littermate controls (mean Null 0.61 ± 0.1,
mean Wt 0.35 ± 0.1,p= 0.054, Table 9). This value might become significant with
increased sample size and gives an indication of increased apoptosis in Erccl Null
livers with age. When all collected data were analysed, a significant difference in
apoptosis between Erccl Null and Wt livers could be observed, with increased levels
of apoptosis in Erccl- deficient livers (Null 0.9 ± 0.2, Wt 0.5 ± 0.1, p= 0.046, Table
9).
In conclusion, the striking polyploid liver phenotype in Erccl- deficient animals was
confirmed. Increased levels of apoptosis could also be detected in Erccl Null livers
when compared to Wt.
6.3 Detection of lipid accumulation in Erccl- deficient liver by Oil Red O stain
Liver samples of 5 (ID # 29), 14 (ID #15) and 21 (ID #26) day old animals were
taken and processed for Oil Red O staining. Lipid accumulated in the cytoplasm of
all livers, irrespective of genotype at a young age, leading to the formation of micro-
and macrovesicles (Figure 32). At 14 days of age, macro- and microvesicular lipid
accumulation persisted in Erccl- deficient liver with decreased levels of accumulated
lipids being visible in Erccl Wt littermates where microvesicular lipid accumulation
was predominant. When Oil Red O staining was performed on livers of both
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genotypes at the age of 21 days, micro- and macrovesicular lipid accumulation was
still apparent in the cytoplasm ofErccl- deficient liver. In contrast, only very small
amounts of lipid were detectable in Erccl Wt littermates (Figure 32). In conclusion,
lipid accumulated in young livers independent of genotype with a gradual
disappearance of cytoplasmic lipids in Erccl Wt livers and persisting levels of lipid
in Erccl Null livers with age.
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Figure 32: Lipid accumulation in Erccl- deficient and Wt liver. Livers were stained with Oil
Red O 5 (pair # 29), 14 (pair # 15) and 21 (pair # 26) days after birth. Pictures were taken
with a 40x objective. Lipid vesicles are stained in red and cytoplasm and nuclei are stained in
blue.
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6.4 Characterisation of triglyceride content in Erccl- deficient and Wt liver
In an attempt to further characterise the lipid accumulation seen in older Erccl Null
livers, we analysed the triglyceride content of 19-21 day old Erccl Null and Wt
livers (ID # 19, 23, 24, 26). Triglycerides are one of the lipids possibly accumulating
in the cytoplasm ofErccl- deficient livers with age as Oil Red O stains triglycerides
and other hydrophobic lipids, such as cerebrosides and cholesterol esters.
Cytoplasmic triglycerides are also found after CCI4 induced damage to livers, where
the damaged endoplasmic reticulum is found to reduce the release of triglycerides
into the plasma and an accumulation takes place in the cytosol of hepatocytes (Weber
et al. 2003). Higher triglyceride levels were detected in our Erccl- deficient animals
when compared to Wt littermate controls (Figure 33). However, this difference was
not significant because of a high variability of triglyceride content observed in
Erccl- deficient livers (p= 0.24 by paired, two- tailed Student's t- test). An increase












Figure 33: Triglyceride levels in Erccl- deficient and Wt liver. Samples were taken from 19-
21 day old animals (from littermate pairs with ID # 19, 23, 24 and 26). The amount of
triglyceride is given as pMol/g of liver. The mean of four different samples is given. The SEM
is indicated with error bars.
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6.5 Characterisation of levels of reactive oxygen species in Erccl- deficient
and Wt livers
The amount of reactive oxygen species (ROS) was measured in Erccl- deficient and
Wt littermates of different age using the CM-H2DCFDA - method. CM-H2DCFDA
is a cell permeable diacetate ester which fluoresces upon reaction with ROS. The
assay was done on freshly isolated hepatocytes plated in lx FIBSS. The amounts of
ROS were normalised to the amounts of cell protein measured per sample and were
expressed on a relative scale giving the ratio ofROS in Erccl Null versus Wt livers.
For statistical analysis, we grouped animals into 2 age groups, from 5-7 days and 9-
21 days. An increase in ROS could be detected in Erccl- deficient liver at 5 and 7
days of age when compared to Wt littennates (Figure 34). Furthermore, this trend of
increased ROS in Erccl Null liver reversed with increased age, leading to higher
amounts of ROS in Erccl Wt livers when compared to the Null littermates. This
increase in ROS in Null livers compared to Wt was not significant when both age
groups were compared using the Wilcoxon matched pair test (p= 0.08). Flowever,
ROS levels in 12 day old Erccl Null hepatocytes were surprisingly low and differed
from all other data points of the same genotype. In conclusion, Erccl- deficient livers
show a trend towards higher levels ofROS at a young age compared to Wt
littermates, but this difference is reversed in older animals.
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Figure 34: Reactive oxygen species in Erccl- deficient and Wt hepatocytes. The amount of
ROS normalised to the amount of protein in isolated Null and Wt hepatocytes is shown on a
relative scale. The mean of 3 wells is given for each sample. The SEM is indicated with error
bars. The age of the animals is given in days. Littermate pairs # 26 (21 days old), # 27 (12
days old), # 29 (5 days old), # 30 (7 days old) and # 31 (9 days old) are shown.
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6.6 Analysis of malondialdehyde adducts in Erccl- deficient and Wt livers
Malondialdehyde adducts are a form ofDNA adduct found in an environment of
high oxidative stress. The most common form ofmalondialdehyde adducts are
malondialdehyde deoxyguanosine (MidG) DNA adducts. In addition,
malondialdehydes can also react with DNA forming interstrand cross- links (Leuratti
et al. 1998). We subjected Erccl- deficient and Wt livers of different age to
immunoslot blotting to determine the M]dG content in liver DNA. 1 day after birth,
nearly 2 times higher levels ofM]dG adducts could be detected in livers ofErccl-
deficient animals when compared to Wt littermates (n=2, Table 10). This difference
was not significant resulting from a high variability in the amount ofMidG adducts
found in Erccl- deficient livers (p= 0.41, Table 10). An increase of sample size could
possibly result in this difference becoming significant. At 10 days of age, similarly
low amounts ofMidG DNA adducts were apparent in Erccl- deficient and Wt livers
(n=2, p= 0.99, Table 10). Moreover, 14-20 day old Erccl- deficient animals showed
nearly 2 times lower levels ofMidG DNA adducts in their livers when compared to
Wt littermates (n=3). This difference was significant with the p- value being < 0.01.
In summary, Erccl- deficient livers, when compared to Wt littermates, display high
amounts ofMidG adducts soon after birth. The levels ofMidG DNA adducts are
lower at the end of the maximum life span of the Erccl- deficient animals, so that in
20 day old animals, levels ofMidG DNA adducts are higher in Wt controls than in
their Erccl- deficient littermates.
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Table 10: Malondialdehyde adducts in Erccl- deficient and Wt liver. Levels of
deoxyguanosine malondialdehyde adducts (IVLdG) are given per 108 nucleotides. Animals
were grouped according to age and genotype. The three age groups consisted of animals
being 1,10 and 14-20 days old. ID numbers of littermate pairs are indicated for each group.
The mean of malondialdehyde adducts is given for the different age groups. The SEM and
the p-value, obtained from a paired t-test for the null hypothesis that there is no difference
between genotypes, are given.
RMG
Genotype ID# Age nucleotides p value
(days) (mean ± SEM)
Null 20, 21 1 118.51 ± 71.7
Wt 20, 21 1 67.86 ±33.1 0.41
Null 13, 14 10 24.35 ± 14.2
Wt 13, 14 10 24.3 ± 11.7 0.99
Null 15, 17, 19 14-20 68.16 + 13.2
Wt 15, 17, 19 14-20 113.62 ±11.5 0.007
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6.7 mRNA expression studies in Erccl- deficient and Wt livers using RT
Real- time PCR
RT Real- time PCR was performed on Erccl- deficient livers and Wt littermates
aged 4- 21 days. The expression of selected genes involved in cell cycle regulation,
apoptosis and oxidative damage response was determined in duplicate experiments
with the same set of samples. A normalisation factor was calculated from expression
levels of the two reference genes, Gapdh and Tbp, for each sample following
Vandesompele et al. (2002). The standard curve method was used, as reliable
standard curves were produced for each run, and all calculations were performed
following Larionov et al. (2004). The mean of both experiments was taken and the
expression ratio ofNull to Wt livers was plotted on a log scale. The SEM for each
sample set is indicated with error bars.
6.7.1 Insulin- like growth factor binding protein 2 (IGFBP2)
IGFBP2 binds to insulin- like growth factor (IGF) I and II, thereby regulating the
availability of IGF to a range of tissues. Igfbp2 expression has been found to be
upregulated in cell sorted fractions ofpolyploid hepatocyte nuclei compared to
diploid nuclei from wild type mice (Pin et al. unpublished data). We examined the
expression in 9 pairs ofErccl Null and Wt livers aged 4-21 days. Igfbp2 expression
was upregulated in all Erccl- deficient livers when compared to Wt littermate
controls, independent of age (Figure 35). This upregulation resulted from increased
levels of Igfbp2 mRNA levels in Null livers with a more or less constant expression
of Igfbp2 in Wt livers in all but littermate pair #15. The highest expression of Igfbp2
was found in 14 day old Erccl Null liver where the increase was found to be 25- fold
(ID # 15). In this sample pair, Igfbp2 mRNA levels were increased in Null liver with
a slight decrease inWt liver mRNA levels being apparent at the same time. The
average increase in Erccl- deficient livers was around 3- fold (ratio mean for all
samples, excluding pair # 15: 3.3 ± 0.6; overall ratio mean: 5.7± 2.5). Overall,
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increased Igfbp2 mRNA levels were detected in Erccl Null livers when compared to
Wt control littermates.
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Figure 35: Igfbp2 expression in Erccl- deficient and Wt liver determined by RT- Real- time
PCR. The ratio of Null versus Wt expression is given. A log scale is used to display the
ratios. Each sample was run twice. The mean and the SEM are given for each pair. For each
sample a normalisation factor was calculated for the reference genes Gapdh and Tbp. All
samples were normalised before calculating the ratio of Igfbp2 expression. Order of Ercd
Null/Wt pairs: Erccl 4 days old (# 11); 4 days old (# 12); 10 days old (# 13); 10 days old (#




p21 is involved in cell cycle regulation and has been found to be upregulated in
Erccl- deficient, polyploid hepatocyte nuclei using immunohistochemistry and at the
mRNA level using northern blotting (Chipchase et al. 2003, Nunez et al. 2000). This
upregulation ofp21 was confirmed at the mRNA level in 4-20 day old Erccl Null
livers when compared to Wt littermates (Figure 36). The increase in p21 expression
resulted from an upregulation in Null livers with Wt livers expressing p21 more or
less constantly apart from in littermate pair #13 where Null levels were constant and
Wt levels changed. Again, the highest levels ofp21 mRNA were found in 14 day old
Erccl- deficient liver where a 30- fold increase was observed (ID # 15). The average
level ofp21 expression lay typically around 2- fold (ratio mean for all samples,
excluding pair # 15: 2 ± 0.3; overall ratio mean: 5.3± 3.3).p21 was downregulated at
21 days of age where mRNA levels were 2- fold lower in Erccl- deficient liver
when compared to Wt (ID # 26). This decrease resulted from a decrease in p21
mRNA expression inNull liver with Wt liver expressing similar levels compared to
all other Wt livers examined. In summary, an upregulation ofp21 mRNA was
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Figure 36: p21 expression in Erccl- deficient and Wt liver determined by RT- Real- time
PCR. The ratio of Null versus Wt expression is given. A log scale is used to display the
ratios. Each sample was run twice. The mean and the SEM are given for each pair. For each
sample a normalisation factor was calculated for the reference genes Gapdh and Tbp. All
samples were normalised before calculating the ratio of p21 expression. Order of Erccl
Null/Wt pairs: Erccl 4 days old (# 11); 4 days old (# 12); 10 days old (# 13); 10 days old (#
14); 12 days old (# 27); 14 days old (# 15); 19 days old (# 17); 20 days old (# 19); 21 days
old (# 26).
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6.7.3 Transforming growth factor p (TGF p)
TGF P is a multi- functional protein that is involved cell cycle regulation, modulation
of differentiation, induction of apoptosis and angiogenesis and in maintenance of
genome stability (Romero- Gallo et al. 2005). Tgffi overexpression has been found to
be a marker of liver cancer progression (Romero- Gallo et al. 2005). When Tgffi
mRNA levels were determined in Erccl Null and Wt livers of different age,
increased levels of Tgffl were found in most younger Erccl Null livers when
compared to Wt controls (Figure 37). The highest levels were found in 4 day old
Erccl Null livers with 3- fold increased Tgffi mRNA levels (ratio mean = 3 ± 0.95).
On average Tgffi was nearly 2- fold upregulated in 4-14 day old Erccl- deficient
livers (ratio mean = 1.9 ± 0.4). The difference in expression was caused by
upregulation of Tgffi in Null livers in some littermate pairs and downregulation in
Wt liver expression in others. In contrast, in 19-21 day old livers, Wt expression of
Tgffi mRNA was 2- fold higher compared to Nulls (ratio mean = 0.6 ± 0.06). In
summary, high Tgf/3 mRNA levels were apparent in young Erccl Null livers with a
decrease in older livers.
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Figure 37: Tgf/3 expression in Erccl- deficient and Wt liver determined by RT- Real- time
PCR. The ratio of Null versusWt expression is given. A log scale is used to display the
ratios. Each sample was run twice. The mean and the SEM are given for each pair. For each
sample a normalisation factor was calculated for the reference genes Gapdh and Tbp. All
samples were normalised before calculating the ratio of Tgff} expression. Order of Erccl
Null/Wt pairs: Erccl 4 days old (# 11); 4 days old (# 12); 10 days old (# 13); 10 days old (#




BAX is a pro- apoptotic factor which has been shown to be downregulated in rat
liver after exposure to oxidative damaging agents (Holmes et al. 2002). Expression
studies ofBax in Erccl- deficient livers and Wt littermates showed an upregulation
ofmRNA in 4-14 day old Erccl- deficient livers (Figure 38). The highest levels of
Bax mRNA were found in 14 day old Erccl Null liver when compared to a Wt
control with a 5- fold increase (ID # 15). The average increase in Bax expression was
found to be around 2- fold in 4-12 day old Erccl- deficient liver (ratio mean = 1.7 ±
0.1) . Bax mRNA levels decreased in Erccl Null livers from 19 days of age onwards,
showing a 1.5- fold downregulation when compared to Wt livers (ID # 17, 19, 26
ratio mean = 0.7 ± 0.2). The Wt liver Bax mRNA levels were consistent throughout,
with changes in ratio being caused by differences in Null liver expression ofBax
mRNA in all samples but littermate pair # 26. Surprisingly, at 21 days of age,
slightly higher levels ofBax mRNA were found in Erccl Null livers compared to
Wt, but note the relatively large error bars associated with this ratio (ID # 26). In
summary, 4-14 day old Erccl- livers showed increased levels ofBax mRNA in
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Figure 38: Bax expression in Erccl- deficient and Wt liver determined by RT- Real- time
PCR. The ratio of Null versus Wt expression is given. A log scale is used to display the
ratios. Each sample was run twice. The mean and the SEM are given for each pair. For each
sample a normalisation factor was calculated for the reference genes Gapdh and Tbp. All
samples were normalised before calculating the ratio of bax expression. Order of Erccl
Null/Wt pairs: Erccl 4 days old (# 11); 4 days old (# 12); 10 days old (# 13); 10 days old (#
14); 12 days old (# 27); 14 days old (# 15); 19 days old (# 17); 20 days old (# 19); 21 days
old (# 26).
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6.7.5 Proliferating cell nuclear antigen (PCNA)
PCNA is a processivity factor for polymerase § and 8 and is essential for DNA
replication and repair. Pcna expression was found to be increased in rat liver in
response to oxidative damage (Holmes et al. 2002). In addition, Hsia (2000) found
increased levels ofPCNA protein in Erccl- deficient livers when compared to Wt
samples. When Erccl- deficient and Wt livers were compared for Pcna mRNA
levels a slight downregulation was noted in all Erccl Null livers from 4-21 days of
age (Figure 39). The lowest levels ofPcna mRNA were found in 4 and 19-20 day old
Erccl- deficient livers with 1.5 - fold lower levels at 4 days of age (ratio mean = 0.7
± 0.02) and nearly 3- fold lower levels at 20 days of age (ratio = 0.4). The difference
in expression was caused by downregulation ofPcna in Null livers in some littermate
pairs and upregulation ofPcna expression in Wt livers in others. In summary, a
slight decrease in Pcna mRNA levels was detected in Erccl Null livers.
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Figure 39: Pcna expression in Ercrf- deficient and Wt liver determined by RT- Real- time
PCR. The ratio of Null versus Wt expression is given. A log scale is used to display the
ratios. Each sample was run twice. The mean and the SEM are given for each pair. For each
sample a normalisation factor was calculated for the reference genes Gapdh and Tbp. All
samples were normalised before calculating the ratio of Pcna expression. Order of Erccl
Null/Wt pairs: Erccl 4 days old (# 11); 4 days old (# 12); 10 days old (# 13); 10 days old (#
14); 12 days old (# 27); 14 days old (# 15); 19 days old (# 17); 20 days old (# 19); 21 days
old (# 26).
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6.7.6 Redox factor 1 (REF-1)
REF-1 is involved in the defence mechanism after oxidative injury as part of the
BER pathway and has been shown to be upregulated in rat livers after challenge with
oxidative damaging agents (Holmes et al. 2002). Previous immunohistochemistry
studies in Erccl- deficient livers suggested an upregulation ofRef-1 in Erccl-
deficient livers when compared to Wt samples (Chipchase 2002). RT Real- time PCR
studies using Erccl Null and Wt livers aged 4-21 days could not reveal a trend in
Ref-1 expression with Ref-1 mRNA levels showing a small increase in some Erccl-
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Figure 40: Ref-1 expression in Erccl- deficient and Wt liver determined by RT- Real- time
PCR. The ratio of Null versus Wt expression is given. A log scale is used to display the
ratios. Each sample was run twice. The mean and the SEM are given for each pair. For each
sample a normalisation factor was calculated for the reference genes Gapdh and Tbp. All
samples were normalised before calculating the ratio of Ref-1 expression. Order of Erccl
Null/Wt pairs: Erccl 4 days old (# 11); 4 days old (# 12); 10 days old (# 13); 10 days old (#




Polymerase P is involved in BER where it catalyses the filling of single nucleotide
gaps after oxidative damage. Polymerase /3 mRNA levels were found to be
upregulated in rat liver after exposure to oxidative stress (Holmes et al. 2002). When
mRNA levels ofpolymerase ft were determined in Erccl Null and Wt livers of
different age, no trend could be detected in mRNA expression between the genotypes
(Figure 41).
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Figure 41: Polymerase P expression in Erccl- deficient and Wt liver determined by RT-
Real- time PCR. The ratio of Null versusWt expression is given. A log scale is used to
display the ratios. Each sample was run twice. The mean and the SEM are given for each
pair. For each sample a normalisation factor was calculated for the reference genes Gapdh
and Tbp. All samples were normalised before calculating the ratio of polymerase p
expression. Order of Erccl Null/Wt pairs: Erccl 4 days old (# 11); 4 days old (# 12); 10 days
old (# 13); 10 days old (# 14); 12 days old (# 27); 14 days old (# 15); 19 days old (# 17); 20
days old (# 19); 21 days old (# 26).
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6.8 Discussion
Erccl- deficient livers were further characterised to gain a better understanding of
the mechanisms involved in the premature ageing phenotype of those mice. A
hallmark ofErccl- deficiency is the increase in levels of polyploid hepatocytes at a
very young age which is comparable to levels seen in 2 year old Wt livers (McWhir
et al. 1993, Weeda et al. 1998). We confirmed the increased levels of ploidy in our
Erccl- deficient livers aged 1-21 days when compared to Wt littermates and
established a time related pattern for the onset of polyploidy in Erccl Null livers. At
1 -5 days of age there was no significant difference in levels of polyploidy between
the genotypes. This changed when 10-14 day old livers ofErccl Null and Wt
animals were compared. Significant differences in tetraploidy become apparent at
this time point. In addition, in 19-21 day old Erccl Null livers, levels of tetra- an
octaploidy were significantly increased when compared to Wt littermates. Overall,
with increased age, an increase in polyploidy was observed in Erccl Null livers. This
could be caused by accumulating DNA damage with age, triggering polyploidisation
as a protective mechanism (Weeda et al. 1998). In addition, Erccl- deficiency might
cause changes in nuclear gene regulation, leading to the onset ofpolyploidy over
time. Interestingly, levels of octaploidy were lower in our Erccl- deficient mice
when compared to our previous results (McWhir et al. 1993, Nunez et al. 2000). In
both cases there were high levels of tetraploid hepatocytes from 12 days of age
onwards. The two studies were conducted more than 6 years apart in different mouse
houses. Differences in milk composition due to changes in food given to the mothers
could explain the differences in polyploidy levels. It has been shown that
environmental factors such as food uptake play a role in ploidy levels of the liver
(Gupta 2000). The animals are all on a non- inbred background which might have
changed with time, leading to differences in levels of ploidy. In addition, 6 week old
AdenoCre infected Flox/Null livers showed higher levels of octaploidy, but not
tetraploidy, 1 week after infection when compared to infected Flox/Wt livers. This
discrepancy between total levels of tetraploidy and octaploidy in Erccl- deficient
livers and AdenoCre infected Flox/Null livers could be explained by the difference in
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age. AdenoCre infection occurs in 6 week old animals, where some polyploidisation
has already occurred. AdenoCre infected animals of a younger age might give rise to
a similar pattern of polyploidisation when compared to the simple Erccl- deficient
animals.
If oxidative damage was responsible for the liver failure in our Erccl- deficient
animals the life span of those animals could be improved by adding antioxidants such
as Vitamin E and C to the food (Wu and Cederbaum 2003). The antioxidants should
be passed on in the mother's milk to the pups and help to increase life span,
rendering it possible to study the effects ofErccl- deficiency in slightly older
animals.
S- phase levels were high in young animals independent of genotype, decreasing
with age. This decline in replication is to be expected as part of the normal
maturation process and correlates with a decline of replicating haematopoietic cells,
typically apparent in liver after birth (Gupta 2000). Nunez et al. (2000) found lower
levels of replication in Erccl Null livers when compared to Wt controls. However,
this difference was not significant. Our data do not support the finding that
replication is impaired in Erccl Null livers. A difference in methodology could be
the reason for this discrepancy as Nunez et al. (2000) used BrdU staining to
determine replication potential whereas we used flow cytometry. As discussed
earlier, BrdU staining is the more accurate method of S- phase determination. This
might be particularly important given that only small changes in levels of S-phase
would be predicted between the genotypes.
Although not always significant when the data were analysed by age, we observed a
tendency towards increased levels of apoptosis in Erccl Null livers when compared
to Wt littermate controls using flow cytometry. Apoptosis could be triggered by
increased levels ofDNA damage using the p53 signalling pathway where
polyploidisation does not provide sufficient protection. When all data were analysed
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together significantly higher amounts of apoptosis were apparent in Erccl Null livers
compared to Wt. In fact, Dolle et al. (2006) suggest that one possible mechanism
leading to liver failure in Erccl- deficient animals could be increased rates ofDNA
damage- induced apoptosis. My in vivo data are in accordance with my previous
findings which found increased levels of apoptosis in Erccl- deficient hepatocyte
cell cultures with time in culture. Artificial cell culture conditions might be
responsible for a more pronounced effect seen in hepatocytes in vitro when
compared to my in vivo results.
Lipid accumulation is a sign ofmalfunction of oxidative pathways in the liver. Free
fatty acids are metabolised through (3- oxidation in mitochondria with excess fat
being converted to triglycerides and other hydrophobic lipids and stored in the
cytoplasm (Patrick 2002). In addition, increased levels ofROS can damage
respiratory chain components in the mitochondria through lipid peroxidation, leading
to a defect in mitochondrial function (Fromenty et al. 2004). To help maintenance of
mitochondrial function, repair mechanisms have evolved to guarantee genomic
stability of the mtDNA. Recently, Achanta et al. (2005) found an involvement of p53
in mitochondria. A translocation of p53 into mitochondria was followed by
interaction with mtDNA polymerase y, enhancing replication and repair of the
mitochondrial genome. We found elevated levels of lipid accumulation in young
Erccl- deficient and Wt livers. This accumulation of cytoplasmic lipids disappeared
in older Wt livers, but persisted in Erccl- deficient livers of a similar age. An
increase in oxygen pressure at birth could be responsible for increased levels of
oxidative stress in liver of both genotypes after birth, leading to accumulation of lipid
which could be caused by mitochondrial damage. Where functional repair
mechanisms are in place, lipid metabolism can be restored, resulting in a decrease of
lipid vesicles in the cytoplasm. Another explanation might be that prior to birth,
oxidation of lipids is inactive in the liver, leading to lipid accumulation. This lipid
storage can then be used as a source of energy in Wt liver after birth, but not in Erccl
Null livers where repair pathways are abrogated, resulting in accumulation ofDNA
damage and mitochondrial dysfunction. This could lead to persistent, macrovesicular
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lipid accumulation in Erccl- deficient livers. In fact, Hsia (2000) found a disruption
of the outer mitochondrial membrane in Erccl- deficient livers when compared to
Wt, showing that Erccl- deficiency influences mitochondrial function in an indirect
manner. Lipid accumulation in older livers has been noted in our conditional Erccl
knockout model using AdenoCre virus in vitro and in vivo. In addition, lipid
accumulated in all cultures independent of genotype after DNA damage. Therefore,
lipid accumulation seems to be a general feature ofErccl- deficiency and liver DNA
damage.
When triglyceride levels were compared between Erccl Null and Wt livers, no
significant difference in amount of accumulated lipids could be established between
the genotypes. This was partly because of a high amount of variation in Erccl Null
livers. Alternatively, although triglycerides are a common form of lipid found in
cytoplasmic vesicles, Oil Red O also stains other hydrophobic lipids such as
cerebrosides and cholesterol esters (Lillie and Ashburn 1943). The macrovesicular
lipid vesicles might therefore primarily contain other types of lipids in Erccl-
deficient liver when compared to Wt. Differences in lipid composition could also
explain the variability in triglyceride content between Erccl Null livers of similar
age. The Oil Red O staining patterns are generally regarded as the more reliable
indicator of differences in lipid accumulation between Erccl Null and Wt livers.
ROS levels were determined in young Erccl- deficient livers and Wt littermates.
Higher amounts ofROS were found in Erccl Null livers after birth. In older animals,
this correlation was however inverted, with ROS being highest in Wt livers. In
addition, higher levels ofmalondialdehyde adducts were established in young Erccl
Null livers when compared to Wt. This difference was not significant because of a
high variability in MidG in Null livers. Older Wt livers showed higher levels of
malondialdehyde adducts when compared to Erccl Nulls. It seems that levels of
ROS and malondialdehydes correlate in both genotypes which can be explained by
the biological effects of ROS. During ROS generated lipid peroxidation,
malondialdehyde adducts occur as a by-product (Niedernhofer et al. 1997). In
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addition, arachidonic acid metabolism and synthesis of prostaglandins lead to
malondialdehyde formation endogenously (Leuratti et al. 1998). Malondialdehyde is
known to react with DNA at neutral pH forming deoxyguanosine (M)dG) and, to a
lesser extent deoxycytidine adducts, deoxyadenosine adducts and interstrand cross¬
links, in a variety of tissues including liver (Leuratti et al. 1998). Malondialdehyde
adducts, especially the major adduct deoxyguanosine, are usually repaired by NER
pathways (Singh et al. 2001). Background levels ofMidG lie in the range of 50-120
adducts per 108 nucleotides in human disease free liver (Singh et al. 2001). In
o
contrast, carbon tetrachloride treated rat livers displayed 38 MjdG adducts per 10
nucleotides with base levels being around 21 MidG per 108 nucleotides in control
animals showing inter- species differences in malondialdehyde adduct background
levels (Singh et al. 2001).The MidG levels observed in young Erccl Null animals
and in old Wt livers lie within the range in human tissue, but are highly elevated
when compared to rat malondialdehyde levels. Furthermore, even base levels in
young Wt animals and older Erccl Null animals are relatively high showing that
oxidative stress might be apparent in both genotypes after birth and just before
weaning. The fluctuation of both ROS and malondialdehyde adducts could be caused
by differences in DNA repair capacity where disruption of various signalling
pathways caused by unrepaired DNA damage leads to ROS and malondialdehyde
accumulation in an indirect manner. Even though no significant difference in ROS
and MidG levels could be established between genotypes, small differences in levels
of oxidative stress and DNA damage could still have important physiological effects
on hepatocytes. Overall, Erccl- deficient mice show a premature aging phenotype
with their elevated levels of liver polyploidy, accumulation of large lipid vesicles,
runted appearance and premature death. These data fail to provide evidence that this
is due to elevated levels of oxidative DNA damage. Premature ageing phenotypes
have been created when the proof- reading capacity ofmitochondrial polymerase y
was disabled, with mice showing reduced body weight, hair loss and premature death
(Trifunovic et al. 2004, Kujoth et al. 2005). Although elevated levels ofmtDNA
mutations were apparent in those mice, an increase in markers of oxidative stress,
such as ROS and malondialdehyde adducts, was not established. Instead the
accelerated development of the ageing phenotype resulted in increased levels of
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apoptosis which were thought to be responsible for tissue dysfunction (Kujoth et al.
2005). Similar mechanisms could be responsible for the phenotype in Erccl-
deficient livers. Therefore, the lack of significant differences in ROS and MidG
levels between Erccl Null and Wt animals could mean that increased levels of
apoptosis, rather than oxidative stress leads to liver failure in Erccl- deficient
animals.
We further characterised Erccl- deficiency in liver by using RT Real- time PCR to
determine the expression of selected genes involved in cell cycle regulation,
apoptosis and oxidative damage response. Glyceraldehyde 3- phosphate
dehydrogenase (Gapdh) and Tata- binding protein (Tbp) were chosen as reference
genes, as the use of one reference gene only can lead to 10-25% erroneous
normalisation (Vandesompele et al. 2002). GAPDH has recently been shown to be
regulated by mitogenic stimuli in a variety of experimental settings (Radonic et al.
2004). However, Vandesompele et al. (2002) examined several reference genes in a
variety of tissues showing that GAPDH and TBP were stably expressed in liver. In
addition, although TBP is found in low abundance in liver, it is also one of the
reference genes with the lowest overall range ofRNA transcription making it ideal as
a second reference gene (Radonic et al. 2004).
Growth factors are multifunctional cell signalling units with insulin- like growth
factor I (IGF) being involved in cell growth, regulation and differentiation. IGF II is
responsible for degrading IGF I protein (Schneider et al. 2000). Their effect is
mediated through cell surface receptors and insulin- like growth factor binding
proteins (IGFBP) which bind IGF in biological fluids, thereby helping IGF
circulation in the body (Scheider et al. 2000). In addition, IGFBP are thought to have
autocrine and paracrine functions. IGFBP2 is expressed in a variety of tissues, but
most abundantly in liver and kidney. It acts mainly as an inhibitor of IGF I
bioactivity and its overexpression led to reduced growth capacity and a reduction in
liver weight when compared to Wt littermates (Schneider et al. 2000). High serum
levels of IGFBP2 are also associated with liver cirrhosis and diabetes mellitus
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(Schneider et al. 2000). Wood et al. (2000) constructed Igfbp2 knockout mice that
displayed a reduction in male spleen weight and an increase in liver weight, showing
that Igfbp2 acts in a tissue- specific manner and that its loss can be counterbalanced
by other Igf binding proteins. Pin et al. (unpublished data) showed that lgfbp2
mRNA expression was highly upregulated in polyploid hepatocyte nuclei. Our
findings are in accordance with this as we showed that Igfbp2 mRNA expression was
increased in Erccl Null livers when compared to Wt littermates. IGFBP2 expression
is influenced by hormones such as transforming growth factor P (TGFP) and IGF
(Hoeflich et al. 2001). Therefore, higher IGF levels stimulate cell growth and DNA
replication, leading to upregulation of IGFBP2 at the same time. In addition, there is
evidence that IGFBP2 itselfmay stimulate cell proliferation independent of IGF
(Hoeflich et al. 2001). In conclusion, Igfbp2 could be seen as a molecular marker for
polyploidisation in the liver where increased levels of IGFBP2 lead to a decrease in
IGF with a subsequent reduction in proliferation. This decline in proliferation might
then favour polyploidisation. In addition, upregulation of Igfbp2 could contribute to
the runted phenotype seen in Erccl Null animals.
p21 is involved in cell cycle regulation and is a mediator of p53 pathways, with p53
independent pathways also existing (Kinoshita et al. 2002). It acts as a cyclin
dependent kinase (CDK) inhibitor at different stages of the cell cycle and is classed
as a Cip/Kip family member along with p27 and p57 (Luedde et al. 2003). p21
mRNA levels were upregulated in Erccl Null livers when compared to Wt
littermates. This is in accordance with Chipchase et al. (2003) who found a
correlation between enlarged hepatocyte nuclei and increased p21 expression in
Erccl Null and Wt liver using immunohistochemistry. As enlarged nuclei are mainly
a phenotypic characteristic ofErccl - deficient livers, an increased p21 expression is
primarily expected in Erccl Null livers. A G2 arrest has previously been found in
enlarged nuclei ofErccl Null hepatocytes and p21, which showed upregulation at
the mRNA level, has been suggested as a possible mediator of the G2 arrest (Nunez
et al. 2000). p21 along with proliferative stimuli, could be involved in the premature
liver polyploidy in Erccl- deficient animals. The variation observed inp21 mRNA
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expression between different littermate pairs has previously been observed by
Chipchase et al. (2003) where immunohistochemistry revealed inter-nuclear
differences of p21 expression. Especially in littermate pair # 14 the Erccl Null liver
showed very high levels ofp21 mRNA which probably reflects a real change, as the
Wt liver p21 mRNA levels in this littermate pair are comparable to Wt liver mRNA
levels of the majority ofWt samples examined. In general, where major differences
in expression between Wt and Null for a variety of genes have been observed, this
difference is caused by variation in gene expression in Nulls, rather than changes in
Wt livers.
Transforming growth factor p (TGF P) is a potent inhibitor of cell proliferation and
known to be a tumour suppressor in a normal cellular context (Romero- Gallo et al.
2005). It is upregulated in response to partial hepatectomy, suppressing hepatocyte
replication once liver mass is restored. TGF P signalling occurs through membrane
associated serine threonine kinases (Stenvers et al. 2003). However, TGF P is also a
known pro- metastatic factor and tumour promoter in a variety of tumours including
hepatocellular carcinomas (HCC) (Tang et al. 2003, Romero- Gallo et al. 2005). This
switch of function has been demonstrated in a breast cancer cell line in vitro (Tang et
al. 2003). We investigated the expression patterns of Tgfp in Erccl Null and Wt
livers of different age. In 4- 14 day old livers, Tgf mRNA seemed to be upregulated
in Erccl- deficient livers with a trend towards lower levels in older Erccl Null livers
when compared to Wt. Tgffi mRNA upregulation in young Erccl Null livers might
be a mechanism trying to prevent cell proliferation of hepatocytes with unrepaired
DNA damage.
Oxidative stress induced upregulation of proliferating cell nuclear antigen (PCNA),
redox factor 1 (REF-1) and Polymerase P was observed in rat liver (Holmes et al.
2002). We therefore investigated the expression patterns of those oxidative stress
markers in Erccl Null and Wt livers. In addition, mRNA of the pro- apoptotic factor
BAX was found to be downregulated in rat liver after treatment with an oxidative
damage inducer (Holmes et al. 2002). BAX is a mediator of p53 induced apoptosis
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and known to be a tumour suppressor (Knudson et al. 2001). BAX heterodimerises
with anti- apoptotic family members rendering them inactive whilst a
homodimerisation leads to activation ofBAX and insertion into the mitochondrial
membrane (Reed 1998). A translocation ofBAX from the outer to the inner
mitochondrial membrane helps to release mitochondrial cytochrome C during
apoptosis. When we examined Erccl Null and Wt livers, an upregulation ofBax
mRNA was noted in 4- 14 day old livers with downregulation ofBax mRNA being
apparent thereafter. In addition, an increase in apoptosis levels was indicated in older
Trcc/Null livers when compared to Wt using flow cytometry. Accumulation ofDNA
damage and oxidative stress in Erccl Null livers might lead to increases in apoptosis
where polyploidisation cannot protect against rises in DNA damage. BAX has indeed
been shown to be part of the cellular response to oxidative stress (Knudson et al.
2001). Increased survival might be necessary in older Erccl- deficient liver to
tolerate accumulating DNA damage to a certain extent. This would predict the
observed downregulation of Bax mRNA and apoptotic mechanisms in old murine
livers to counteract an otherwise fatal reduction of liver mass.
PCNA is a processing factor for polymerase y and s and also functions as a DNA
clamp during translesion bypass when post- translationally modified, allowing the
switch from a high fidelity polymerase to specialised polymerases (Friedberg 2005).
Its subcellular localisation has been shown to change in response to oxidative stress
(Holmes et al. 2002). In addition, p21 inhibits PCNA- mediated DNA polymerase
activity upon binding (Jaime et al. 2002). No clear difference in Pcna mRNA
expression was noted between young Erccl Null and Wt animals. This is in
agreement with the observation that S-phase levels did not differ between genotypes
when examined by flow cytometry, showing that similar levels ofDNA replication
take place in both genotypes. Results obtained by Holmes et al. (2002) showing
elevated levels ofPcna mRNA after oxidative stress in rat liver could not be
confirmed. ROS levels in our Erccl Null animals might not be high enough to trigger
a PCNA response. In addition, species related differences in PCNA expression might
be accountable for this difference. Furthermore, response to an external oxidative
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damage inducer used by Holmes et al. (2002) in the liver might differ from
mechanisms triggered by endogenous oxidative damage. Hsia (2000) found elevated
PCNA protein levels in Erccl Null livers using Western blotting. This discrepancy in
Pcna mRNA and protein levels could be because of post- translational modifications
of the protein, allowing higher levels of PCNA protein to persist in Erccl Null livers
without affecting mRNA levels.
Chipchase (2002) noted a possible upregulation ofREF-1 in Erccl Null liver
compared to Wt using immunohistochemistry. In addition, an upregulation of Ref-1
mRNA expression in rat liver was apparent after exposure to an oxidative damage
inducer. We found a high variability in Ref-1 mRNA expression between liver pairs
and could therefore not see any trend in Ref-1 mRNA levels between genotypes.
REF-1 is involved in BER where its function as an AP endonuclease is essential
(Meira et al. 2001). Apart from 5'- endonuclease activity, REF-1 also displays as a 3'-
phosphodiesterase and 3'- phosphatase activity. Furthermore, REF-1 is required for
redox activation of spontaneously oxidised transcription factors, highlighting its
involvement in the cellular stress response (Raffoul et al. 2004). REF-1 expression
could therefore be taken as an indirect indication ofBER activity which does not
seem to be upregulated in Erccl- deficient livers where NER is abrogated. REF-1
has also been shown to recruit polymerase P to incised AP sites leading to insertion
of new nucleotides (Raffoul et al. 2004, Sugo et al. 2004). Polymerase P, the smallest
described polymerase with a single 39 kDa polypeptide, also mediates excision of
abnormal 5'- dRP during BER, a rate- limiting property that can be enhanced upon
REF-1 interaction (Esposito et al. 2000). No clear trend in polymerase ft mRNA
expression was noted in Erccl Null and Wt livers, strengthening the observation that
BER upregulation is not apparent in Erccl- deficient livers. Because of the close
relationship between the ubiquitously expressed Polymerase P and REF-1 similar,
non- descript expression patterns in Erccl Null and Wt livers should therefore not be
surprising.
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In conclusion, RT Real- time PCR revealed the upregulation of several proteins with
a possible role in polyploidisation. An upregulation of Igfbp2 and p21 mRNA was
found in Erccl Null livers when compared to Wt and might help to mediate increases
in tetra- and octaploidy observed in Erccl- deficient livers. A tendency towards
increased levels of apoptosis was apparent in Erccl Null livers when compared to Wt
controls. Moreover, Bax mRNA levels were highest in younger Erccl Null livers and
dropped belowWt levels from 19 days after birth. More accurate determination of
apoptosis with for example caspases- 3 cleavage assays might help to understand the
exact mechanism of apoptosis in more detail. The lack of increased oxidative
damage, like malondialdehyde DNA adducts, in older Erccl- deficient livers when
compared to Wt controls agrees with the RT Real- time PCR analysis of oxidative
stress markers. Oxidative stress markers did not display a rise in mRNA levels at any
examined age, showing that the different amounts ofROS and malondialdehyde
adducts in younger Erccl- deficient animals did not cause a change in molecular
expression patterns. However, malfunction of oxidative pathways which might be a
cause ofmitochondrial damage were apparent in the form of accumulating lipids in
the cytoplasm ofErccl- deficient livers. Measurement ofmitochondrial membrane
potential might give a more direct indicator ofmitochondrial status in Erccl Null
livers.
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Conclusions and future work
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We conducted a study in an attempt to clarify the role ofErccl in the liver in a
conditional knockout system in vivo, in vitro and in complete knockout mice. The
establishment of a conditional, transgenic, liver- specific knockout model proved
more difficult than anticipated as TTRCre Erccl Flox/Null and Flox/Wt mice only
displayed very low and irreproducible levels of recombination upon tamoxifen
administration. A lack of Cre recombinase expression, or rapid clearance of
hepatocytes following tamoxifen administration, could explain these results. Western
and northern blotting should help to determine the expression patterns ofCre
recombinase in our mice in more detail. Caspase cleavage and TUNEL assays might
be able to elucidate the levels of apoptosis after tamoxifen administration.
One conclusion from this study is that Erccl seems to be essential for liver
maintenance and that a lack of protein resulted in possible rapid clearance of
hepatocytes in vivo. The higher amounts of apoptosis in infected Erccl Flox/Null
cultures spontaneously and after exposure to UV and GO highlights the involvement
ofErccl in hepatocyte survival. Both its function in the NER pathway and in
oxidative damage repair seem to be required for hepatocyte maintenance. In addition,
Oil Red O data in 6 week old AdenoCre infected mice suggest a clearance of infected
Flox/Null hepatocytes that accumulate large amounts of lipid in the cytoplasm 3
weeks after infection. Moreover, Erccl knockout animals displayed an upregulation
ofBax, a pro- apoptotic factor, at the mRNA level in younger animals. It would be
interesting to examine Bax mRNA levels in AdenoCre infected Erccl Flox/Null and
Flox/Wt livers 1 and 3 weeks after infection to clarify the amounts of apoptosis
caused by Erccl downregulation. Other apoptosis markers such as caspase cleavage
might help to determine the apoptotic status in Erccl knockout livers in more detail.
In general, it seems that apoptosis is a mechanism of protection in liver at an early
stage during Erccl- deficiency before other mechanisms of protection can occur.
Alternatively, apoptosis and polyploidy could act at the same time helping to protect
Erccl- deficient livers.
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Polyploidisation is another response to Erccl deficiency in the liver. As a
consequence of the short survival ofErccl- deficient hepatocytes in vitro, the
development of polyploidisation could not be followed up in primary hepatocyte
cultures. In addition, polyploidisation was only apparent in some AdenoCre infected
Flox/Null animals where higher levels of octaploidy correlated with higher amounts
of cytoplasmic lipid accumulation 1 week after infection. This polyploidisation is a
rather striking finding given that recombination levels were found to be below 25%
in those livers. Polyploidisation was apparent in Erccl knockout livers from 10 days
of age where increased levels of tetraploidy became established. Small rises in
octaploidy were visible towards the maximum life span of the animals. These
findings underline the importance of polyploidisation as a mechanism of protection
in the liver. The difference in polyploidy patterns between complete Erccl knockout
livers and AdenoCre infected livers might be explained by the difference in age of
AdenoCre administration. The upregulation of IGFBP2, which regulates the
availability of IGF, in Erccl- deficient liver could be taken as a marker for
polyploidy status as IGFBP2 levels have previously been implicated with higher
polyploid status in hepatocyte nuclei (Pin et al. unpublished data). In addition, p21
mRNA was upregulated in Erccl- deficient livers. It has previously been suggested
that p21 is implicated in G2 arrest found in Erccl- deficient livers thereby helping to
establish polyploidisation in hepatocytes (Nunez et al. 2000, Chipchase et al. 2003).
Polyploidisation is most pronounced at later stages (3 week old) suggesting that there
is a greater requirement for this protective (but ultimately unsuccessful) mechanism
in the later stages ofErccl deficiency in mice.
Another common feature ofErccl- deficient livers is the accumulation of
cytoplasmic lipid. In older infected Erccl Flox/Null hepatocyte cultures this
accumulation of lipid becomes apparent in the form ofmicrovesicles in the
cytoplasm. Furthermore, after UV irradiation all hepatocyte cultures accumulate lipid
vesicles independent of genotypes. These vesicles disappear in infected Erccl
Flox/Wt and uninfected Erccl Flox/Null cultures with time. A similar pattern of lipid
accumulation was observed in Erccl- deficient livers and Wt littermates where
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macrovesicular lipid accumulation was evident in young livers. This lipid
accumulation persisted in Erccl Null livers with age, but a disappearance of lipid
was noted in Wt littermate controls. In 6 week old AdenoCre infected Flox/Null
livers, macrovesicular lipid accumulation was noted 1 week after infection and
disappeared 3 weeks after virus infection, possibly indicating clearance ofErccl-
deficient hepatocytes. In summary, lipid accumulation seems to be a feature caused
by DNA damage in the liver. Repair of damaged DNA leads to lipids being used
during mitochondrial oxidative pathways, but lipids persist where repair mechanisms
are disturbed. Hsia (2000) found a disruption of the outer mitochondrial membrane
suggesting that mitochondrial dysfunction, as an indirect consequence of loss of
Erccl, might be responsible for the cytoplasmic lipid accumulation observed. It
would be interesting to examine the mitochondrial membrane potential between
Erccl Null and Wt animals to clarify the relationship between mitochondrial
membrane damage and accumulated cytoplasmic lipid in more detail. This could be
done using a flow cytometry based assay and the JC-1 dye. This dyes changes from
mono- to polymers when changes in mitochondrial membrane potential are apparent.
Lipid accumulation seems to be an early response to loss ofErccl in the liver, even
appearing before polyploidisation occurs. Lipid accumulation was apparent in all our
models ofErccl deficiency. Therefore, a lack of polyploidy in vitro and in some
AdenoCre infected animals in vivo does not mean that different mechanisms are
operating in the different models.
Lipid accumulation in the liver was apparent in some patients undergoing oxaliplatin
treatment for ovarian cancer (D. Jodrell, personal communication). Differences in
ERCC1 status might be involved in the response to oxaliplatin treatment and the
increased side effects of the drug as manifested in lipid accumulation in the liver.
The outcome of the treatment might be predictable by determining ERCC1 status in
patients. In addition, our cell culture system could be used to compare the response
ofErccl- deficient hepatocytes to oxaliplatin treatment in more detail.
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A sudden increase in oxygen pressure at birth might be responsible for accumulation
of lipids in young animals independent of genotype. Higher levels of ROS and MDA
adducts in young Erccl- deficient livers could result from this sudden rise in oxygen
pressure with alternative mechanisms of repair becoming important at later stages of
Erccl deficiency. However, a rise in ROS and MDA level occurs in Wt livers with
age. In older Erccl Null mice, ROS and MDA levels are reduced when compared to
the Wt controls. This could be an indirect marker ofmalfunctioning liver metabolism
where high levels ofDNA damage start contributing to the liver failure observed in
Erccl Null mice toward their maximum life span. Indeed, increased levels of
albumin have previously been found in those mice pointing to malfunction of liver
metabolism (McWhir et al. 1993).
More and more evidence suggests an involvement ofERCC1 deregulation in cancer.
ERCC1 polymorphisms, although silent, have been associated with worse prognosis
of colon and ovarian cancer (Ford et al. 2000, Isla et al. 2004). Overexpression of
ERCC1 was also found in HCC (Fautrel et al. 2005). In addition, Erccl seems to
play a special role in the liver as response to loss is much more severe compared to
loss in for example skin. Therefore, more research will be needed to elucidate the
exact role ofErccl in the liver.
In general, conclusions drawn from a comparison of individual mice between the two
Erccl genotypes should be taken as an indication of possible molecular events only.
All our Erccl animals are on a mixed genetic background which can lead to variation
between individual animals of the same genotype, regardless of experimental setting.
In addition, the health status of the individual animal might be important as Erccl
Null animals can die before reaching their maximal life span of 3 weeks. Molecular
events in unhealthy animals are likely to differ from those obtained from healthy
mice. Gender differences have so far not been noted in our Erccl Null and Wt
animals but might play a role when comparing individual animals only. To overcome
these limitations, an increase in sample size would be necessary, comparing a
number of animals for each treatment and time point. Experiments could be better
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designed by reducing the amount of time points at which experiments are carried out.
In addition, one treatment, for example amount of virus given per animal, rather than
several different treatments will increase sample size and might help to elucidate the
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